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Abstract
Osseointegration is the process of de novo bone regeneration on the surface of an endosseous
titanium (Ti) implant in vivo. This neo formation of bone underlies the physical integration of a Ti
implant in bone at a level sufficient to restore loss of function; for example, of mastication due to
absent teeth. The outer atoms of a bulk of Ti metal form a stable and passive surface oxide layer
that serves as a substrate for the amalgamation of tissue reparative components, which entail the
formation of an osseous bond between tissue and fixture. This interaction was empirically
demonstrated to be highly affected by the characteristics of the surface an implant in experimental
studies querying the varied effects of additive or subtractive physical modifications, as well as
altered chemical compositions, of Ti implant surfaces on osseointegration. Subsequent clinical and
experimental practices have demonstrated that rough surfaced implants perform comparatively
‘better’ than their smooth surfaced counterparts by promoting bone growth on the fixture. Moreover,
a particular surface modification that yields high surface energy combined with a widely tested
micron scaled topographical roughness (modSLA) has been shown to further promote the timely
enhancement of osseointegration compared to its hydrophobic rough counterpart (SLA). The
biological mechanisms underlying this apparent enhancement of osseointegration by modified Ti
implant surfaces are still subject to intense study due to the materials’ implications in bone related
tissue engineering applications. Amongst the several views being opined is a proposition mainly
arising from in vitro experimentation, which suggests modified Ti implant surfaces possess an
‘intrinsic’ osteoinductive potential that affects uncommitted reparative cells by inducing a temporal
and magnitudinal enhancement in cellular differentiation and function; in turn, implying the early
formation of functional osteoblasts and bone tissue matrix in an in vivo scenario. The observations
of differential cellular behavior include the apparent modulation by the modified surfaces, of a cell
surface receptor tyrosine kinase Axl in human osteoblasts. The proposed role of the receptor in
negatively regulating osteogenic mineralisation in uncommitted pericytic cells suggests an
association with the altered response of cells to these substrates. The aim of this project was to
examine and test the hypothesised differential modulation of Axl in the responses of human marrow
derived mesenchymal stromal cells to modified Ti implant substrates.
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1 Introduction Bone Bone tissue
1
1 Introduction
1.1 Bone
1.1.1 Bone tissue
Bone or osseous tissue may be defined as an extracellular matrix composed of a scaffold of tri-
fibrillar collagen molecules with interspersed non-collagenous proteins and calcium phosphate
mineral (Hall, 2005). It is a hard connective tissue in vertebrates that in combination with vascular,
lymphatic, connective or nervous structures forms the organ, bone. A total of 213 different bones
combine to form the skeletal system of the human that constitutes ~ 18 % of the weight of an adult
body (Tortora and Derrickson, 2009a; Clarke, 2008). The anatomical aspects of a prototypic bone
are divisible into seven structural entities (illustrated in figure 1-1). Of these, the diaphysis,
epiphyses and metaphyses form the larger bone structure, with the articular cartilage and
periosteum occurring on the outside and, medullary cavity and endosteum within. These structural
entities occur in various relative proportions in the diverse range of bones that form the human
skeleton (Clarke, 2008).
Bone tissue is macroscopically organised into two distinct architectural forms. These are cortical
and cancellous that constitute 80 % and 20 % of the adult human skeleton, respectively (Clarke,
2008)(figure 1-2). The former is relatively dense and compact while the latter is spongy with a
‘honey comb’ of branching bars and/or plates called ‘trabeculae’ (Vassilios et al., 2001). The
architecture of cancellous bone accommodates a higher level of vascular tissue compared to
cortical bone, which nourishes bone marrow and its embedded populations of various stem cells
(Tortora and Derrickson, 2009a). Cortical and cancellous bones are chemically identical; roughly
estimated to comprise of 25 %, 25 % and 50 % of water, collagen fibres and crystallized mineral
salts, respectively. The predominant mineral salt is a combination of calcium phosphate and
calcium hydroxide, which combine with di-cations and carbonates to form the mineral half of bone
called hydroxyapatite (chemical formula: Ca5(PO4)3(OH)) (Tortora and Derrickson, 2009a).
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Figure 1-1 Macro-structural
Image shows a long bone (humerus, arm) with structural segments highlighted along a
descending vertical axis on the left hand side of image; and sub
transverse section on the right hand side. The centre diaphysis constitutes the hollow body.
It predominantly consists of cortical osseous. The epiphyses form the poles of a long bone.
They are cancellous, made of trabecular bone with relatively higher vasc
marrow content. The metaphyses are cartilaginous sub
that later turn to a calcified epiphyseal line at adulthood. Prior to this, the metaphyses
instigate longitudinal growth of a bone. The articular cartilage
cartilage covering the epiphyses. It occurs at articular joints to reduce friction between
adjoined bones during motion. The periosteum is an almost continuous bi
surrounding the external surface of bone except at
dense irregular fibrous connective tissue that mainly serves as a substrate for tendon and
ligament attachment. The inner osteogenic layer is highly vascularised and contains
osteogenic cells. The medullary cavity
The endosteum is a single cell layer membrane that lines the internal bone surface facing
the medullary cavity. Image taken with permission from
Bone
organisation of bone
-cortical structures of a
-epiphyseal zones of bone growth
is a thin layer of hyaline
joints. Its outer layer is composed of a
is the hollow cylindrical space within the diaphysis.
(Tortora and Derrickson, 2009a)
Bone tissue
2
ularisation and
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Figure 1-2 Micro-structural organisation of
Figure shows a cross section along the transverse and sagittal planes of a hypothetical
disaphyseal segment of
compact cortical bone in the
canal, resident blood and lymphatic vessels are surrounded by concentric rings of lamellae.
Spaces between lamellae are either lacunae (osteocyte sites) or emanating canaliculi,
indicated in the magnified representation on the upper right hand side are trabecular rods
that lamellae are arranged into.
bone indicating the irregular arrangement of lamellae.
from (Tortora and Derrickson,
Bone
bone
a bone. (a) The axis from right to left shows periosteum followed by
middle and spongy bone to the left. An osteon,
(b & c) Magnified views of the cross section
Figure re-produced with permission
2009a).
Bone tissue
3
Haversian
of trabecular
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The micro-architecture of cortical bone ascribes it a unique stiffness to sustain large forces
compared to cancellous bone. Cortical bone is composed of many repeating structural units called
osteons or Haversian systems (figure 1-2). Each osteon is essentially a cylinder with many internal
concentric rings encircling a central canal that averages 0.2 mm in diameter and 10 mm in length
(Clarke, 2008). The centre hollow canal of the osteon is the Haversian canal and may be occupied
by small blood vessels, nerves or a lymphatic vessel. This canal is surrounded by concentric layers
of mineralised extracellular matrix sheets called lamellae. In between the lamellae occur spaces
called lacunae. These spatial confinements contain the terminal state of the bone producing
osteoblast, called the osteocyte, which becomes entrapped in the ECM during osteogenesis.
Individual osteocytes are physically linked via intercellular filaments through cellular gap junctions,
radiating in all directions from lacunae occur in small channels called canaliculi, extending like a
network throughout cortical bone. Several osteons are separated from each other by interstitial
lamellae, and the collection of all osteons is encircled by circumferential lamellae that lie directly
beneath the periosteum. This arrangement of osteons is not present in cancellous bone. Instead,
lamellae are arranged in an irregular concentric manner to form beams or rods, the spatial
arrangement of which gives it the spongy macroscopic appearance. Blood vessels, nerves and
lymphatic channels diffuse from the periosteum into bone through the transverse perforating
Volkmann’s canals. These connect with equivalent structures in the Haversian canals or in the
medullary cavity to form a closed circulatory circuit (Sikavitsas et al., 2001; Tortora and Derrickson,
2009a).
The collection of ‘cranio-facial’ bones, which are of interest to this study, are fourteen in number:
these include two nasal bones, two maxillae, two zygomatic bones, the mandible, two lacrimal
bones, two palatine bones, two inferior nasal conchae, and the vomer (Tortora and Derrickson,
2009b). These bones vary in structure in the ratios of cortical to cancellous bone, which clinical
dentistry has classified in to four types based on radiographic appearance and resistance to
surgical drilling (Lekholm et al., 1985). Type 1 is homogenous compact cortical bone that occurs in
relative majority in the anterior mandible and maxillae. The other types consist of varying ratios of
cortical to cancellous bone, and occur mainly towards the posterior of jaw, primarily of the maxillae.
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Type 2 consists of a thick layer of cortical bone surrounding a core of dense cancellous. Type 3
consists of a thin layer of cortical bone around dense cancellous. Type 4 consists of a thin layer of
cortical bone surrounding a core of low density cancellous. In general, type 1 occurs predominantly
in the anterior portion of the jaw, and transitions through types 2 and 3 to type 4 towards the
posterior (Lekholm et al. 1985).
The physiological functions of bone can be roughly categorised into mechanical, synthetic and
metabolic (Clarke, 2008). Bone provides shape and protection to inner organs and in combination
with muscular activity creates movement. The skull bone is further endowed with the reception and
transmission of sound waves through a process called ‘bone conduction’ (Stenfelt, 2011). From the
synthetic perspective, it serves as a life-long reservoir of progenitor cells that form blood and
mesenchymal tissues (De Silva Merielles, 2008). The metabolic aspects are several but primarily
pertain to the maintenance of calcium and phosphorus levels in blood. Interplay between paracrine
hormonal feedback loops of the parathyroid hormone and thyroid-secreted calcitonin, strive to
maintain plasma calcium ion concentrations within the homeostatic range of 9 and 11 mg / 100 ml
by instructing the absorption or release of ions through osteogenesis or bone remodeling,
respectively (Tortora and Derrickson, 2009a). In addition, bone also has been considered to have
endocrine function through fibroblast growth factor 23 and osteocalcin (OC), which are suggested to
have a role in the regulation of serum calcium and phosphorus levels (Fukumoto and Martin, 2009).
1.1.2 Ontogeny
The process of osseous tissue formation is called osteogenesis or ossification (Gilbert, 2000;
Shapiro, 2008). This occurs in four discreet scenarios: embryonic bone formation, post natal bone
development, bone remodeling and fracture repair (Dimitriou et al., 2005). It may additionally take
place in the form of ectopic bone formation in certain pathological states such as vascular
calcification (Vattikut and Towler, 2004), as well as in a de novo form on the surface of endosseous
implants.
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1.1.2.1 Embryonic bone development
The process of osteogenesis is initiated in the embryo. Fetal bone is derived from the paraxial
mesoderm. Three distinct lineages of embryonic cells generate different segments of the osseous
skeletal assembly. The somites form the axial skeleton, lateral plate mesoderm the limb skeleton,
and the cranial neural tube form the branchial and cranio-facial bones (Gilbert, 2000; Clarke, 2008;
Chung et al., 2004).
Fetal bone development initiates from embryonic mesenchymal stem cells in two distinct modes;
intramembranous and endochondral ossifications (Mackie et al., 2011; Shapiro, 2008). The former
underlies the formation of bones of the skull and mandible while the latter concerns formation of the
limbs and axial skeleton. In intramembranous osteogenesis, neural crest derived mesenchymal
cells proliferate and condense into sheets that form compact nodules. These form either blood
capillaries or osteoblasts. The osteoblasts form an ‘ossification’ centre and secrete osteoid, a
collagen rich calcium-nucleating proteoglycan matrix, eventually becoming entrapped within it as
‘osteocytes’ (Clarke, 2008). The osteoid serves as a high affinity platform for the deposition of
calcium mineral salts, which calcify the osteoid to form ‘woven bone’. This type of bone is
characterised by irregularly orientated collagen fibrils, large space between fibrils and vascular
structures, and low mineral quantity that confer low mechanical integrity to the skeleton (Chung et
al., 2004; Sikavitsas et al., 2001). The mesenchymal precursors at the periphery form the
periosteum over these bones (Gilbert, 2000; Shapiro, 2008).
The process of endochondral ossification forms the vertebral column, pelvis and limb bones. It
comprises bone formation through an endochondral intermediary in a process that takes place over
five steps. It initiates with the aggregation of mesenchymal precursors in the shape of prospective
bones and their commitment to a chondrocytic lineage by the action of lineage specific transcription
factors (Mackie et al., 2011). This is followed by the cells compaction to dense nodules and
differentiation to terminal chondrocytes. This pre-cartilaginous stage is characterised by the
downregulation of expression of the SOX9 transcription factor, believed to signify the transition from
chondro- to osteo- genesis (Hattori et al., 2010). In the third phase, differentiated chondrocytes
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divide and secrete hyaline cartilage forming a framework referred to as the cartilage model. The
chondrocytes continually proliferate and secrete ECM molecules to advance the interstitial growth of
the cartilage model, as well as outer peripheral cartilage formation through appositional growth
originating from an embryonic structure called perichondrium. These cells later cease replication in
the fourth stage and turn into large hypertrophic chondrocytes, which secrete collagen type X and
fibronectin to enable mineralisation (Shapiro, 2008; Mackie et al., 2011).
Hypertrophic chondrocytes in the centre of the developing organ die by apoptosis due to the lack of
nutrient supply(Mackie et al., 2011). Their apoptosis forms empty lacunae that fuse to form small
cavities. In the fifth stage, angiogenesis causes the generation of new osteoblasts in the middle and
peripheral zones of the model, which instigate the continual replacement of cartilage with osseous
(Clarke, 2008). In combination with the small cavities, the osteoblasts lead to form a trabecular
matrix within the developing organ while peripherally replacing the perichondrium with the cortical
osseous generating periosteum (Gilbert, 2000; Tortora and Derrickson, 2009a; Chung et al., 2004).
1.1.2.2 Post natal bone development
The epiphyseal plate is a layer of hyaline cartilage with chondrocytes. It underpins the increase in
post-natal bone length through the interstitial growth of cartilage and its replacement with osseous
on the disaphyseal side of the plate via endochondral ossification (Shapiro, 2008). The periosteum
increases bone thickness by forming osteoblasts that deposit osseous on the periphery of the organ
(Tortora and Derrickson, 2009a; Clarke, 2008).
Bone is continually ‘recycled’ through the tightly regulated process of remodeling through which
initially laid woven bone is converted to a stronger lamellar bone (Sikavitsas et al., 2001). This is a
synergistic process, mediated by hormonal feedback loops that involves bone resorption by the
osteoclast and formation in layers by osteoblasts (Clarke, 2008). The dynamics of this process
differs in different regions of the skeleton and with age. It is highest in regions of high density of
cancellous bone, presumably to accommodate change in incurred forces by the sensitive tissue
type, and during post fetal to early youth (Sikavitsas et al., 2001).
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Combinations of the three primary parts of bone development occur during all forms of bone
fracture healing, which has been grouped into primary and secondary based on the type of
ossification (Dimitriou et al., 2005; Fazzalari, 2011). Primary fracture healing occurs exclusively in
cortical bone and is mediated by the periosteum. This is similar to intramembranous ossification
with the exception of the membrane sheets being replaced in this instance with layers osteoblasts
covering all edges of the fracture and striving to regenerate osseous continuity in the organ. The
secondary form of bone healing, which mainly occurs in long bone fractures, is a combination of
endochondral and intramembranous ossification that involves the formation of a semi-cartilagenous
intermediate and its resulting transformation into a hard callus (Dimitriou et al., 2005).
Bone formation may additionally take place in pathological instances as ectopic ossification in
tissues other than bone. This has been recorded, for example, in fibrodysplasia ossificans
progressiva (FOP) (Shore et al., 2006) and related muscular calcifications, as well as in instances of
vascular calcification (Johnson et al., 2006). These pathological states represent situations that
entail the formation of bone with related marrow and vascular components in soft tissues such as
muscle, tendon, and cardio-vascular system (Chen et al., 2008). A further case, which is the subject
of this study, is the formation of bone on the surface of endosseous dental implants leading to their
stable integration. This has been proposed to represent a de novo form of osteogenesis (Davies,
2003).
1.1.3 Cells
Bone contains an array of different cell types. These include non-osseous cells, such as vascular,
nervous and immune cells, and osseous specific cells: marrow stroma, osteoblasts, osteocytes and
osteoclasts. The latter maintain the physiological integrity of the skeletal system through life (Aubin,
2001). The marrow stroma resides in vascular rich cancellous bone. These are reticular stromal
connective tissue cells that sequester adult stem cells (Aubin, 2001). Two types of stem cells are
believed to occur within bone marrow stoma; the hematopoietic and mesenchymal stem cells. The
former gives rise to blood progenitor cells while the latter is believed to instigate the lifelong
replenishment of mesenchymal tissue precursors. The osteoblasts and osteocytes are bone
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generative cells that represent two different stages in the life cycle of the same cell type, while
osteoclasts are bone degenerative cells originating from monocytes (Fujita and Janz, 2007).
The osteoblast originates from an adult mesenchymal stem cell (MSC) through the tightly regulated
sequential process of osteogenic differentiation (Marie, 2008). This is a complex molecular process,
believed to surround a key axis involving Wnt/β-catenin positive signaling, which modulates bone 
morphogenic protein type 2 (BMP2), p53, osterix and alkaline phosphatase axis (Fujita and Janz,
2007). The induction of this axis entails a sequence of cellular ‘transformations’, in which an MSC
initially commits to a pre-osteoblastic progenitor phase characterised by the expression of collagen
type 1, osteonectin and alkaline phosphatase with high cell proliferation rates (AR Guntur and CJ
Rosen, 2011; Shapiro, 2008). This state leads to the pre-mature phase of a functional osteoblast
that produces osteoid tissue. Osteoid formation is divisible into two phases; collagen matrix
elaboration, and pre-calcification assembly (Clarke, 2008). Initially collagen fibril subunits are
translated and secreted by the cells into the ECM where they align and polymerise to form a fibrillar
collagenous scaffold. The cells produce Alkaline phosphatase and matrix components including
bone sialoproteins (types 1 and 2), and Osteocalcin amongst the many. In the pre-mineralisation
phase of a maturing osteoblast, these components are secreted by means of budding cytoplasmic-
membrane vesicles (50 – 200 nm size) that attach at points in the osteoid to form calcium
nucleation sites (Sikavitsas et al., 2001). In the matrix bound vesicles, Ca2+ ions and inorganic
phosphate are combined to form ‘octa-calcium phosphate’, which then penetrates the vesicle
membrane, and combines with the highly osteogenic microenvironment to grow into hydroxylapatite
(Anderson et al., 2005; Chen et al., 2008). This molecular interplay accommodates two modes of
osteogenic extracellular matrix mineralization, which initiates with homogeneous mineralization of
calcium nucleation mediated by non-collagenous calcium binding (sialo) proteins and later through
calcium ions in the environment via heterogeneous mineralization (Shapiro, 2008; Sikavitsas et al.,
2001). The mature osteoblast co-secretes several different factors (Clarke, 2008), but of importance
are the soluble osteoclastogenic inhibitory factors that determine the balance between bone
formation and resorption Two important ones being osteoprotegrin (OPG, pseudo-receptor for
Receptor Activator of Nuclear Kappa Ligand (RANKL)) and growth differentiation factor 15 (GDF-
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15) (Caetano-Lopes et al., 2007). The former (OPG) binds RANKL expressed on the surface of
osteoblasts, preventing its interaction with its cognate receptor RANK, a cell surface molecule
expressed on monocyte-macrophage lineage cells (Takahashi et al., 2011). The mature osteoblast
would be later faced with a probability of further maturing to the terminal form of an osteocyte,
estimated to be achieved by 20 percent of cells while 80 percent perish by apoptosis. The
osteocytes are characterised by their cellular processes traversing in all directions, from lacunae to
lacunae, forming a network of what many regard as a bone sensory systems that regulates the
larger part of bone physiology by sensing changes in physiological levels of calcium or hormones,
as well as enacting as a ‘mechanosensor’; transducing mechanical forces felt from the external
environment to an instigated biological response (Sikavitsas et al. 2001).
The osteoclast undertakes bone resorption. It originates from the fusion of hematopoietic monocytic
cell populations through the effects of macrophage-colony stimulating factor (M-CSF) and ligand of
receptor activator of nuclear factor kappa B (RANKL), eventually taking the form of a multinucleated
bipolar cell with a high quantity of mitochondria and lysosomes (Novack and Teitelbaum, 2008).
This process is negatively regulated by a ligand to RANKL called osteoprotegrin (OPG). The dorsal
face of the cell in contact with bone is ruffled with emanating cellular processes. It overlies a bone
resorption pit, enclosed on all ends by sealing zones. An osteoclast resorbs bone by secreting
hydrogen ions into the pit, thus reducing the pH and then secreting acidic enzymes that extract the
calcium phosphate crystals first and then digest the organic phase(Novack and Teitelbaum, 2008).
The resulting ions and protein fragments are endocytosed and released into the extracellular fluid
through the ventral side of the cell (Sikavitsas et al., 2001).
1.2 Osseointegration
1.2.1 Discovery
Per Ingvar Branemark coined the term osseointegration to define the phenomenon of titanium (Ti)
metal integration in living bone tissue. The observations leading to this discovery were made in vital
microscopy experiments performed in the early1950s aimed at examining bone repair and
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microvascularisation in rabbits (Branemark, 1983). A vital microscope is an optical device that
consists of a metallic chamber housing an objective lens. The device would be implanted
transdermally with the objective set over a site of interest. Visual examinations in situ in real time
would be conducted by mounting the implanted device to a specialised microscope (Branemark et
al., 1964).
The early designs of vital microscopes relied on incident and reflected light, and were restricted in
application to capillary beds in the ears and eyes of subject animals. For his purpose, Branemark
used a modified design vital microscope, in which the metal chamber was made from Ti metal, and
transillumination was used as a source of light. The choice of Ti was largely based on the metal’s
known corrosion resistive properties considered capable of withstanding the variable in vivo
environment, as well as its large scale availability due to the developing air industry of that time (Ulf
Bagge, 1989).
The Branemark chamber would be implanted in vivo, supported by appendages screwed into bone,
with the lens placed over a site of interest comprising cortical bone ground to a thickness of ~ 10 -
20 um with respect to the underlying marrow. This allowed the visualisation of bone
microvasculature and marrow, and their inter-relationship in tissue repair (Branemark and Harders,
1963). When retrieving the devices, Branemark and colleagues noticed host bone to have grown
into spaces present on the Ti devices rendering them ‘inseparably incorporated’ in living bone
tissue (Branemark et al., 1969). This observation was followed by a series of successful
experiments in animals, and trials in humans with screw shaped Ti fixtures for edentulism (lack of
teeth). These successful attempts led Branemark, and a Swiss scientist named A Schroeder, to
present clinical and histological evidence, respectively, to the concept of intra-osseous integration
of Ti implants (Branemark et al., 1977); (Branemark, 2005).
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1.2.2 Definition
1.2.2.1 Present working definitions
Osseointegration does not have one single definition. It has been variably defined by different
observers, using different scientific methods and scales. These have predominantly included long-
term clinical trials, evaluation of implant-bone interfacial mechanical parameters, and histological &
morphological details of the bone-implant interface (Santos et al., 2002).
The initial definition provided by Branemark following a 10 year review of screw shaped Ti dental
implants in humans was that it is a system of implanting a Ti made screw shaped device in bone to
form a ‘direct structural and functional connection between living tissue and the surface of the
implant’ (Branemark et al., 1977). This definition was modified to include a mechanical evaluation of
healing that considered osseointegration to have occurred if there was no progressive relative
motion between the fixture and surrounding living bone and marrow under functional levels i.e. oral
movements, such as mastication, in a ‘load bearing condition’ (carrying an artificial tooth)
(Branemark, 2005). Histological and microscopic examinations further defined it as the state
attained by clinically successful implant devices, characterised by ‘the close apposition of new and
reformed bone with (an implanted) fixture that at the light microscopic level has no intervening
connective or fibrous tissue’ (Branemark, 2005; Santos et al., 2002).
1.2.2.2 Limitations of definitions
These attempts at defining the phenomenon presented a ‘consequent’ view of clinically scaled
osseointegration; i.e. measurements of variables in successful cases of implantation. This state of
success had been known very early to be a function of a multitude of factors, which primarily
include (i) host bone variables; (ii) site of implantation; (iii) competence of surgical procedure; (iv)
implant material; (v) implant design and finish; (vi) implant loading time and conditions; and (vi) host
hygiene (Albrektsson et al., 1981; Wennerberg and Albrektsson, 2009; McNutt and Chou, 2003) .
This apparent lack of a ‘true’ perspective of this process partly underlies the inexplicable state of
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implant failure (Santos et al., 2002); the other reason is the incredible variability between studies
and specimen, preventing any collective inference (Wennerberg and Albrektsson, 2009).
Take the following for example: a failed outcome is reported to be relatively higher for the posterior
than anterior maxillae (Tinsley et al., 1999) suggesting that an implant that may be retained well in
the anterior mandible (reported >90% success rate) may not perform in a comparable manner in the
posterior maxilla (reported 35% success rate) of the same patient (McNutt and Chou, 2003).These
anatomical sites differ in the ratio of cortical to trabecular bone, (ironically) based on a classification
derived to counter the tissue related factor of implant failure by providing a reference for evaluating
implant sites (Lekholm et al., 1985). The multi-factorial variability of the possible outcomes of this
process bears an obvious burden: with all lateral aspects aside, what is osseointegration?
1.2.2.3 Biological perspective
The biological events constituting osseointegration are not fully known (Brett PM et al., 2004; Wall
et al., 2009; Raghavendra et al., 2005). This is largely due to the widely acknowledged
effectiveness of dental implants that are applied in a relatively larger proportion to single tooth
replacements, thus negating the incentive to oppose general ethical standards for intrusive study of
its complexities in living organisms. But also due to the relative higher interest in the commercial
status of working endosseous implants compared to the work the implant conducts in vivo. A
derivative of this fact is the lack of consensus on implant design parameters, evaluation methods
and efficacy studies (Wennerberg and Albrektsson, 2009).
A biologic perspective may consider osseointegration synonymous to a novel form of wound
healing, which combines primary or cortical bone-fracture healing with de novo bone regeneration,
to form an osseous continuity between implant and tissue (Marco et al., 2005);(Dimitriou et al.,
2005; Davies, 2003; Davies, 2007). Systemic in nature, it is suggested to initiate with the
recruitment of tissue reparative elements to the bone-implant interface, where a synergy between
the ‘response of the host to the implant and behavior of the biomaterial in vivo’ determines the
outcome of the process (Puelo and Nanci, 1999).
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1.2.3 Biological paradigm of osseointegration
A model depicting the process of osseointegration has been drawn from histological and ultra-
structural studies of Ti implants retrieved from animal and human sources. It proposes a tandem
sequence of in vivo events instigated systemically in bone tissue in response to implant placement.
These are osteoinduction, osteoconduction and bone remodeling (Davies, 2003; Davies, 2007;
Davies, 1998; Albrektsson and Johansson, 2001). Osteoinduction is the initial event constituting the
migration of tissue progenitor cells to the implant surface and their attachment, proliferation and
subsequent differentiation on the substrate. It is followed by osteoconduction, which is the formation
of woven bone at the bone-implant interface leading to an osseous union between implant and
adjacent tissue. Osteoconduction is further divided to (i) contact osteogenesis, the de novo bone
formation on the surface of the implant, and (ii) distance osteogenesis, the formation of bone on the
surface of old bone apposing the implant. These steps occur within the initial stages of implant
placement, in parallel to processes constituting normal tissue repair (such as angiogenesis; debris
clearance; immunity). They are followed at a later stage of healing by physiological bone
remodeling, an osteoclast and osteoblast mediated replacement of the woven osseous continuity
with structurally robust lamellar bone over the course of time.
1.2.4 Practicality of biological paradigm
The biological paradigm of osseointegration is described below in a hypothetical scenario of the
placement of a cpTi root form endosseous dental implant into an anterior mandibular bone site,
assuming a controlled surgical process, good patient health, bone tissue variables and a smooth Ti
implant surface. An endosseous implant is commonly a screw shaped threaded cylindrical object
(figure 1-3). It is placed in the alveolar ridge of jaw bone where it remains submerged under the oral
mucosa till the point of being loaded with an abutment. It is inserted in bone by surgically drilling a
cavity transcending only one cortical plate. The implant is generally of a diameter slightly wider than
that of the cavity, and upon insertion through a ‘screwing’ process, laterally displaces cortical bone
to form a tight junction. This effect is called press-fit. It causes compaction and circumferential
necrosis of bone in a region 0.1 mm from implant surface, laterally extending 2/3rd of the length of
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The haematoma forms in the space at the bone implant interface from blood being discharged from
severed vessels. Small molecules such as water, ions and serum proteins adsorb the electro-
statically negative surface of the implant, saturating it almost instantaneously. In the mean time,
platelets amass at the implant site and attach to the implant surface through Von Willebrand factor,
and RGD (Arginine-Glycine-Aspartic acid) motif containing implant adsorbed proteins (Lindhe et al.,
2000). Platelets initiate a coagulation cascade, releasing factors and cytokines (platelet-derived
growth factor and Transforming growth factor-beta), which form a positive feedback loop, further
recruiting & activating platelets as well as inflammatory and uncommitted cells (Lindhe et al., 2000).
Subsequently, a fibrin clot is formed at the interface that stabilises by three days post implantation
(Davies, 2003) (Raghavendra et al., 2005).
It is in these initial three days that angiogenesis is initiated from the ends of sheared vessels
emanating from proximally displaced trabecular bone and marrow. This transforms the stable fibrin
clot into a highly vascularised ‘Granulation’ tissue, which persists for a period of three weeks post
implantation (Lindhe et al., 2000). Un-differentiated adult stem cells recruited to the wound are
believed to use this fibrin meshwork to reach the implant surface (Davies, 2003), where
overwhelming differentiation cues induce their osteogenic commitment and osteoprogenitor
proliferation, eventually forming osteoblasts that deposit mineralised matrix on the implant surface.
This phase of progenitor cell migration to the surface of the implant and osteoblastic differentiation
constitutes osteoinduction while that of mineralized bone deposition is osteoconduction
(Albrektsson and Johansson, 2001).
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the deposition of layers of osteoid (collagen and associated proteins) that later mineralise to
osseous. This process is called contact osteogenesis while that occurring on the opposing bone
surface, which is reminiscent to primary bone healing, is termed distance osteogenesis (Davies,
2007; Dimitriou et al., 2005). The initial type of bone formed during osteoconduction is woven bone
that is composed of loosely packed collagen fibrils lacking an ordered spatial arrangement with low
mineral density. Woven bone formation continues till two months, during which it is progressively
replaced by lamellar bone through the osteoclast mediated remodeling of bone. This subsequently
leads to complete healing by six months post implantation that is clinically scaled as a fixture with
lack of relative motion with reference to surrounding bone and radiographic lack of intervening soft
tissues at the bone - implant interface (Sakka and Coulthard, 2011; Marco et al., 2005). It is after
such an assessment that an abutment and artificial tooth are loaded to restore masticatory function.
Osseointegration can only happen due to the presence of de novo bone regeneration on the
implant surface during contact osteogenesis. In an adult organism, osseous tissue, particularly from
the cranio-facial region, is reformed by osteoblasts on pre-existing bone largely through the process
of primary cortical wound healing, in which adjacent ends of a fractured bone re-establish osseous
continuity through intramembranous ossification (Dimitriou et al., 2005). However, in contact
osteogenesis, osseous formation is initiated on an inanimate metallic surface, and to an extent that
the continuity formed is sufficient to withstand strong forces of jaw motion without major impediment
to host tissue.
1.3 Implant surface modifications
1.3.1 Titanium biocompatibility
Biocompatibility is a contextual term that generally defines a material’s ability, due to its inherent
physical and chemical properties as well as commercial viability, to perform with an appropriate
response in a specific application (Brunette et al., 2000). The high probability of integration of Ti
metal to bone was an important discovery at that time as prior metal implants had predominantly led
to ‘fibrous-integration’, i.e. the encapsulation of a metallic implant by a fibrous ECM. The occurrence
of fibrous tissue at the material-tissue interface was considered to be recognition and rejection of
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the metal by the body, as the nature of this soft tissue was incapable of providing adequate
integration and functionality to the implant (Santos et al., 2002). Indeed, it was the widespread
occurrence of fibrous-integration that led to the initial skepticism surrounding osseointegration when
it was first discovered, and remained until after a decade of clinical trials and innovative
experimental findings were presented. Osseointegration highlighted Ti, and its properties attributing
‘biocompatibility’ with bone were studied.
From the physical perspective, Ti metal has an inherently low modulus of elasticity and low stiffness
that render it ideal to receive mechanical forces, and distribute them across to surrounding bone,
hence permitting the functional replacement of a missing tooth (Liu et al., 2004). However, the
primary factor considered to underpin the biocompatibility of Ti metal is the chemical nature of its
‘native’ surface oxide layer. Ti is a transition element and is highly reactive in an elemental state,
spontaneously forming a stable ~ 3 - 7 nm thick oxide layer on the surface. This layer is credited to
impart the metal with corrosion and ion-leaching resistance, biological inertness (non-immunogenic)
and the observed potential to assimilate with bone compared to other metals (Brunette et al., 2000;
Marco et al., 2005). The oxide layer enacts as a barrier by encasing the elemental reactive and
toxic bulk from the bio-chemically variable in vivo environment, but more importantly serves as an
organic substrate that is recognised as self by the body’s tissue-reparative apparatus, and which
leads to the amalgamation of molecules, cells and eventually bone (Liu et al., 2004). The assembly
of this apparatus is stepwise, in which protein adhere and saturate the implant surface, making way
for adhesive interactions between the cell and newly-conditioned substrate (Puelo and Nanci,
1999). Verily, it is this interaction, as stated in 1.2.2.3, which largely determines the outcome.
1.3.2 Implant failure to surface modification
The terms implant success and failure that are applied to assess the presence or absence of
osseointegration, respectively, have been deemed obscure (Santos et al., 2002). Their ambiguity
stems from the lack of a true characterisation of osseointegration but also from the high variability in
the designs and criteria applied to examine implant efficacy from study to study (Wennerberg and
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Albrektsson, 2009). Appropriate histological and microscopic methods developed towards the late
1970s to evaluate the bone implant interface indicated the presence of fibrous tissue that
encompassed 60-70 percent of the implant surface compared to 25-30 % of bone implant contact
(BIC) (Schwartz et al., 1999). Though the relative little BIC was found to provide adequate
biocompatibility in the short term, complicated by the series of variables linked with implant
integration, an endemic rate of ~ 10 to 30 % failure were attached with mandibular and maxillary
implants, respectively, in the long term (McNutt and Chou, 2003).
Attempts to overcome the endemic of implant failure led to the empirical alteration of implant
surface characteristics in early and mid 1980s (Schwartz et al., 1999). A surface is a physical
aspect of matter comprising the outermost layer of atoms of the bulk of an object or medium that
interacts with that of another material bulk (Brunette et al., 2000). In Ti implants, the surface forms
the larger part of the implant in contact with living tissue. The importance of implant surfaces in
osseointegration led to a set of physical and chemical parameters being applied to define it
(Brunette et al., 2000) . These parameters are tabulated in table 1-1.
Table 1-1 Properties of an implant surface
Primary physical-chemical properties of an implant surface. Adapted from (Brunette et al.,
2000)
Surface
Characteristic
Definition
Chemical
Composition
Measure of the types, electrochemical states and assemblies of various atoms
and chemical moieties present on surface.
Chemical
Structure/Order
Measure of the spatial orientation & arrangement of chemical moieties present on
the surface.
Topography Physical texture or landscape in terms of pits waves, peaks, pores and undulation.
Surface Energy Measure of the electrochemical kinetics of the surface. It includes the quantitative
measurement of adsorption of bio-molecules, wettability/contact angle of liquid
(polar vs. non-polar) & surface energy
Mechanical
Properties
An estimate of the mechanical elasticity and contractility of the surface forming
atomic layers
Surface Dynamics Mobility of atoms across and along a surface. It is influenced major by physical
properties of the metal.
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The surface characteristics of Ti implants that have undergone substantial modification over the
past two decades are surface topography and surface energy. Chemical composition has been
altered and tested in various scenarios but shown to be inferior in the long run compared with nude
Ti (Liu et al., 2004).
1.3.3 Topographical modifications
Surface topography is a physical measure indicative of the spatial configuration / geometric
landscape or architecture of a substrate. It is a term that is difficult to define as it encompasses
physical and chemical interactions between at least two entities, and will inadvertently be different
from material to material and the prospective application (Assender et al., 2012). The significance of
topography in directing cell fate was first reported by 1911 by R.G.Harrison who noted the
movement of embryonic cells on spider web fibers holding a piece of neural tube tissue (Harrison,
1911). This phenomenon was termed contact guidance in 1934 by Paul Weiss, who later
hypothesised this movement to be controlled and under the guidance of adsorbed proteins (Curtis
and Wilkinson, 1998).
In the case of Ti, modifications and testing over the years, arising mainly from the
acknowledgement of the importance of surface characteristics on osseointegration (Albrektsson et
al., 1981), led to two levels of surface topographical modifications for endosseous implant design;
micro and nano metric scaled topographical modifications. Micro topography is the measure of
physical landscape of a surface within the dimensional range of 1 - 10 µm along a vertical axis from
a mean surface plane. It is characterised by textural features such as pits, peaks, pores &
waviness. Nano topography, on the other hand, is a physico- chemical measure of the geometric
landscape of a surface within a spatial dimensional range of 1 - 100 nm (10 to 1000 Ǻ, angstrom) 
from a mean plane. At this spatial range, physical features influence chemical forces emanating
from surface constituent atoms and molecules, which inadvertently alter surface energy. Surface
energy, though influenced by topography, is strictly a chemical variable that increases the surface’s
electrostatic negativity and apolarisation to water; rendering it wettable and highly hydrophilic. This
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parameter is determined by measuring the ‘contact angle’ between a water droplet and a surface
that reflects the ratio of adhesive forces between surface - water and cohesive forces between
water - water molecules: the higher the adhesive than cohesive forces, the smaller the contact
angle and more ‘hydrophilic’ a substrate, and vice versa (Liu et al., 2004; Brunette et al., 2000;
Guehennec et al., 2007).
Micro and nano topographical modifications are created by treatment methods in an additive or
subtractive manner with respect to a reference polished surface. Table 1-2 lists the common
methods used to modify Ti dental implant surfaces. Among these, the subtractive treatment of
blasting a surface with solid particles and ‘pickling’ it in a solution of strong acids has shown to
introduce topographical characteristics that render a Ti implant with comparatively better contact
with bone and anchorage relative to plane polished surfaces in vivo (Buser et al., 1991; Gotfredsen
et al., 1995; Wannerberg et al., 1996).
A surface treatment that has become an industrial standard is the SLA surface prepared by
Straumann AG (Waldenburg, Switzerland). SLA is an acronym for sand blasted large grit acid
etched. This substrate is generated by blasting a plane Ti surface with large alumina particles of ~
250 µm in diameter with compressed air, and then ‘attacking’ the surface oxide layer with acidic
treatment in HCl / H2SO4, followed by multiple rinses in distilled water (Rupp et al., 2006). This
treatment yields a surface of the appearance of osteoclast resorbed bone and gives it a mean
roughness value (Ra: arithmetic mean of the absolute height of all points in a surface profile) of 4.12
µm along the z-axis, in comparison to 0.03 µm of the plane polished Ti surface. An SEM micrograph
of a polished and its derived SLA surface are shown in figure 1-5. The rough surfaces, though
different in their potentials to adsorb water, have the same topography. An easy way to describe
their roughness is as a surface resorbed by osteoclasts, with large craters formed by the blasting of
alumina particles, superimposed by many tiny ‘crypt’ like indentations formed by acid etching that
collectively yield a highly uneven topography (Ferguson et al., 2006; Rupp et al., 2006).
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Table 1-2 Overview of surface modification for titanium Implants
Table from (Liu et al., 2004)
Surface modification methods Modified layer Objective
Mechanical methods
Machining Rough or smooth surfaces
formed by subtraction
process
Produce specific surface
topographies; clean and roughnen
surface; improve adhesion in bonding
Grinding
Polishing
Blasting
Chemical methods
Chemical treatment
Acidic treatment <10 nm of surface oxide layer Remove oxide scales and
contamination
Alkaline treatment ~ 1 μm of sodium titanate gel Improve biocompatibility, bioactivity or 
bone conductivity
Hydrogen peroxide ~ 5 nm of dense inner oxide
and porous outer layer
Improve biocompatibility, bioactivity or
bone conductivity
Sol-gel ~ 10 μm of thin film, such as 
calcium phosphate, Ti-oxide
and silica
Anodic oxidation 10 nm to 40 nm of TiO2 layer,
adsorption and incorporation
of electrolyte anions
Produce specific surface improved
corrosion resistance; topographies;
biocompatibility, bioactivity or bone
conductivity
Biochemical methods Modiﬁcation through silanized 
titania,
photochemistry, self-
assembled monolayers,
protein-resistance, etc.
Induce speciﬁc cell and tissue 
response
by means of surface-immobilized
peptides, proteins, or growth factors
Physical methods
Thermal spray
Flame spray
Plasma spray
HVOF
DGUN
~30 to ~200 µm of coatings,
such as
titanium, HA, calcium silicate,
Al2O3, ZrO2, TiO2
Improve wear resistance, corrosion
resistance and biological properties
Plasma Vapour Deposition
Evaporation
Ion plating
Sputtering
~1 nm of TiN, TiC, TiCN,
diamond and
diamond-like carbon thin ﬁlm 
Improve wear resistance, corrosion
resistance and blood compatibility
Ion implantation and deposition ~10 nm of surface modiﬁed 
layer and/or
     implantation 1μm of thin 
ﬁlm 
Modify surface composition; improve
wear, corrosion resistance, and
biocompatibilityBeam line ion implantation
Glow discharge plasma
treatment
~1 nm to ~100 nm of surface
modiﬁed layer 
Clean, sterilize, oxide, nitride surface;
remove native oxide layer
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Figure 1-5 Surface modifications of Ti implants
Images are scanning electron micrographs of Ti discs used in this study. Non
Ti discs of 15 mm diameter, with one side bearing a fabrication of the original implant
modification, were taken at x10
while the right is of an SLA rough hydrophobic surface. The modSLA is identical to the SLA
and hence not shown. The P surface has a mean R
μm.    
The SLA preparatory method inadvertently
surface that have the potential to alter surface energy
topographical features, yielded on every SLA surface, are normally masked by atmospheric
contaminants that adsorb the substrate upon exposure to air
the preparatory method to exclude
adsorbing it. This is achieved in the case of ‘modified SLA’ (modSLA), prepared just as SLA but
being rinsed in an N2 atmosphere rather
in water, pH=4-6 (Rupp et al., 2006)
large quantity of hydroxyl ions retained
2006; Zhao et al., 2007). These hydroxyl ions greatly increase the
energy, rendering it hydrophilic as assessed by a dynamic water contact angle analysis
analysis, an object of length ‘
In this process, the angle at
surface is measured. A large angle between the surface of the material and line of liquid represents
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00 magnification. The left image is of a polished Ti surface
a of < 0.5 μm. The SLA has a R
introduces nano-topographical features on an implant
(Mendonca G et al., 2008)
but can be ‘unmasked’ by modifying
atmospheric contact of surface and prevent
than air and securely stored in an isotonic
. By preventing contamination, the modSLA
on the surface oxide compared to an
modSLA substrate’s
l’ is immersed and the emersed in a liquid of a certain surface tension
which the liquid advances or recedes with respect to the material
of modified Ti surfaces
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-sputter coated
a of ~ 4.2
. These nano-
contaminants from
solution of NaCl
has a relatively
SLA (Rupp et al.,
surface free
. In this
.
1 Introduction Implant surface modifications In vivo effects of modified Ti surfaces
25
hydrophobicity, high cohesive (liquid-liquid) to adhesive (liquid-material) forces. A small angle
indicates relative hydrophilicity, where adhesive forces between the liquid-material overcome
cohesive forces between liquid molecules. In most cases the liquid used is water, which yields
measurements of 0o for the modSLA compared to 138.3 + 4.2o angles for SLA and 96 o angle for P
surface (Buser et al., 2004; Zhao et al., 2007).
1.3.4 In vivo effects of modified Ti surfaces
The variability in the methods employed to create and characterise various modified surfaces by
different manufacturers underlies a lack of consensus in the findings derived from manufacture to
manufacturer (Wennerberg and Albrektsson, 2009). This section reviews the in vivo findings derived
using Straumann AG manufactured SLA and modSLA implant surfaces compared to their control, a
polished machined surface (P).
The effects of the SLA surface have been evaluated through clinical trials in humans and
experimental observations in subject animals. The modSLA surface has been assessed largely in
pre-clinical settings in experimental subjects (Bornstein et al., 2010). In the clinical trials, the SLA
surface had been observed to present healing periods of 6 – 8 weeks compared to 6 months for the
conventional plane surface implant, demonstrating a 99 % success rate over a five year follow up.
The pre clinical trials conducted thus far indicate the modSLA to be capable of inducing significantly
more healing than SLA at 2 weeks post implantation, making it possible to load the fixture with an
abutment by the third week (subjects = 40 in number ) in the posterior mandible with a 96 %
success rate over a three year follow up (Bornstein et al., 2010); (Wennerberg and Albrektsson,
2009).
Experimental analyses comparing both surfaces in vivo have followed two common methods; a
histo-morphometric assessment of bone implant contact, and interfacial strength between tissue
and fixture by removal torques. These have more recently moved to in vivo molecular analyses,
using tissue specimen retrieved from subjects at various time intervals for genetic and molecular
examinations.
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The ‘traditional’ analyses have applied histological and morphometric evaluations to implant
integration in various animal subjects, comparing different loading times, a range of bone qualities,
and time points of analysis etc. The examinations indicate a significantly higher bone implant
contact % (BIC) and removal torque values in the case of the modSLA compared with SLA by as
early as two weeks post implantation (Buser et al., 2004; Ferguson et al., 2006; Bornstein et al.,
2008).
The recent analyses have applied basic science to query in vivo events by retrieving implants and
examining specimen with molecular techniques. One such assessment has indicated more stable
hematoma clot formations on the modSLA suggesting that the surface’s enhancement effects
extend to the spatial orientation of clot constituting elements at the interface (Schwartz et al., 2010).
This effect of modSLA also occurs with implant bound bone debris formed during placement. These
have been shown to be retained at a significantly higher ratio compared to soft tissue on the
modSLA than SLA and are suggested to mediate the comparative increase in BIC (Bosshardt et al.,
2011). These observations have been further substantiated by gene expression analyses of
retrieved samples that indicate a temporal up-regulation in skeletogenesis related genes’
expression compared to SLA as early as 4 d post implantation (Ivanovski et al., 2011).
1.3.5 In vitro effects of modified Ti surfaces
In vitro studies on the biological effects of Ti implant surface characteristics on cellular responses
imply these have an intrinsic influence on cellular function (Mendonca et al. 2008). Experimental
evaluations have mostly followed a typical methodology of fabricating implant surfaces on a disc of
a size suitable for use in a 1.96 cm2 surface area of a well of a 24-well tissue culture treated plate.
Cells are suspended in either growth or osteogenic inductive media and seeded on the discs under
the influence of gravity. The cell types predominantly studied include osteoblastic cell lines (MG63)
and primary alveolar bone derived osteoblast cultures, but other cell types have also been applied
such as, human umbilical cord endothelial cells (Zhang et al., 2010), dendritic cells (Kou et al.,
2011) and more recently bacterial bio-films (Almaguer-Flores et al., 2011).
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This model of study is two-dimensional, and has been deemed artificial and incapable of recreating
osseointegration in the absolute context (Wennerberg and Albrektsson, 2009). The obvious
advantage of this model is its simplicity of setup that allows the examination of various cell types
under controlled conditions and at different sub-cellular levels. The major disadvantage is that this
system does not model the complex interaction between the many cell types involved in the in vivo
situation. Even though it is a simple and easy accessible model, experimental questions have to be
tested in isolation. A 3-d model of the cell surface interactions, perhaps involving compressed
collagen matrices and more than one cell type, would present a better model for examining more
complex questions.
The parameters of cellular responses that have been predominantly assessed in vitro are
adsorption of proteins, cellular attachment, morphological adaptation, viability and proliferation and,
osteogenic mineralisation. These correlate with the steps that constitute the current paradigm of
osseointegration. The inferences drawn from such studies on the SLA and modSLA substrates are
summarised in the following points.
1.3.5.1 Molecular and cellular adsorption
The adsorption characteristics of serum equivalent proteins, such as bovine serum albumin with
analytical protein quantification assays have shown these adhere uniformly to all surfaces at any
time measured. However, that the quantity of adsorbed protein is usually higher on the rough
surfaces, believed to be due to the extra surface area offered by the substrate (Nishimoto et al.,
2007). Cellular attachment of osteoblastic cells, assessed with microscopic techniques at >1 h post
contact, have demonstrated a higher attachment number on the rough compared to smooth (Lai et
al., 2009; Miron et al., 2010). Moreover, cells are reported to adapt a more stretched morphology on
the rough with cytoplasmic processes emanating into topographical features within the vicinity. The
polished Ti surface seem to cause cellular spreading as opposed to stretch, yielding a near uniform
‘fried egg’ like morphology at 3 hours post contact (Wall et al., 2009). Rough surfaces are reported
to also elicit defined actin filament reorganizations with a relatively aberrant focal adhesion kinases
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distribution compared to the smooth surfaces (Lai et al., 2009; Nishimoto et al., 2007; Miron et al.,
2010).
1.3.5.2 Viability and proliferation
Cellular viability and proliferative rate of cells is significantly higher on the smooth than rough
surfaces (Zhao et al., 2007). This has been observed in almost every study examining the effects of
rough surface topographies on cellular function (Masaki et al., 2005; Brett PM et al., 2004; Olivares-
Navarrete et al., 2011; Miron et al., 2010; Vlacic-Zischke et al., 2010; Zhang et al., 2010; Wall et al.,
2009; Schwartz et al., 2009b; Lai et al., 2009). These studies have applied the traditional two-
dimensional cell culture model with analyses usually made over the initial week following contact
with the MTT assay as the preferred method.
1.3.5.3 Osteogenic mineralisation
The osteogenic differentiation of cells on the different substrates have been evaluated by genetic
expression of bone physiology related genes such as Runx2, osteopontin, bone sialoproteins, as
well as microarrays of whole transcriptomes; quantitative assessments of osteoblastic phenotypic
protein markers, mainly with alkaline phosphatase, osteocalcin, osteoprotegrin and transforming
growth factor β-1 measurements; and functional evaluations of osteogenic phenotypic 
characteristics such as calcium deposition and calcified nodule formation via Alizarin Red S staining
of monolayers, or spectrophotometric analysis of deposited calcium.
These analyses, in summary, point towards a phenomenon, described in relative detail in section
1.3.6, that in summary infers a novel enhancement of osteogenic differentiation to be induced in
cells cultured on the rough Ti modified surfaces. The observations drawn for osteoblastic cells
cultured on the SLA and modSLA surfaces are that
a. The rough surfaces induce a relative up-regulation in the expression of a select set of
genes, many key to bone physiology. Examples of solitary genes being differentially
modulated are the instance fibroblast growth factor receptor type 5 (Brett et al. 2004);
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Wnt5a, Runx2, osteopontin and bone sialoprotein type 2 (Wall et al. 2009; (Harle et al.,
2004)
b. increased matrix mineralisation assessed by significantly higher levels of Alizarin Red S
retention by monolayers cultured on rough surfaces (Miron et al., 2010; Wall et al., 2009),
and
c. an elevation in the levels of different osteoblast specific protein markers, such as alkaline
phosphatase, osteoprotegrin and osteocalcin, on the rough modSLA than SLA (Rausch-
Fan et al., 2007)(Schwartz et al. 2009).
Recent studies have shown the selective engagement of cell surface integrin subunits ITGA2 and
ITGB1 by Ti, and their enhanced modulation by surface roughness and hydrophilicity, to be linked
with the TGF-b1 regulation of OPG synthesis (Schwartz et al., 2009b). The authors later showed
that a particular Wnt3a based pathway that attenuates osteogenic differentiation through negative
regulators Dkk -1 and -2 proteins (Fujita and Janz, 2007) is also negatively influenced by the
osteoinductive potential of the modified surfaces (Olivares-Navarrete et al., 2010b). The overall
inference drawn is that rough and additionally rough-hydrophilic modified Ti surfaces induce a
temporal and magnitudinal enhancement in the in vitro osteogenic responses of human osteoblastic
cells.
1.3.5.4 Immunological effects
The enhancement effects of modified Ti surfaces extends to dendritic cells, which seem to produce
higher levels of anti-inflammatory cytokines and anti-osteoclastogenic regulators in response to the
rough surfaces (Kou et al., 2011).
1.3.6 Mechanisms of effects of surface modifications
A number of different theories have been proposed in an attempt to define the significance of
implant surface roughness on osseointegration. Three of these are prominent (Mendonca G et al.,
2008). The initial hypothesis is the ‘bio-mechanistic’ view, which proposes that rough surfaces
present a higher surface area for bone to contact with and thus, promote BIC % and mechanical
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fixation of the implant by a process of physical interlock. A mathematical model has been drawn that
hypothetically tested this idea by measuring the interfacial shear strength between bone and an
implant surface with mathematical algorithms. This relayed the dimensions of pits sized 1.5 µm
deep and 3 – 5 µm wide to be optimum for implant integration, which corroborated with the findings
of studies employing substrates of a similar surface architecture (Hansson and Norton, 1999).
Mechanical interlock of the implant with bone is an ultimate requirement for the successful
assessment of osseointegration. Recent developments in cell-implant observations have, however,
deemed mechanical interlock a downstream consequence of initial healing events rather than an
underpinning factor for the enhanced osseointegration of rough surfaces.
The second view promotes the proposition of ‘de novo bone formation’. It suggests that surface
topography offers a faster substrate for fibrin fibres, formed during the initial platelet cascade, to
adhere to. Accordingly, migrating MSCs are suggested to use these fibres as scaffolds to
translocate to the surface where they differentiate to an osteoblast phenotype. The newly formed
osteoblasts deposit an all important cement line or lamina lamitans on an implant surface (Davies et
al 2005; Davies et al 2003; Davies et al 1996). It proposes this cement line formation to occur in
four arbitrarily sub-divided stages, promoted by the rough surfaces due to the fibrin mediated early
and denser influx of osteo-precursors. This process initiates with the secretion of a collagen-free
organic matrix that serves as a calcium nucleation platform for mineralisation. This entails calcium
phosphate crystalisation that in turn attracts collagen fiber assembly to form osteoid on the cement
line at the interface. The mineralisation of the osteoid forms an osseous link of the implant surface
with adjacent bone that is subsequently replaced with secondary, lamellar bone through
remodeling. The core of this proposition is the formation of an amorphous collagen-free layer of
sialoproteins, reminiscent of a cement line formed at the juncture of old and new bone, which
precedes direct bone formation on the implant. There is an exception to this theory. Contrary to it is
the proposition originating from ultrastructural scanning microscopic studies (SEM) that report a
non-uniformly distributed layer of amorphous material some 20 – 400 nm thick, peripheral to the
cement line. This layer may occur spread over different sections in positively identified samples and
is suggested to be composed primarily of proteoglycans that precede the cement line formation
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(Sennerby et al., 1992). This finding implicates a delay in fibrin attachment and polymerisation and
therefore, negates it a primary role in mediating increased osseointegration by the rough surfaces.
The third view comes from in vitro experimental findings that, in brief, suggest rough surfaces
induce a temporal and magnitudinal enhancement in osteogenic cell activity and function. It
suggests that osteoblastic cells are influenced to produce an osseous tissue microenvironment on
the in vitro substrate (Boyan et al., 2003a) reminiscent of their innate response to osteoclast
resorbed pits in vivo (Boyan et al., 2003b). A mode of cellular activity implicated here is
mechanotransduction. This proposes that rough surfaces exert minute mechanical stimuli / forces
on surrounding bone tissue, which are sensed by local osteocytes that transduce the physical
stimulus from the cell membrane to load-responsive genes in the nucleus by means of a
mechanosome; a protein complex attached with mechano-sensory receptors (Pavlako FM et al.,
2003). This novel concept has been gaining support as various osteogenic effectors, such as the
Runx2 osteogenic master transcription factor, are shown to be modulated by mechanical forces,
and in some instances over riding cytokine or hormonal influence (Ziros et al., 2008). The role of
mechanical forces in osteogenic developmental processes has implicated the Rock and RhoA
GTPAses in mediating cell shape and cytoskeletal-tension related adaptive enhancements in
osteogenic differentiation (McBeath et al., 2004) by means of downstream non-canonical Wnt
ligand WNT5A (Santos et al., 2010).
1.4 Mesenchymal stromal cells
1.4.1 Definition
Adult tissue resident stem cells are generally defined as lineage unspecified, functionally un-
differentiated, mononuclear cells. They play an intrinsic role in the parental tissue’s homeostatic
repair by serving as a self-renewable source for prospective progenitor cells capable of
differentiating into constitutive cell types in vivo, while also being able to home in to other tissues to
participate in extra-parental tissue repair (Loeffler and Roeder, 2002). Human bone marrow
contains at-least two adult tissue stem cell populations. These are the well characterised
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hematopoietic stem cell (HSC) and the putative marrow derived mesenchymal stromal cell (MSC)
(Horwitz et al., 2005). HSCs occur as circulating non-adherent somatic stem cells and have been
found to be restricted to forming blood constituting myeloid and lymphoid precursors. The MSCs are
mainly identifiable by their in vitro properties, particularly the cell types distinct characteristic to
strongly attach to tissue culture plastic (TCP) as opposed to HSCs (De Silva Merielles, 2008).
These cells are generally defined as TCP adherent mononuclear cells, negative for HSC markers,
with a high replicative potential that can lead to single cell derived clonal colonies, and that are
multipotent to differentiate to osteoblastic, adipocytic and chondrocytic like cells in vitro when
induced with appropriate stimulants (Jones and McGonagle, 2008); (Lazennec G and Jorgensen,
2008; Horwitz et al., 2005).
1.4.2 Identity
In vivo, however, MSCs have not yet been well characterised, and lack a true identity. They are
thought to be a heterogeneous population of multipotent cells that form part of a supporting reticular
network, thought to regulate HSC differentiation, and are functionally implicated in the homeostatic
repair of mesoderm tissues. This perception of MSCs is largely based on information that is known
from experimental observations rather than an investigation of the true function of the cellular entity
(Lazennec G and Jorgensen, 2008; De Silva Merielles, 2008; Caplan, 2008; Benayahu et al., 2007).
The heterogeneity of MSC isolates infers that a tissue culture plastic adherent bone marrow isolate
is a population of different cell types that vary in lineage commitment and differentiation potentials.
This population is proposed to contain a small proportion of the extremely rare true somatic adult
stem cell, combined with a larger proportion of early stem derived progenitor cells of mesoderm
tissues and their somewhat committed precursors (Benayahu et al., 2007). This heterogeneity is
considered to be a function of the methods applied to isolate and study these cells and is an
obstacle in delineating the cells true biological importance. The identity of the MSC has also largely
not been addressed due to the lack of a singular discriminative marker as the present set of
markers may represent an overlapping repertoire of proteins between the three theoretical sub-
populations within an adherent isolate, all the while ignoring their heterogeneity such as the
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transcription and post translational modification of important lineage determining regulators.
Attempts at characterizing the cell type on the basis of a consensus of cell surface expressed
molecular markers has revealed three categories of proteins that differentiate MSCs from cells of a
similar in vitro profile. These are elaborated in tables 9-1, 9-2 and 9-3 (Appendix I) as positive,
negative and undetermined markers, respectively. At the present, these markers, in particular
Stromal cell antigen (Stro-1) (Simmons and Torok-Storb, 1991), are applied in assessing the
multipotentiality of a TCP adherent population of marrow isolate derived cells; however, in
combination with single cell colony forming unit assays, and tri lineage differentiation assays. The
MSC’s capacity to differentiate to osteoblastic, adipocytic and chondrocytic like cells not being
tested in vivo at a single cell level further emphasises the lack of absolute compared to relative
understanding of the cell type (Benayahu et al., 2007; Lazennec G and Jorgensen, 2008; Jones
and McGonagle, 2008; Kolf et al., 2007). The present nomenclature assigned to the TCP adherent
marrow isolate is the mesenchymal stromal cell abbreviated as MSC, with the prefix h indicative of
human origin (Horwitz et al., 2005).
1.4.3 Biology
Cell transplantation and grafting experiments, as well as the isolation of MSC like cells from other
anatomical sites such as adipose tissue, periosteum, tendon, muscle, synovial membrane, skin and
lungs have lead to the perception that these represent a population of cells, possibly derived from a
common embryonic ancestor, differentially distributed across the body during development, and
responsible for carrying out post-natal repair of mesoderm tissue (De Silva Merielles, 2008; Caplan,
2008). A cell type that has been recently hypothesized as being ‘parental’ in lineage to MSCs is the
perivascular cell, or pericyte. This cell occurs the outer lining on endothelial cells in capillaries and
micro vessels and is regarded as a vasculature resident predecessor of true mesenchymal stem
cells (Crisan, 2008). Pericytes have been isolated on the cell surface expression of 3G5+, CD146+
CD34- from human fetal and adult tissues, and shown to be capable of clonogenic self renewal,
forming single cell derived colonies, and undergoing osteogenic, adipogenic, chondrogenic and
myogenic lineage differentiation in vitro (Crisan, 2008; Collet et al., 2003; Farrington-Rock et al.,
2004). This proposition implies the MSC to be part of a regenerative system that like the many
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systemic organisations (immune and nervous systems etc), is engaged in replacement of tissue to
recuperate loss of organ function; albeit to a limited extent.
1.4.4 Cellular characteristics in vitro
It has been estimated that true multipotent MSC comprises 0.01 % to 0.001 % of the tissue culture
plastic adherent mononuclear marrow cell isolate positive for Stro-1 cell surface anitigen (Simmons
et al. 1991). These cells are proposed to have a fibrobrlastic, trigonal morphology in culture (figure
1-9) (Pittenger et al., 1999). Colter and colleagues, using morpho-metric parameters, have
catergorised three distinct types of cells in an isolate of marrow derived MSCs seeded at clonal
densities (1 to 10 cells.cm-2). The initial two are said to be small ‘recycling stem cells’ that are
characterised by the presence of a prominent nucleus and high nucleus to cytoplasm ratio. These
are essentially identical differing primarily in their cytoplasmic granularity, with the type 1 agranular
and type 2 highly granular; but also slightly with respect to their repertoire of cell surface markers
(Colter et al., 2001).. The third morphological form that an MSC may take in culture is that of a large
spindle or flattened like cell that Colter et al. termed as a mature marrow stromal cell (Sekiya et al.
2002; Colter et al. 2001; Colter et al. 2000). The recycling stem cells occur at a very small
proportion of the culture at any given time.
It should be stated here that these denominations are rather arbitrary. Though worthy of
appreciation, these are incapable of deciphering the complexity of a culture of MSC as an isolate of
these cells is heterogeneous with respect to cellular lineage and multipotentiality, and has a colony
forming unit percentage of at most 45 (see ‘Specimen characterisation data sheets’ in appendix
VI).However, the cells cultured in the process of this thesis displayed the morphological
characteristics described by Colter et al. when seeded at clonal densities, as shown in figures 1-6
and 1-7, which show dividing duplets of cells interspersed within a semi-confluent culture of human
MSCs, with an obvious relative difference between the mitotic cells from the rest of the specimen.
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MSCs can undergo osteogenic commitment in ceramic or Titanium diffusion chambers placed
under the periosteum, and have been used in pre-clinical trials for tissue regenerative purposes, of
which the prominent examples include myocardial infarction (Williams and Hare, 2011), pulmonary
tissue (Tzouvelekis et al., 2011), and osteogenesis imperfecta (Aslan et al., 2006; Soejitno et al.,
2010). It should be noted that the potential of these cells to undergo differentiation in vitro depends
on their length in culture; a common opinion is that these cells substantially lose their ability to
undergo chondrogenic differentiation after the third passage, whereby their tendency to undergo
adipogenic differentiation increases, with osteogenic differentiation thought to be capable up to five
passages (Mark Clemens, visiting lecturer from University College London, personal
communication).
1.4.5 Implicated function in osseointegration
The MSC has been hypothetically assigned a major role in the establishment of osseointegration. It
is hypothesised that MSCs, originating from proximal and distal niches, migrate to the implant-bone
interface. Here, they differentiate to osteoblastic cells that deposit the initial osseous matrix on the
implant surface and adjacent bone, eventually forming an osteoid joint between fixture and tissue.
The enhanced integrative effects of rough implant surfaces indirectly implies the parallel differential
enhancement in MSC activity by these implant surfaces. The biological mechanisms underlying this
suggested functional enhancement are largely unknown. Fewer studies have been conducted
examining the effects of rough Ti surfaces on MSC activity than committed osteoblastic cell lines.
The nature, implied role and the ability to induce osteogenic differentiation in MSCs renders them
an important experimental specimen, which may yield findings closer to the truth than that obtained
with committed osteoblastic cell lines (Tuan, 2011).
1.4.6 MSC responses to modified Ti surfaces
To assess the role of surface topography on osteogenic responses, an early study was undertaken
with human marrow derived mesenchymal stromal cells (hMSC); with the rationale that any
differences between the osteogenic potential of the surfaces would be exhibited by cells of a limited
capacity of phenotypic function (Wall et al 2009). The study analysed early responses at 3 hours, 1,
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3 and 5 days post seeding, to a polished Ti surface (P), rough-hydrophobic SLA and the then-newly
introduced SLActive surface (now widely referred to as modified SLA; modSLA) by assessing
differences in attachment & morphology, proliferation, mineralisation, viability/apoptosis and global
gene expression. It demonstrated hMSCs bear distinct morphological differences between the
surfaces with a higher viability and proliferative rate of cells on polished than rough. In addition, the
authors suggested that this restriction in cell number changes on the rough was in part due to
cellular apoptosis and necrosis occurring very early after cell-surface contact, incurring an increase
in Stro-1 positive cells (Wall et al. 2 009). Furthermore, the study showed rough surfaces to cause
significantly higher levels of calcium deposition, assessed by Alizarin Red S staining, on rough
(modSLA > SLA) compared to polished surfaces. Global gene expression profiles with microarrays
demonstrated the selective upregulation of osteogenic genes by rough compared to polished
surfaces; notably amongst which were a set of cytoskeletal markers, Fibroblast Growth Factor type
5 (FGF5), Wingless- type MMTV integration site family member 5A (Wnt5a), beta-catennin, all three
components of collagen type 6, RUNX2 transcription factor, osteopontin and the integrin-dependant
bone sialoprotein protein type 2.
Collectively, the results suggested cells to have been primed towards an enhanced osteogenic
program of differentiation by micro-topography, and to added extent nano-topography, of the SLA
and modSLA surface preparations, respectively. Additional studies of hMSCs to the Ti surfaces
have implicated candidate integrin subunits (ITGA2 and ITGB1) in the differential response of cells
to Ti surface modifications by regulating downstream synthesis of osteoprotegrin through
intermediary TGF-b1 (Olivares-Navarrete et al., 2010a). The authors have recently implicated
WNT5A, a molecule first observed selectively upregulated on the modSLA by (Wall et al. 2009), in
the effects of rough surfaces on hMSC osteogenic responses (Olivares-Navarrete et al., 2011).
This, in parallel with the known induction of osteogenic differentiation by WNT5A and rock-Rho
GTPase (Santos et al., 2010), and the implied role of the latter in stretch mediated differentiation in
uncommitted cells (McBeath, 2004), strongly suggest that a (i) surface topography enhances
phenotypic differentiation and that (ii) this mechanism is (partly) regulated by mechanotransduction
based signaling, generated from rough topographical features.
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1.5 Axl/Gas6 signal transduction pathway
1.5.1 Description
Axl is a cell surface Receptor Tyrosine Kinase (RTKs) discovered as an oncogene associated with
the progression of Chronic Myelogenous Leukemia in humans (Liu et al., 1988). It is classed as a
member of the ‘TAM’ family of RTKs that includes homologous c-Mer and Tyro3. The TAM
receptors notably differ from other RTKs in the structure of the extra cellular domain that consists of
two N-terminal Immunoglobulin repeats juxtaposed to two Fibronectin type 3 repeats, resembling
adhesion molecules found within the neural system; as well as a unique conserved intracellular
kinase domain sequence of Lys-Trp (Ile/Leu) Ala (Ile/Lue) Glu-Ser (O'Bryan et al., 1991). Axl is a
ubiquitously expressed protein, detected at notable levels in the hippocampus and cerebellum of
brain, monocytes / macrophages, platelets, endothelial cells, heart, skeletal muscle, liver, kidney
and testis of humans. Furthermore, it has been detected to be ectopically expressed in different
human cancers, including myelogenous leukaemia, colon, lung, esophageal, thyroid and breast
(Hafizi and Dahlback, 2006). A strong Axl expression is reported to occur in normal bone marrow
stromal cells that assayed negative for CD34 antigen (Neubauer et al., 1997).
Gas6 (growth arrest specific gene 6) is a secreted growth factor identified through a process of
subtractive hybridisation in mammalian cells subjected to serum-deprivation induced growth arrest
(Schneider et al., 1988). It was found to bind TAM receptors in an affinity dependent order;
Axl>>Tyro3>Mer (Stitt et al., 1995). Gas6 resembles a blood anti-coagulation factor called Protein S
by 44 % sequence homology. Gas6 is structurally composed of an N-terminal vitamin-K dependent
γ-carboxylated glutamic acid domain (Gla domain), two epidermal growth factor-like repeats and 
two C-terminal globular laminin G-like domains (Linger et al., 2008). γ-Carboxylation is a necessary 
post translational modification required to activate the Gas6 ligand. It is deregulated in states of
altered homeostasis, particularly in the state of vascular calcification, a process quite synonymous
with osteogenesis (Demer and Tintut, 2008; Johnson et al., 2006). The underlying transcriptional
control of the molecule is unknown (Berk, 2001).
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1.5.2 Signal transduction pathway
Activation of Axl is reported to occur in either a conventional or atypical manner (i.e. a ligand
dependent or ligand independent manner, respectively) (Linger et al., 2008). The conventional
activation of the receptor occurs with a Gas6 molecule binding to an Axl molecule followed by
dimerisation of two 1:1 Axl / Gas6 receptor-ligand complexes. This leads to autophosphorylation of
three tyrosine residues (Tyr-779, Tyr-821, Tyr-866) within the C-terminal cytoplasmic domain of the
receptor. Axl may form such dimers with fellow TAM members and also with the receptor for
Interleukin 15 suggesting it to vary in functional potential through a ‘cross-talk’ mechanism with
other cellular pathways (Budagian, 2005a). The atypical form of Axl activation is observed to occur
in vitro in cells that exogenously express the receptor protein. The binding nature may either be
homophilic with two Axl molecules dimerising, or heterotypic between an Axl molecule & a TAM
family member. The biological significance in vivo of such atypical binding is unknown (Linger et al
2008). The cleaved extra cellular domain of Axl is plasma soluble and is an additional mode of
function; although presently of an unclear purpose (Budagian, 2005b).
The phosphotyrosines of an auto-Phosphorylated Axl dimer, in particular tyrosine 821, act as
substrate docking sites for phosphatidyl inositol 3 kinase (PI3K), phospholipase gamma (PLC-γ), 
Growth factor receptor-bound protein 2 (Grb2), cellular homolog of Src (c-Src), lymphocyte-specific
protein tyrosine kinase (Lck), suppressor of cytokine signaling 1 (SOCS-1), cytoplasmic signaling
protein Nck2, phosphoprotein RanBPM and tensin domain like phosphatase C1-TEN. These
molecules contain phosphotyrosine binding SH2 domains that interact ‘preferentially’ with Y821
phosphotyrosine of Axl (Hafizi and Dahlback, 2006). The downstream effectors present an
association of Axl with various cellular processes that are primarily known to include cell survival;
proliferation; cytoskeletal dynamics and cellular migration (figure 1-12).
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Figure 1-10 Axl signal transduction pathway
Ligand dependent dimerisation of cell surface Axl leads to recruitment of primary
downstream signal transducers (blue circles). These catalyse the formation of inositol tri-
phosphates that are required for the recruitment of PI3K (Phosphatidylinositol3 Kinase). Axl
induced PI3K instigates survival signaling by activating anti-apoptotic Akt kinase, which
stabilises NfκB that further upregulates anti-apoptotic Bcl-XL and Bcl-2. The primary 
molecules RanBPM and Nck2 link Axl with PUNCH & Integrin-linked kinase (FAK) proteins
that collectively serve as signaling platforms at focal adhesion sites, thus affecting
cytoskeletal dynamics. Src/Lck are presumed to act through the Ras/ERK pathway to
transduce mitogenic signals. Ras/ERK is dispensable and not required for Axl survival but is
implicated in cytoskeletal reorganisation through the modulation of small GTPases Rho and
Rac. TWIST is an anti-inflammatory IFNα induced basic helix-loop-helix DNA binding 
transcription factor that inhibits NFκB-dependent transcription of TNFα and is also a 
negative regulator of osteogenic differentiation. Figure taken with permission from (Linger et
al., 2008). Annotations derived from (Linger et al., 2008; Hafizi and Dahlback, 2006; Lee et al.,
1999).
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1.5.3 Biological implications in cell substrate responses
Axl was highlighted as a gene expressed early on at significantly higher levels in human alveolar
osteoblasts in contact with rough Ti surfaces (Brett et al. 2004). It was observed to have been
significantly downregulated by hMSCs at 5 days on the rough compared to polish Ti (Wall et al.
2009; Supplementary data). These observation correlate with the biological functions attributed to
the pathway; as a potent anti-apoptotic protein (Shankar S L, 2006), role in the modulation of
cytoskeletal re-organisation through rock-Rho GTPase (Linger et al., 2008; Goruppi et al.,
2001)(Linger et al 2008; Goruppi et al 1999), cellular adhesion (McCloskey et al., 1997)(McCloskey
et al 1997) and, of interest to this study, osteogenic differentiation of uncommitted cells (Collet et
al., 2006; Collet et al., 2003).
The association of the Axl / Gas6 pathway with survival through activation of PI3K and up-
regulation of anti-apoptotic BCL proteins implies it may be modulated by cells in response to
surface induced apoptosis. But of more importance is the observation of receptor down-regulation
prior to calcification in bovine pericytic cells in vitro, reversed by the addition of receptor agonist in
the form of recombinant proteins (Collet et al. 2003; Collet et al. 2006) and supported by the
demonstration of inhibition of calcification in vivo by statins through restoration of Gas6/Axl
signaling (Son et al., 2006). These imply a possible involvement of the receptor in the differences
observed in the osteogenic responses of cells to the rough surfaces. The small GTPase Rho-A and
its downstream effector ROCK have been shown to be modulated by ‘stretched’ stromal cells
compared to rounded cells, leading to the induction of an osteogenic phenotype in the former, and
an adipogenic in the latter (McBeath et al 2004) presumably due to down-regulation of a master
adipogenic instigator PPAR-γ (Peroxisome proliferator-activated receptor gamma) (David, 2007). 
The modulation of small GTPase Rho-A has been linked with Axl signaling through Ras/ERK by
cytoskeletal stress (Goruppi et al., 2001). These observations strongly implicate the functional
significance of the pathway in the differences observed on the rough surface.
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1.6 Statement of thesis
1.6.1 Observations
Osseointegration is a complex biological phenomenon, reminiscent of neo bone formation, and
composed of a series of overlapping cellular and molecular events, which seek to integrate an
inanimate biocompatible material (predominately Ti), of specific dimensions, into living bone. The
dynamics of osseointegration are highly affected by topographical modifications of Ti implants.
Clinical evidence had indicated an increase in peri-implant bone accrual, larger bone to implant
contact and faster bone conduction on rough compared to smooth implants. Furthermore, recently
completed pre-clinical studies have shown that a hydrophilic rough surface can additionally promote
osseointegration compared to the rough-hydrophobic surface modification; these substrates bear
the exact physical topography but different chemistries. In vitro examinations of certain osteogenic
parameters in osteoblastic and mesenchymal stromal cells cultured on smooth and modified Ti
substrates indicate a novel enhancement by rough implant topographies, suggestive of a relative
promotion in osteogenic phenotypic differentiation and function, which are additionally supported by
the hydrophilic nature of the modified rough modSLA surface. An observation of selective
upregulation at the gene level implicates the differential modulation of a cell surface tyrosine kinase
receptor called Axl, a molecule functionally associated with cellular osteogenic differentiation in
uncommitted pericytes, in these enhanced osteogenic responses of uncommitted cells to the rough
Ti surfaces.
1.6.2 Hypothesis
The cell surface receptor Axl is differentially modulated in the osteogenic responses of human bone
marrow derived mesenchymal stromal cells (hMSCs) to different Ti implant surface modifications.
1.6.3 Aims
The aims were to (i) investigate differences in the phenotypic and osteogenic responses of cells to
the different substrates; (ii) compare the modulation of the Axl / Gas6 pathway in cells cultured on
different substrates; (iii) examine the effects of deregulating the Axl / Gas6 pathway on cell-
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substrate responses; and (iv) assess the functional significance of Axl in the altered responses of
hMSCs to modified Ti surfaces.
1.6.4 Objectives
The objectives of this project are listed below.
a. Form an understanding of hMSC phenotypic responses to the different substrates by
examining cellular attachment, morphological differences in spreading, and cellular viability
and proliferation.
b. Form an understanding of hMSC osteogenic responses to the different substrates by
comparing the expression of osteogenic markers, cellular mineralisation and soluble
osteoblastic protein secretion over the course of culture.
c. Examine the hypothesised differential modulation of Axl and Gas6 genes by rough surfaces
in hMSCs by comparing temporal differences in gene and protein expression of the
receptor, its ligand and a downstream effector called TWIST1 that is implicated in osteo-
inhibitory effects of the pathway. Furthermore, examine the effects of Axl receptor de-
regulation on cellular proliferation, mineralisation and osteoblastic soluble protein secretion
over the course of culture.
d. Attempt to query the differential modulation of Axl in cell to surface responses by assessing
the effects of receptor de-regulation on the expression of stem cell pluripotency associated
genes.
These experimental investigations were conducted in an in vitro two dimensional cell culture model
that consisted of cells, suspended in liquid medium and plated under the influence of gravity onto a
substrate immobilized in a sterile culture vessel. The experimental substrates assessed in this study
were tissue culture plastic (TCP), polished cpTi (P), hydrophobic sand blasted large-acid etched
(SLA) and hydrophilic SLA (modSLA). The TCP was used as a control for substrate material-type
dependent effects on cell responses. This was because (i) it is the substrate that houses primary
cells outside their natural environment, and is their ‘cognate’ substrate in vitro; (ii) TCP may
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inadvertently incur changes in primary cells as they adapt to their new substrate; and (iii) it is the
prime reference for comparison as aspects of bone development in human cells have been largely
conducted on TCP. The polished surface was used as a reference control for Ti surface
modifications’ influenced effects on cellular responses.
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2 Materials and methods
2.1 Modified titanium surfaces
2.1.1 Preparation
Titanium discs fabricated with the modified implant topographies were manufactured and provided
by Institut Straumann AG (Walderberg, Switzerland). The implant surfaces were re-produced on
discs that were of a 1.8 cm2 surface area (15 mm diameter), designed to use in ~ 1.96 cm2 24-well
tissue culture treated plates. Three types of titanium surfaces were used in this study. The first was
a control surface with a smooth topography referred in this study as the polished (P) surface, due to
its near mirror-like reflectivity. The other two types were micro-rough surfaces. The first of these
was a rough hydrophobic surface SLA, an acronym for Sand-blasted Large grit Acid-etched. The
next of the rough surfaces was the rough hydrophilic modified SLA (modSLA) surface. It is
produced in conditions that disallow surface contamination by hydrocarbons and thus, increases
surface free energy, which in turn renders the surface hydrophilic, i.e. relatively more amenable to
the flow of water molecules compared to the hydrophobic SLA.
A detailed description of the manufacturing methods and characterisation of these surfaces is
provided in (Rupp et al., 2006). In brief, the Ti discs were punched out from sheets of commercially
pure Ti (of grade III). The crude discs were polished to a mirror on one side with SiO2 grinding
paper with a grit diameter of 15 - 600 μm. These discs were further treated with diamond paste in oil 
and finally with a SiO2 suspension to obtain a fine mirror-like surface. The polished Ti surface has
been analysed by scanning electron microscopy to to have a Ra value, representing the average
vertical distance between the lowest and highest points within topography, of 0.6 μm. The SLA 
discs were prepared by blasting a polished surfaces with large alumina particles, average in a
diameter by 250 μm, and then acid-etching in a hot solution of hydrochloric (HCl) and sulphuric 
(H2SO4) acids. Following acid etching, the discs would be washed several times in de-ionised water
and air dried. The modSLA surface was produced on polished discs with a method similar to that
used for the SLA surface, with the exception of the final rinse being conducted under nitrogen
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protection. By minimizing chances of contamination by atmospheric oxygen and organic chemical
moieties, the modSLA has a higher surface energy. The modified discs were supplied sealed in
glass tubes, immersed in isotonic NaCl at pH 4 - 6. The mean Ra value of the SLA and modSLA
titanium surfaces is reported to be similar at 3.22 + 0.88 μm (Rupp et al. 2006). The hydrophilicity 
due to high surface energy of the modSLA surface has been evaluated with advancing contact
angle measurements by (Rupp et al. 2006) to be 91.31, 139.88 and 0 degrees for the polished, SLA
and modSLA surfaces, respectively.
2.1.2 Passivation
The polished and SLA titanium discs were passivated prior to experimentation to remove excess
hydrocarbon buildup on the surfaces. This was performed by washing discs in a 10 % (v / v)
solution of 10 M nitric acid in distilled water, followed by several washes in de-ionised water. Discs
were air-dried in a sterile environment and later ultra-violet irradiated for 1 hour on each side prior to
use. The modSLA discs were supplied submerged in saline in sterile glass tubes and were required
to be kept submerged in a liquid medium through the course of experimental setup to prevent
transformation of the surface oxide layer.
2.1.3 Raman spectroscopic characterisation of surfaces
An attempt at assessing the chemical ‘cleanness’ of the modSLA compared to SLA surface was
conducted in this study using Raman spectroscopy. This technique analyses the spectrum of
emitted photons generated by incident monochromatic light to obtain an identity of the chemical
nature of the target, such as oxides, hydrocarbons, etc, in comparison with the non-excited state,
referred to as the background. The analysis in this study was conducted in a LabRAM HR
spectrometer (Horiba Jobin Yvo; UK) fitted with a 633 nm incident laser. The analysis was
performed on an area measuring five 40 x 40 µm squares at the center of an SLA and modSLA disc
in air. The analysis was performed at x50 objective with a grating of 1800 Raman shifts (also known
as wave numbers that bear the units = cm-1).
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A Raman spectrum for the polished surface could not be obtained due to the highly reflective nature
of the surface, which strongly interfered with an optical receiver of the device. A spectrum for the
modSLA surface could also not be obtained due to no difference between background and
excitation states; suggesting a ‘very clean’ preparation without a trace of detectable surface
contaminants. The SLA surface, however, showed differences with respect to the larger
background. The results of this analysis are shown in figure 2-1. The first is observed at 1400
Raman Shifts and was suggestive of a carbon contaminant. The second and third peaks were
observed at 450 and 600 Raman Shifts and reflected the presence of a form of Ti oxide, most likely
anatase due to its high incidence in biomaterial preparations. A surface plot representing the
regions of the SLA surface where these peaks were detected is shown in figure 2-1 (b and d). It
indicates that the carbon contamination was at a lower extent but homogenously distributed while
the anatase and titanium oxide contaminants occur at high intensities in interspersed foci.
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2.2 Cell culture
This project entailed the culture primary human bone marrow derived mesenchymal stromal cells
(hMSCs). The aspects of cell culture applied are explained over the following sub-sections.
Accompanying tables of information are provided in appendix III ‘tabulation of cell culture materials’,
from tables 9-5 to 9-9.
2.2.1 Environment & consumables
Cell culture was used for the maintenance, propagation, experimentation and storage of adherent
primary human cells in sterile conditions. This work was conducted in a fully equipped tissue culture
laboratory. The macro equipment used for tissue culture is tabulated in table 9-4. Most tissue
culture consumables were acquired sterile. Non-sterilised items, including micropipette tips, forceps,
were autoclaved and oven dried at 60o C prior to use. The general consumables used for cell
culture are detailed in table 9-5. The flasks and tubes were procured sterile and were disposed
following a single use. The cell culture media and reagents used are tabulated in table 9-5. The
instruments and consumables used for the sterilisation of equipment are tabulated in table 9-
6.Practice
A cycle of cell culture normally constituted reviving a cryopreserved cellular specimen, and
propagating it in an appropriate medium and vessel for a period of time in humidified conditions.
During this period, medium would be replaced twice every week to replenish cellular nourishment
and remove metabolic waste. Under ideal conditions, cultured cells increased in numbers forming
confluent monolayers. These were detached, and either re-propagated (sub-culture), used in
experimentation, or cryopreserved. The details of cell culture practice undertaken are elaborated in
the following sub-sections.
2.2.1.1 Culture media
All liquid reagents and media were pre-warmed in water bath for ~ 30 min prior to use. Complete
growth medium (GM) comprised αMEM basal medium supplemented with fetal bovine serum (FBS) 
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and antibiotics at 10 and 1 % of the final volume, respectively. The osteogenic inductive medium
(OM) comprised Dulbecco’s Modified Eagle’s Medium low glucose supplemented with 10 % lot
selected fetal calf serum, 1 % antibiotics, 0.1 % fungicide, dexamethasone at 10 nM; β-
glycerolphosphate at 10 mM; and ascrobate-2-phosphate at 50 μM. The volumes of medium used 
per culture vessel substrate area are tabulated in table 9-7.
2.2.1.2 Specimen revival and propagation
Cellular specimens were normally stored in male-capped cryovials in liquid nitrogen. These stored
cells were revived by half immersing a cryovial in a water bath and transferring thawed contents to
pre-warmed growth medium in a 15 ml tube. The number of cells in suspension would be estimated
with a hemocytometer by combining 10 μl of suspension with 10 μl trypan blue and counting total 
number of non-stained cells in the corner four 1 mm2 boxes of the 9 boxed-grid. The average count
was used in the formulas tabulated in table 2-1 to estimate the quantity of cells in suspension.
Table 2-1 Cell number calculations
Formulae used to quantify cells in a 1:1 cell suspension with Trypan blue with a
haemocytometer. Here C = cell concentration. A = average count from 4x 1 mm2 boxes of a
haemocytometer. Df = dilution factor (2 throughout this study). Cn = total cell number
Variable Formula
Estimated cell concentration C (cells/ml) = A (cells) x Df x 104.ml-1
Estimated total cell number Cn (cells) = C x Vf
2.2.1.3 Sub-culture
Cellular detachment from a substrate was carried out with a Trypsin/EDTA solution. This was
performed by twice washing cells with divalent-cation-free PBS and incubating the monolayer with
Trypsin/EDTA solution at the proportion of 1 ml reagent per 25 cm2 of substrate area in humidified
conditions for up to 5 min. Detached cells were collected in growth medium and pelleted at 1000 x g
for 5 min; and later re-suspended in a smaller known volume of growth medium. Cells were counted
as described in 2.2.2.2. A known number of cells were added to culture vessels containing pre-
warmed medium. The volume of inoculate was calculated with the arithmetic formula; Vi x Ci = Vf x
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Cf, if Ni = Nf, where V = volume of suspension, C = concentration of suspension, N = number of
cells, i = initial and f = final. Cultures would be incubated in humidified conditions with bi-weekly
medium changes till attaining a ~80 percent confluence. The population doubling level of cells of a
specimen were determined with the equation (Log10NF – Log10 No)/Log2, where NF = number of cells
harvested, and No = number of cells initially seeded.
2.2.1.4 Cryopreservation
Cells were cryopreserved in freezing medium formed by supplementing growth medium with FBS
and DMSO to a final percentage of 30 and 5 percent, respectively. Pelleted detached cells were
suspended at a density of 1 – 5 x 105 cells per ml in freezing medium. An aliquot of 1 ml of
suspension would be added to individually marked cryovials, which were capped and stored at -80o
C for 24 h before being transferred to cryogenic liquid nitrogen tanks.
2.2.2 Culture of mesenchymal stromal cells
Human bone marrow derived stromal cells (hMSCs) from three unrelated donors (N = 3; Caucasian;
male; 20-30 year age group) were obtained from the Centre for Gene Therapy, Tulane University
(New Orleans, USA). These cells were isolated from bone marrow aspirates on their ability to
adhere to tissue culture plastic compared to non-adherent hematopoietic adult stem cells. The
hMSCs had been pre-characterised for colony forming unit formations, osteogenic, chondrogenic
and adipogenic differentiation, and the expression of a repertoire of stromal cell surface markers by
the suppliers (Appendix IV: Cell specimen characterization data sheets).
The cells were cultured according to the parameters suggested in (Colter et al., 2000; Colter et al.,
2001; Colter et al., 2000; Sekiya et al., 2002; Sekiya et al., 2002). Cells were expanded at a low
density (100 cells.cm-2) in GM with αMEM as basal medium. Cultures were harvested for 
experimentation on attaining 80 % confluence with trypsin/EDTA. Experiments were performed with
cultures that had undergone a maximum of three passages or at most 15 population doublings.
Osteogenic differentiation was induced by seeding cells at a relatively higher density of ~1.25 x 104
cells.cm-2 in OM.
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The cumulative population doublings were evaluated for the first vial of each of the three hMSC
donor specimens used in this study. This was performed by setting up parallel cultures of
specimens in T150 flasks at 100 cells.cm-2 in GM; recording cell numbers harvested at subculture,
and calculating cumulative figures for population doublings as described in 2.2.2.3. The results of
this analysis are presented in figure 2-2. It indicates two of the donor specimens (7043 and 7081) to
be highly similar in population doubling characteristics. This was not the same for the specimen
7032, which although seeming to be highly replicative in the first passage, failed to thrive at a
comparable level in later passages.
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Figure 2-2 Cumulative population doublings of cultured hMSCs
The cells were plated at 100 cells.cm-2 in GM in T150 flasks till confluent colonies appeared.
Cell numbers were determined with haemocytometric counts at the start and end of culture.
The values were used to calculate the cumulative population doublings of each specimen
over five passages. Donor 7032 exhibited a lag in population doublings following the second
passage. Donor cells 7043 and 7081 exhibited similar proliferative characteristics through all
passages. This finding indicates differences in the replicative, and hence probably, the
phenotypic characteristics of the different hMSC specimens.
2.2.3 Cell culture optimisation
The in vitro behavior of cells is highly influenced by fetal bovine serum (FBS) (Kuznetsov et al.,
2008; Caterson et al., 2002). This protein rich mixture acts as a source of hormones, growth factors,
and peptide metabolites for cultured cells. The lack of a system to characterise and categorise FBS
based on the relative proportions of all constituents entails a level of variability in cell culture
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conditions and hence, experimental results. To control the variable affects of different lots of FBS
on cell culture and experimental settings, a serum batch test was undertaken to acquire a serum lot
optimum to support low density growth and in vitro osteogenic mineralisation of hMSCs. The list of
sera types tested is provided in table 9-4 (appendix II). The protocol for testing sera types
comprised a 10 d colony forming unit (CFU) assay, a 10 d proliferation curve and a 14 d
osteogenic-like differentiation assay. The methodologies applied are described in sections 2.4,
2.5.3, and 2.7.2, respectively. The hMSCs used for this experiment were expanded in respective
FBS types prior to experimentation to negate the effects of serum adaptation.
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Figure 2-3 Frequency distribution bar chart of colony size
Each bar shows CFU numbers per FBS type per size of diameter (mm). Approximately 100
cells were seeded per T75 flask in GM and cultured for 10 days. Samples were fixed/stained
with crystal violet in methanol. Images of CFU cultured flasks were analysed with Image pro
plus. Total colonies were counted and mean diameters (mm) of all counted colonies were
determined with image software. Readings were analysed with Graphpad Prism for
frequency distributions (Bin minimum = 1 mm; Bin range = 1 mm). Sera A to D cultured cells
produced colonies of higher sizes at a higher frequency than sera types E and F.
The CFU analysis revealed all serum types to be able to support hMSC growth at clonal densities.
This is inferred from the observation of near equal numbers of colony formations by all serum types
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that averaged 2 mm in diameter (figure 2-3). The cumulative number of colony forming units larger
than 2 mm was 32, 38, 36, 16, 11 and 13 for A, B, C, D, E and F, respectively, indicating a
difference in the potential of serum types to support colony growth above the standard 2 mm mean
diameter mark.
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The images of the colonies formed by FBS types A, B and C displayed a relatively denser stain as
shown in figure 2-4. The hMSCs cultured in these sera also formed relatively well defined circular
colonies compared to E and F as shown in figure 2-4.
Figure 2-4 Colony formations in different FBS types
Images of crystal violet stained colonies formed by ~100 hMSCs seeded in a T-75 tissue
culture flask for 10 days.Sera types A, B and C produced highly prominent colonies
compared to E and F. Scale bar (2 mm) is provided in the upper left corner of the image.
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The osteogenic mineralisation of cells indicated that hMSCs deposited higher levels of mineral in
serum types A to D compared to lower levels in types E and F. A quantitative assessment of
deposited calcium levels is provided in figure 2-5, which shows a significantly higher quantity of
calcium detected in samples cultured with serum types A to C compared with E and F.
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Figure 2-5 Calcium mineralisation in different sera types
Figure is a box and whisker plot of calcium concentrations determined in 0.5 ml lysates of
samples cultured in OM supplemented with different sera types for 14 d. Approximately 2.5 x
104 hMSCs were cultured in 24 well plates in triplicate. Serum types A, B and C had induced
significantly higher levels of matrix mineralisation compared to E and F indicating these to
be highly supportive of osteogenic differentiation. Readings are presented as minimum to
maximum range of data points with large and small horizontal lines depicting median and
mean, respectively. ** = p < 0.01, and *** = p < 0.001; N = 1, n = 3.
Additionally, in a separate experiment, monolayers of hMSCs (donor type 2, 7043) were cultured in
osteogenic inductive medium supplemented with different sera. Monolayers were stained with
Alizarin Red S as stated in section 2.7.1. The results of this analysis are shown in figure 2-6. It
shows a higher intensity of staining in samples A to C and least stain in samples E and F.
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Figure 2-6 Staining for calcium mineralisation in different sera types
Image is a scan of a 24-well plate with hMSCs cultured in osteogenic medium supplemented
with one of the seven serum types. Triplicate cultures were maintained for 14 d, and then
stained for Alizarin Red S according to the protocol stated in section 2.7.1.Scans were
acquired according to the method described in section 2.3.3. Samples A through to D
displayed high levels of stain indicative of a high level of calcium mineralisation. The
absence of a monolayer in B1, D1 and E3 is attributable to the process of de-lamination,
seen to also be occurring in samples D2 and D3, which can be loosely defined as the
detachment of a confluent monolayer of adherent cells from its in vitro substrate. Sampls E
and F show the least relative stain suggestive of a weaker capability of promoting
osteogenic mineralisation in hMSCs.
2.3 Microscopy and imaging
2.3.1 Light microscopy
Light microscopy was used to visualize cellular confluence and morphology at different stages of
culture with an inverted light microscope. Normal observations were conducted with x4 and x10
magnification objective lenses.
2.3.2 Scanning electron microscopy
Scanning electron microscopy (SEM) was conducted on a Cambridge Stereoscan S90B
(Cambridge Instruments; UK). Samples were imaged either uncoated with Back-scattered SEM or
following a sputter coat. The former analysis highlights organic entities as dark objects against a
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bright inorganic (Ti) background, and was useful for the quantitative estimation of cells attached to
the different discs. The latter was directed at qualitative evaluations, such as shape, spreading etc.
An SEM analysis would be initiated by washing a sample (cells cultured on a Ti disc) several times
with divalent-cation-free PBS with gentle aspiration. The sample would then be fixed in 4%
glutaryldehyde in 0.14 M sodium cacodylate buffer (pH 7.3) (Sigma) at 4o C overnight. The sample
would be dehydrated in a graded series of alcohols (50 %, 70 %, 90 % and twice 100 %) and finally
critically dried in hexamethyldisilazane (TAAB Laboratories) for 5 min. The dehydrated samples
were normally stored in a case mounted onto stubs in a sealed dessicator. Samples were then
sputter coated sputter-coated with gold/palladium using a Polaron E5100 coating device (Polaron
CVT, Milton Keynes, UK). Samples were stored in a dessicator till viewing.
2.3.3 Plate scanning with document scanner
A further imaging method (advised by Prof. Timothy Arnett, UCL, Dept. of Anatomy) employed the
usage of a flat bed document scanner (Epsom photo 4200). For this purpose, samples exclusively
comprising cells cultured on tissue culture plastic dishes were stained, washed, and air dried dishes
placed on a scanner with a piece of white paper laid on top of the samples (forming a white colored
background). Images were acquired at 800 dots per inch (dpi). Images were cropped to highlight
samples.
2.3.4 Image analysis
Images were analysed with the Image Pro Plus software, version 4. Many of the panels of images
used in this thesis were prepared using Photopad Editor version 2.01 distributed by NCH Software
(www.nchsoftware.com).
2.4 Colony forming unit analysis
The hMSCs are a highly proliferative cell type capable of forming single cell derived colonies when
plated at extremely low cell seeding densities. The measure of colony forming ability of a cell
population is indicative of the relative proportion of uncommitted/replicative cells; and is evaluated
by a colony forming unit (CFU) assay (Colter et al., 2001). A typical CFU assay was performed by
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culturing ~100 cells in a T-75 flask for 10 days at 370C and 5% CO2 with bi-weekly medium
changes. At 10 days, cultures were fixed & stained in a solution of 3% Crystal Violet in 100%
Methanol, followed by several washes in distilled water and finally air dried. Comparative
parameters included number, density and diameter (> 2 mm).
The CFU analyses were primarily undertaken for fetal bovine serum batch selection and included
the further steps of analysing images representing 80% of surface area of a substrate with Image-
Pro Plus software. The analyses conducted were of colony number and mean colony diameter,
defined as the average of several diameters measured at 2o intervals around the centre of a
somewhat circular object. The measurements were calculated in mm scale of length. Data was
exported from software in a Microsoft Excel file to draw a histogram of size distributions.
2.5 Cell enumeration assays
Three different assays were used to establish cell numbers in experimental settings where
hemocytometric measurements were not applicable. These fluorescence based assays included the
CyQuant nucleic acid stain, Calcein-AM cytoplasmic stain, and the AlamarBlue cell viability assay.
The descriptions of individual assays and their applications in this study are described below.
2.5.1 CyQuant nucleic acid fluorescent stain
The CyQuant GR assay consists of a fluorescent dye that upon intercalating with double stranded
nucleic acid of ruptured cells, exhibits enhanced fluorescence. This is a destructive assay that
requires cessation of sample culture for analysis, and was used for cell enumeration in cell
attachment experiments. A typical assay was initiated by washing samples setup in 24-well plates
three times with di-cation free PBS and cyclically freeze-thawing the culture plate at -80oC,
enclosed in plastic film, for 3 h with 30 min intervals. Samples could be assayed at 3 h or stored at -
80oC for an indefinite time. The staining was conducted by preparing a working solution of dye in
lysis buffer; by diluting 1 ml stock lysis buffer in 19 ml of de-ionised water, to which were added 50
µl of the x400 concentrate of dye in DMSO. This homogenous clear dye solution was added at 150
µl per well of a 24-well plate with a micropipette and allowed to stand for 10 min at 4oC in the dark.
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Samples were then vigorously mixed with a micropipette and 100 µl of homogenate transferred to a
clean well of an opaque 96-well plate. Each sample was handled with an unused micropipette tip.
Fluorescence intensity was measured at excitation 530 nm and emission 590 nm. Total cell
numbers were determined by extrapolating fluorescent intensities of unknown samples from a
standard curve. A limitation of this assay was that the linear detection range with excitation 530 nm
and emission 590 nm filters was reduced to 1x 104 cells. The standard curve for this assay is
provided in figure 2-7.
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Figure 2-7 Standard curve of CyQuant
Figure shows a line graph of a six point standard curve, drawn by plotting mean
fluorescence emission values on y-ais against cell numbers on the x-axis. Fluorescence
values were obtained by plating calculated volumes of stock cell suspension in 24 well
plates. Samples were stained and fluorometric measured made as stated in 2.5.1. Curve was
drawn from zero-subtracted readings using linear regression analysis. Each point
represents mean of two replicates (n=2).
2.5.2 Calcein-AM cytoplasmic esterase activated fluorescent cell label
Calcein- AM (Vybrant Cell Adhesion kit; Molecular Probes; Sigma) is a cell-permeable non-
fluorescent molecule. It is hydrolysed intracellularly by cytoplasmic esterases to yield a highly
fluorescent calcein anion that can be retained in the cytoplasm of living cells for up to 5 h depending
on the cell type. It also has a higher fluorescence emission per cell number, making it an ideal
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assay to estimate cell numbers in attachment experiments. Calcein-AM is a non-destructive assay
that does not require cellular lysis. In a typical assay, cells were labeled in suspension at a
proportion of 5 µM of substrate dye in serum-free GM per of 5 x 106 cells.ml-1 for 40 min in
humidified conditions. Labeled cells were washed three times in divalent-cation-free PBS and viable
cell numbers estimated with a haemocytometer. Viable cells were re-suspended in serum-free GM
and applied to experimentation. End analysis of monolayers depended on the experimental
protocol. In general, fluorescence intensity was measured by gently washing monolayers with
divalent-cation-free PBS and measuring the intensity of emitted fluorescence of a whole surface at
excitation 530 nm and emission 590 nm. Cell numbers were determined by subtracting the
background readings of corresponding cell-free control surfaces and extrapolating the difference
from a standard curve. The standard curve was formed by seeding labeled cells on TCP in a 24-
well plate and measuring fluorescence intensity in situ; without washing samples (figure 2-8).
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Figure 2-8 Standard curve of Vybrant calcein-AM dye
Figure shows a line graph of an eight point standard curve with mean fluorescencent
emission values plotted against cell numbers. Samples were formed in 24-well plates by
plating calculated volumes of stock cell suspensions. Samples were processed as stated in
2.5.2. Curve was drawn from zero-subtracted readings using linear regression analysis.
Each point represents the mean+SEM of three replicates (N=3; n=3).
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2.5.3 AlamarBlue fluorescent-metabolic cell substrate
AlamarBlue is dark blue water soluble solution of a non-fluorescent dye called resazurin. This is a
reduction-oxidation indicator that is metabolized in cellular mitochondria to yield soluble fluorescent
red colored resorufin, which can be measured with fluorescence or colorimetric spectrometry. It is
an extremely easy and time efficient non-destructive assay that due to reportedly null toxicity to
cells can be used for the serial analysis of changes in cell numbers of a culture over an indefinite
course of time. An AlamarBlue assay would be conducted in cells cultured in 24-well plates in 1 ml
of culture medium. The oxidized blue dye was added to culture at 10 % the total volume of
supernatant (i.e. 100 μl dye per 1000 μl medium) and incubated for 4 h in humidified conditions. 
Following, 100 μl of conditioned culture supernatant of each sample would be transferred to an 
opaque microtitre plate, and fluorescence emission measured at excitation 530 nm and emission
590nm. The conditioned medium of cell cultures would be replaced with fresh GM for further
incubation and analyses. Cell numbers were determined by extrapolating fluorescent values from a
standard curve (figure 2-9).
AlamarBlue standard curve
0 50000 100000 150000
0
200
400
600
800
Number of cells
Fl
uo
re
sc
en
ce
em
is
si
on
at
59
0n
m
R2= 0.979
y= 0.006480x + 43.283
Figure 2-9 Standard curve for the AlamarBlue assay
Figure shows a line graph of a nine point standard curve with mean fluorescence emissions
plotted against cell numbers. Samples were formed in 24-well plates by plating calculated
volumes of stock cell suspensions. Samples were processed as stated in 2.5.3. Curve was
2 Materials and methods 2.5 Cell enumeration assays
66
drawn from zero-subtracted readings using linear regression analysis. Each point
represents mean+SEM, n=3.
2.6 Gene expression
Gene expression changes were analysed with real time polymerase chain reaction (RT-PCR) using
the 2-∆∆Ct method. This approach determines the ‘Ct’, threshold cycle, which is the cycle number at
which the reaction enters log exponential phase of amplification. This method comprised three
steps; the extraction of RNA, reverse transcription to cDNA and Taqman probe based RTPCR
assay of relative levels of expression. Descriptions of individual steps are provided in the following
sub-sections.
2.6.1 RNA extraction
Total RNA was extracted with the RNeasy Mini kit from Qiagen according to the manufacturer’s
instructions. These kits employ a silica membrane containing column; to which RNA adheres, and is
washed and later eluted. A typical sample would consist of adherent cells cultured on a substrate in
a 24-well TC plate. These were initially washed x3 with dication-free PBS and homogenized in situ
with buffer RLT (350 μl per 1.96 cm
2). Total RNA was precipitated from homogenate by mixing with
an equal volume of 70 % ethanol in distilled water, and then transferred to a silica membrane
column. The membrane captured total RNA would be washed in a series of different buffers to
remove excess cellular material and finally eluted from the membrane with RNAse-free water (40 μl 
per column). The integrity and quantity of extracted RNA was evaluated by spectrophotometry with
Tecan NanoDrop at excitation 260 nm and emission 280 nm.
2.6.2 Reverse transcription
Reverse transcription was performed with first strand synthesis reactions using the High Capacity
Reverse Transcription Kit from Applied Biosystems. Generally 100 µl cDNA would be prepared from
400 ng of RNA per sample combined in 1:1 with master mix according to the manufacturer’s
instructions. Samples were prepared in 0.2 ml PCR tubes in a thermocycler and later stored at – 80
oC.
2 Materials and methods 2.6 Gene expression
67
2.6.3 Real time polymerase chain reaction
The RT-PCR reactions were performed in a 7300 Real Time PCR System from Applied Biosystems.
These were undertaken in 25 μl reactions with 2.5 μl of cDNA per reaction; equivalent to 10 ng of 
RNA at the estimated 4 ng RNA per 1 μl of cDNA. The sample were run on a 1 h 45 min cycle to 
obtain the crucial ‘Ct’ value; it represents the point at which a particular transcript’s amplification
goes into exponential (log) phase of duplication. The ‘Ct’ values of the different markers were
normalised to the GAPDH house keeping gene of the sample sample to obtain ‘delta Ct’ values.
These were then calibrated to the reference, which comprised ∆Ct values of cells in suspension at
time zero to obtain ∆∆Ct values for each sample. Relative fold values of expression of a gene were
calculated arithmetically with the formula, 2-∆∆Ct. Fold values were calculated separately for each
replicate. These were then combined and used to calculate mean and error of samples with
Graphpad Prism.
2.6.4 Gene expression array
Human pluripotency gene arrays consisting of 384-well Taqman RTPCR micro-fluidic cards were
procured from AppliedBiosystems (Cat # 4385344); and used to evaluate global transcriptional
changes in genes associated with stem cell identity. These arrays contain a reservoir on the right
hand side of the plate, to which a 100 μl 1:1 mix of sample cDNA and Universal PCR master mix 
were added, and spun at 10, 000 x g to fill all rows. These cards were then run in a specialized RT-
PCR thermocycler (AppliedBiosystems 7900 HT) at the UCL Institute of Child Health, London, UK.
Data was exported in the form of Ct values, which were used to calculate relative fold differences in
expression between sampled genes with Graphpad Prism. Mean fold values of three specimens
were plotted in a heat map using the R software from The R Project for Statistical Computing
(www.r-project.org) with a dendogram adjoining similarly expressed genes, the distance between
which was calculated with Euclidean algorithm.
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2.7 Assays for calcium mineralisation
The degree of osteogenic mineralisation was assessed by (i) semi-quantitative Alizarin Red S Stain
dye elution method or (ii) quantitative QuantiChrom Calcium Assay. These are described below. In
addition, mineralisation was assessed in a few instances with the Von Kossa and alkaline
phosphatase stains.
2.7.1 Alizarin red S dye semi-quantitative monolayer stain
Alizarin red s is a red dye that has been used in histology for many years, in detecting calcifum salt
deposits (Puchtler et al., 1969). At acidic pH, the dye binds Ca2+ in a 2:1 molar stoichiometry
through a chelating process (Gregory et al., 2004). Matrix bound dye can be eluted in
cetylpyridinium chloride (CPC; Sigma) and absorbance of dye measured at 562 nm in a
spectrophotometer. These arbitrary units in comparison with a control provide a semi-quantitative
estimate of Ca2+ content between samples. Moreover, the stained samples, when imaged according
to the methods described in section 2.3.4, provided a visual assessment of the extent of calcium
mineralisation in different experiments.
The Alizarin red S stain was carried out by washing culture monolayers gently with divalent-ion free
PBS, and fixing the monolayer in 10 % formalin for 10-15 min. The monolayer would then be
stained with a 2 % Alizarin Red S Solution in deionised water pH = 4.1-4.3 for 10 min followed by x4
washes with water. Samples were then allowed to air dry. Calcium bound dye was eluted with 0.5
ml of 10 % (w / v) cetylpyridinium chloride in 10 mM sodium phosphate buffer, pH=7.2.
Spectrophotometric absorbance of elutant would be measured at 562 nm.
2.7.2 QuantiChrom colorimetric quantification of deposited calcium
The QuantiChrom calcium assay is a sensitive quantitative method of detecting free Calcium ions in
solution. It is a colorimetric assay in which a working reagent forms a blue coloration when in
contact with free-Ca2+; the intensity of which depends on the concentration of the ions. This
intensity was assayed by absorbance at 590 nm in a spectrophotometric plate reader. An assay
was performed by washing a monolayer cultured in 1.9 cm2 24-well TC-treated plate with dication-
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free PBS, and then lysing it with 500 μl of 1 M HCl for < 1 h. A 5 μl aliquot of lysate would be 
transferred to a clear bottom 96-well plate (duplicates per sample replicate); to which 200 μl of 
freshly prepared working reagent were added. The intensity of coloration was read at 562 nm.
Calcium concentrations (μg / ml) were determined by interpolating zero-subtracted absorbance 
values from a 10 point standard curve (figure 2-10). Cells cultured on TCP in GM were used as a
negative control of calcium mineralisation.
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Figure 2-10 Standard curve of calcium quantification assay
Figure shows a line graph of a ten point standard curve of calcium salt formed in a 96-well
plate. Samples were processed and stained as stated in 2.7.2. Curve was drawn from zero-
subtracted readings using linear regression analysis. Each point represents mean+SEM,
n=3.
2.7.3 Von Kossa stain
This stain has historically been used in conjunction with alizarin red s for mineralized tissue as it is
specific for phosphate or carbonate anions (Puchtler et al., 1969). It is a photochemical reaction in
which silver ions initially replace calcium in its salts by binding phosphate, and this complex is later
photochemically degraded with ultra violet radiation to release the silver (University of Utah, 2011).
The process was initiated by washing monolayers twice with divalent-ion free PBS, and fixed in 5 %
glutaryldehyde (Sigma) foe 30 min. Washed samples were flooded with 5 % (w / v) silver nitrate in
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water for 20 min under a 60 watt bright lamp. Samples were then washed x3 with water, and un-
reacted silver removed with 5 % sodium thiosulphate for 5 min. Samples were counterstained with
0.1 % nuclear fast red in water for 5 min, followed by rinsing in water and finally an air dry.
2.7.4 Alkaline phosphatase stain
This stain was conducted as described in (Nakamura et al., 2009). Monolayers were washed with
divalent-ions and fixed in 4 % glutaryldehyde in a way similar to the alizarin red s and von kossa
stain. Samples were then incubated with dye, made up by combining 5 mg Naphtol AS MX-PO4
(Sigma), 200 µl of dimethylformamide (Sigma), 25 ml of Tris-HCl (molecular weight 157.6 g / mol;
initial molarity 0.2 M, pH 8.3), 30 mg red violet LB salt (Sigma) and 25 ml distilled water. Dye was
filtered with Whatman’s no. 1. Samples were incubated with dye for 45 min and then washed with
water x3. Samples were air-dried and imaged as described in section 2.3.3.
2.8 Extracellular matrix collagen quantification
Extracellular matrix collagen was assayed with the Sircol collagen assay kit from Biocolor according
to the manufacturer’s instruction. An assay was conducted by homogenising a monolayer with 400
μl cold 0.5 M acetic acid (Sigma) supplemented with 100 ug/ml porcine pepsin (Sigma-Aldrich). 
Homogenates from three replicate wells were pooled and concentrated overnight with 200 μl 
Isolation and concentration reagent at near 0o C. The pooling of samples was required due to the
small amounts of collagen formed by cells in individual wells. Concentrated pooled replicates of a
sample were centrifuged to pellet collagen; while the albumin rich supernatant was discarded.
Collagen pellets were stained with Sirius red in picric acid for 30 min and later washed in acid-salt
solution to remove excess unbound dye. Bound stain was eluted with 250 μl of an alkali solution. 
Absorbance of 200 μl of each sample was measured at 555 nm in a clear microtitre plate. Total 
quantities were determined by interpolating absorbance values from a 6 point standard curve (figure
2-11).
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Figure 2-11 Sircol collagen assay standard curve
Figure shows a six point standard curve generated from stock (1 mg.ml-1) in 1.5 ml tubes,
and stained as described in 2.8. Curve was drawn from zero-subtracted readings using linear
regression analysis. Each point represents mean of three replicates. Each point represents
mean+SEM, n=3.
2.9 Alkaline phosphatase specific activity assay
Alkaline Phosphatase (ALP) is an enzyme that catalyzes the hydrolysis of phosphate esters
(dephosphorylation) from an array of molecules to produce an organic radical and an inorganic
phosphate (PO4-3). It is mainly expressed in liver and bone cells; in the latter tissue, ALP enacts to
provide inorganic phosphate to a calcifying nucleation site. In this study, cellular ALP quantities
were evaluated with an ALP Specific Activity assay kit (K412; Biovision) that was based on the
Bassey et al method (Bassey et al., 1946). This kit provides a quantitative estimate of cellular ALP
by measuring the molar rate of dephosphorylation of a colorless substrate p-nitrophenyl phosphate
(pNPP) to a yellow colored product nitrophenyl phosphate (NPP) in an alkaline buffer at 37oC. A
typical assay would be initiated by washing a monolayer three times with dication-free PBS and
then homogenising it with 200 μl of alkaline assay buffer (0.3 M 2-amino -2 methylpropane -1,3 
Diol/0.002 M MgCl2 in water; pH=10.25); and centrifuging homogenate at 13,000 x g for 3 min to
pellet insoluble material. A 40 μl aliquot of clear lysate of a sample would be diluted 1:2 with assay 
buffer and incubated with 50 μl of 5mM of pNPP-substrate for 60 min at room temperature. 
2 Materials and methods 2.9 Alkaline phosphatase specific activity assay
72
Reactions were stopped with a solution of 0.9 M NaOH. Absorbance of sample wells was measured
at 405 nm. Absorbance units were interpolated from a 6-point standard curve of NPP to determine
the quantity (umol) of product generated per sample (figure 2-12). This was used to calculate ALP
specific activity by dividing the estimated quantity of NPP generated (umol) by volume of sample
(ml) and then by time of reaction (min). The mean ALP specific activity per sample was normalized
to mean number of cells; determined by the AlamarBlue method that is described in section 2.5.3.
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Figure 2-12 Standard curve of pNPP hydrolysis
Figure shows a six point standard curve of alkaline phosphatase substrate pNPP formed in
96-well plates by incubating with a constant amount of enzyme in alkaline buffer. Reactions
were stopped after 20 min. Curve was drawn from zero-subtracted readings using linear
regression analysis. Each point represents mean+SEM, n=3.
2.10 ELISA
Sandwich enzyme linked immunosorbant assay (ELISA) was used to quantify a select set of protein
molecules. These colorimetric assays were procured as complete kits that could detect target
proteins within a fixed linear range when used according to the manufacturer’s instructions. The
details of the kits used are in table 2-2.
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Table 2-2 Details of ELISA kits
Protein Type Kit
Osteocalcin (OC) Secreted
protein
Invitrogen; KAQ1381
Osteoprotegrin (OPG) Secreted
protein
R&D; DY805
Growth differentiation factor 15 (GDF-15) Secreted
protein
R&D; DY957
Transforming growth factor β 1 (TGFβ1) Secreted
protein
R&D; DY240
Growth Arrest Specific type 6 (Gas6) Secreted
protein
R&D; Dy88g
Total extracellular Axl Cell surface R&D; DYC1643-2
Phosphotyrosinated extracellular Axl Cell surface R&D; DYC2228-2
2.10.1 General protocol
The ELISA kits from R&D Systems were based on a similar sandwich design; in which, a capture
antibody would be initially adsorbed on to the base of a well of a 96-well plate (clear, tissue culture
treated). A sample would be added to the capture antibody, and allowed to bind. A detection
antibody conjugated with an enzyme would then bind the capture antibody bound antigen. The
bound enzyme would reduce the then added substrate at a rate proportional to the quantity of
adsorbed detection antibodies. The quantity of protein would be estimated by interpolating from a
standard curve. All ELISA kits used in this study were provided with lyophilised antibodies and
standards; apart from the osteocalcin kit, which contained pre-coated wells. The protocol applied to
accomplish an ELISA is presented in table 2-3.
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Table 2-3 General protocol for ELISA
Steps are intermediated by washes, which were performed by adding and removing 400 μl of 
0.05 % Tween20 in PBS.
Step Objective Duration Protocol
0 Preparation ~ Prepare reagents: PBS; BSA in PBS (1%); Washing
buffer 0.05% Tween in PBS.
1 Capture antibody overnight Incubating 4 μg / ml in PBS; 100 μl to each well of a 
96-well plate at room temp.
2 Blocking < 1 hr Incubate plate with 1% BSA in PBS.
3 Standards and
sample
< 2 hr Incubate samples in pre-labelled wells. Fresh
prepared standards in duplicate.
4 Detection antibody < 2 hr Incubate 100 ng/ml in PBS per well.
5 Streptavidin HRP 20 min 100 μl per well. 
6 Substrate 20 min 100 μl per well of 1:1 v/v hydrogen peroxide and 
Tetramethylbenzidine
7 Stop ~ 50 μl of 2 N H2SO4 per well.
8 Readings ~ Absorbance measurement at 450 nm wavelength.
9 Calculations ~ Calculate standard curve with linear regression
Subtract background readings from samples; and
interpolate from curve. Normalise readings to cell
numbers (determined with AlamarBlue).
2.10.2 Sample handling
Two different types of proteins were studied; secreted and cell surface bound. The secreted
proteins included growth arrest specific 6 (Gas6), osteoprotegrin (OPG), growth differentiation factor
15 (GDF-15), transforming growth factor beta 1 (TGF-β1) and osteocalcin (OC). These were 
quantified in cell culture supernatant that had been conditioned by cells. The cell surface protein
quantified was Axl; in monolayer homogenates of samples. All samples were collected and stored
at -80o C till the point of analysis. Osteocalcin, Osteoprotegrin, GDF-15 and TGF-b1 were diluted
1:10 in deionised water prior to incubating with capture antibodies in step 3 of the assay protocol.
The Gas6 secreted protein was found to be expressed at minute quantities and required
concentration. It was quantified by pooling supernatants from x6 replicate wells of a sample;
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lyophilizing at – 80 0 C in a freeze dryer; and then reconstituting the pellet with 0.5 ml distilled water,
hence concentrating the samples x12 of the initial. The Axl cell surface molecules were quantified in
monolayer homogenates in a pool of x6 replicate wells of a 24-well plate, homogenized in 600 μl of 
lysis buffer (at 100 μl homogenate per well)..   
2.11 Recombinant protein techniques
The method deemed optimum to query the effects of Axl receptor deregulation was that of
supplementing medium with either an Axl receptor agonist or antagonist. These had been
previously applied in the initial studies linking Axl signaling with cellular mineralisation in
uncommitted bovine pericytes; and were shown to be highly effective in generating a contrast
response from cells (Collet et al., 2003; Collet et al., 2006). The description of the recombinant
proteins and the evaluation of their dose dependent effects relevant to the study are presented in
the following subsections.
2.11.1 Recombinant proteins
The human Axl/Gas6 signaling pathway was agonized or antagonized with recombinant proteins.
The receptor agonist used in this study was recombinant human Gas6 (rhGas6) (885-GS; R&D
Systems). This molecule was heterologously expressed as a 70.5 kDa protein in a murine myeloma
cell line, NS0. The rhGas6 molecule was previously used by (Canfield et al 2003) as an agonist for
Axl signaling. The protein used in this study was procured in a lyophilized form, which was re-
constituted with di-cation-free PBS supplemented with 1 % (v / v) BSA (R&D Systems) to a final
concentration of 100 μg / ml.  
Three Axl receptor antagonists were used in conjunction to knockdown receptor signaling as much
as possible. This mixture (referred in later text as MAb) included recombinant human Axl
extracellular domain (Axl-ECD) (154-AL-x; R&D Systems), and blockade monoclonal antibodies
against the receptor (AF154; R&D Systems) and the ligand (AB885; R&D Systems). The Axl-ECD
has been used previously to knockdown receptor signaling by binding soluble ligand (Collet et al.,
2003) and preventing it from inducing receptor dimerisation. It is a 71.7 kDa protein expressed in
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the NS0 cell line. The Axl-ECD was supplied in PBS and was supplemented with BSA. The
blockade monoclonal antibodies were raised in goats immunized with NS0 derived recombinant
proteins and purified with affinity chromatography. The antibodies were supplied lyophilized and
were re-constituted with divalent cation free PBS to a final concentration of 1 μg / μl. All proteins 
were aliquots in sterile 0.5 ml tubes and stored at – 800C. Aliquots were used as required. The
concentration of rhGas6 used in experiments was 1 μg.ml
-1. The concentration of each of the three
components of the receptor antagonist (MAb) was as follows; Axl-ECD, Cf = 4 μg.ml
-1; anti-Axl
blockade monoclonal antibodies, Cf = 2.5 μg.ml
-1; and anti-Gas6 monoclonal antibodies, Cf = 10
μg.ml
-1. The concentrations of Axl-ECD and rhGas6 were experimentally determined in a dose
curve described below.
2.11.2 Dose effects of recombinant proteins of cellular responses
The optimum measure of forming a scatchard plot to evaluate the dynamics of bindings of receptor
ligand binding, and hence control experimental deregulation of the pathway could not be
undertaken. The effects were instead evaluated as described previously (Collet et al., 2003). The
dose-dependent effects of Axl-ECD and rhGas6 on mineralisation of hMSCs were assessed with
a12 d osteogenic mineralisation experiment; quantifying deposited calcium, according to methods
described in 2.7.2. For this experiment, hMSCs were seeded on TCP in 24 well plates at a density
of ~2.5 x 104 cells per well in OM. The range of concentrations analysed were arbitrarily set above
and below the values reported previously; Axl-ECD 4 μg/ml and rhGas6 0.25 μg/ml sufficiently 
affects bovine vascular pericytes. The concentration range chosen for Axl-ECD was 1, 2 and 4
ug.ml-1; with anti-Axl blockade monoclonal antibodies, Cf = 2.5 μg.ml-1; and anti-Gas6 monoclonal
antibodies, Cf = 10 μg.ml
-1
. The concentrations chosen for Gas6 were 0.125, 0.25, 0.5 and 1 μg/ml. 
The results are presented in figure 2-13. The low doses of Axl-MAb seemed to cause a decrease in
calcium mineralisation; this effect was negated at 4 and 8, which mineralized to a similar extent.
The rhGas6 affected mineralisation by causing a dose dependent decrease in mineralisation, but
the concentration evaluated did not yield complete inhibition.
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Figure 2-13 Effects of Axl receptor-signaling deregulation on hMSC mineralisation
Figure shows bar charts with mean + 1SD N = 1, n = 3 calcium concentration readings
plotted against the concentrations of Axl (a) agonist and (b) antagonist. Human MSCs were
seeded at 25,000 cells per well in 24-well plates. Growth medium was replaced with
osteogenic medium supplemented with recombinant proteins at 1 d post seeding, and
cultures maintained till 12 d. Samples were processes as described in section 2.7.2. (a)
Receptor agonist induced a significant decrease in calcium concentrations. (b) The MAb had
no opposite effect on cells, which mineralised similar to the control at high doses. The
experiment verified (Collet et al. 2003)’s findings that Axl signalling negatively regulates
osteogenic cellular calcium mineral deposition and provided a strong reference for required
receptor agonist concentrations. The lack of effect of the antagonist was considered to be
due to the late time point of 12 d. *, **, *** = p < 0.05, 0.01, 0.001, respectively.
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2.12 Data collection and statistics
2.12.1 Raw data analysis
Raw analytical output from quantitative assays was retrieved with Microsoft Excel. This software
was used to organize data as input for statistical analyses with GraphPad Prism v5.
2.12.2 Statistical analyses
The Graphpad Prism version 5.02 statistical package was used for mathematical calculation and
statistical analyses of raw data. The calculations included (i) basic statistics (mean, median,
standard deviation, and frequency distribution); (ii) linear regression analysis for standard curves of
quantitative colorimetric assays; (iii) a 4 parameter logistic non-linear regression for standard curves
of ELISAs; (iv) interpolation of data sets from standard curves; (v) statistics for the determination of
normality between data sets and (vi) evaluation of significance of the differences of means.
Statistical analyses were conducted after generating a data matrix consisting of readings from three
donors with three replicates per donor (N = 3; n = 3). Data was first tested for normality with
D'Agostino-Pearson normality test. This was followed by repeated measures ANOVA (analysis of
variance) with a 2-way repeated measures test utilizing the Bonferonni post test comparing all
variables. For samples with lesser replicate numbers or less time points, a 1 way ANOVA was used.
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3 Phenotypic responses of hMSCs to modified titanium substrates
3.1 Introduction
A human marrow stromal cell (hMSC) is a strongly adherent cell that is phenotypically proliferative
at the single cell level in vitro, seemingly under a biological pressure to attach and adapt to a
substrate to initiate replication (Benayahu et al., 2007). Examinations of the phenotypic differences
of committed osteoblastic cell lines to the topographically variable Ti substrates have shown that
these differentiated cells adhere at relatively higher numbers to the rough surfaces than smooth, all
the while adapting a relatively stretched morphology, with cytoplasmic processes emanating within
the topographical spaces on the rough compared to a more spread appearance on the smooth
surfaces (Wall et al., 2009; Miron et al., 2010). These cells also display altered proliferative
responses, being highly restricted on the rough compared to the smooth, and thus yielding a
comparatively lower number of progeny on the former over the course of time in culture (Wall et al.,
2009; Schwartz et al., 2009a; Zhao et al., 2007).
The phenotypic responses of uncommitted hMSCs to modified Ti surfaces have been studied to a
relatively lesser extent, but are suggested to differ from those of committed osteoblasts, based on
their phylogenetic difference. The evidence at hand (Wall et al., 2009), measuring attachment at 3
to 24 h post contact has indicated no significant differences in the number of these cells to attach to
the polished, SLA or modSLA surfaces. Though the study did not examine the dynamics of cellular
attachment and morphology at earlier time points, when differences in these are expected to be
highest, it did, however, demonstrate a stark comparison between the morphology of hMSCs on the
different substrates. Cells on the modified surfaces adapt a stellate or stretched form on the rough
compared to a ‘fried egg’ analogous shape of cells on the smooth. Furthermore, rough surfaces
cause a significant lag in proliferation resulting in a lesser number of cells on the rough than smooth
by 7 d (Olivares-Navarrete et al., 2011; Olivares-Navarrete et al., 2010a). Moreover, the rough-
hydrophobic substrate modSLA also seems to challenge hMSCs with pro-apoptotic stimuli, reported
in (Wall et al., 2009) to cause a concomitant increase in the number of Stro-1 positive cells.
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The present, initial section of this thesis hypothesised that human MSCs exhibit different phenotypic
response to the different modified Ti surfaces. It aimed to evaluate hMSC attachment,
morphological and viability on all substrates at different times following initial cell contact. The
specific objectives were to (i) compare cellular attachment at early time points; (ii) contrast
differences in cellular morphology; (iii) compare cellular proliferative responses over the course of
culture; and, (iv) examine the transcriptional activity of viability related genes, in hMSCs seeded on
tissue culture plastic, polished, SLA and modSLA titanium surfaces.
3.2 Experimental protocols
In these experiments, the Ti discs were prepared as described in section 2.1.2. The cellular
specimens were cultured according to the methods described in 2.2.3.
3.2.1 Cellular attachment
Cellular attachment was initially assessed at 1, 3 and 24 h post seeding; and later at various
intervals within a 1 h time frame. The initial analysis was conducted to delineate the point of
maximal cellular attachment while the latter as conducted to identify differences within this time
frame of initial cell attachment.
3.2.1.1 Assessment of cellular attachment at 1, 3 and 24 h
The hMSCs (N = 2; n = 3) were plated on TCP, P, SLA and modSLA at a density of 1 x 104 cells per
disc in serum free-basal αMEM. At 1, 3 and 24 h, cultures were washed twice with divalent cation-
free PBS, and processed with the CyQuant nucleic acid fluorescent dye assay as described in
2.5.1.
3.2.1.2 Assessment of cellular attachment at very early times
Calcein-AM labeled hMSCs (N = 3; n = 3) were prepared as described in 2.5.2. Labeled cells were
seeded on TCP, P, SLA and modSLA at a density of 1.5 x 104 cells.cm-2 in serum-free basal GM.
Cell numbers were enumerated at 5, 15, 30, 60 and 180 min post seeding by washing twice with
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dication-free PBS and measuring fluorescence emissions as described in 2.5.2. Un-seeded
surfaces of each type immersed in 0.5 ml dication-free PBS were used for background control.
3.2.1.3 Image analysis of early cellular attachment
The calcein-AM dye assay derived samples from 3.2.1.2 were further analysed by back-scattered
scanning electron microscopy (BS-SEM) to evaluate relative numbers of attached cells. For this
purpose, samples were fixed in 4 % glutaryldehyde (Sigma-Aldirch) and analysed as described in
2.3.2. Furthermore, morphological differences between cells seeded on the different Ti discs were
examined by sputter coating samples and examining at high resolutions with SEM, according to the
methods described in section 2.3.2.
3.2.2 Cellular viability
Cellular viability of hMSCs on different surfaces was assessed by serially examining cell number
changes and the expression of viability related markers over the course of culture in GM and OM.
The different media were tested due to their differential phenotypic effects on uncommitted cells.
The experiments conducted are detailed below.
3.2.2.1 Cellular proliferation
The effects of different surfaces on hMSC proliferation were assessed by seeding 2000 cells per 15
mm disc and serially assessing cell number changes till confluence with the AlamarBlue assay (N =
3; n = 3). This method is detailed in section 2.5.3. The initial seeding density was chosen due to the
cellular specimen’s phenotype: it is a highly replicative cell that forms colonies, which a high initial
seeding density may inadverterntly affect due to contact inhibition of proliferation.
3.2.2.2 Gene expression analysis of viability related genes
RT-PCR was used to evaluate the expression of pro-apoptotic Caspase 3, viability/anti-apoptotic
BCL-XL and proliferation related Ki-67 antigen in hMSCs. The analysis was conducted in GM and
OM (N = 3; n = 3) at 1, 3, 5, 7 and 10 d post seeding. The methods applied for this analysis are
detailed in section 2.6. A higher cell density was used compared to the proliferation assay as the
RT-PCR analysis would have required a higher intial quantity of total RNA.
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3.3 Results
3.3.1 Cellular attachment
3.3.1.1 Assessment of cellular attachment at 1, 3 and 24 h
The results of this analysis are presented in figure 3-1. It indicates the hMSCs to have attached at
near-maximal numbers to all surfaces by 1 h; without undergoing any significant further increase by
24 h. The trend shows a higher number of attached hMSCs on the smooth surfaces compared to
rough at all time points. The P surface displayed a significantly higher number of cells at 1 h
compared to TCP; but this difference was removed by the 3 and 24 h time points. The rough SLA
had a significantly higher number of cells attached compared to modSLA at 3 and 24 h.
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Figure 3-1 Assessment of cellular attachment at 1, 3 and 24 h
Figure shows mean + 1SD (N = 2, n = 3) number of cells plotted against time on the x-axis.
The hMSCs were plated at 10,000 cells per disc and number of attached cells evaluated with
CyQuant as described in 2.5.1. Figure shows near-maximal attachment of cells at 1 h post
seeding on all respective surface types. Cell numbers increased slightly on plastic but
seemed to remain stagnant on other surfaces. There were significantly lower cell numbers of
the rough compared to smooth surfaces. *, **, *** = p < 0.05, 0.01, 0.001 TCP vs. Ti. #, ##, ###
= p < 0.05, 0.01, 0.001 polished vs. SLA/modSLA. +, ++, +++ = p < 0.05, 0.01, 0.001 SLA vs.
modSLA.
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3.3.1.2 Assessment of cellular attachment at very early times
The results of this experiment are presented in figure 3-2, It shows that the P surface had a
significantly higher number of attached cells compared to TCP and rough at all time points
examined in the 1 h timeframe (p < 0.01). There were no differences between TCP and rough
surfaces in the mean number of attached cells.
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Figure 3-2 Assessment of cellular attachment at very early times
Figure shows mean + 1SD (N = 3, n = 3) number of cells plotted against time in culture.
Calcein labelled hMSCs were plated at 1.5 x 104 cells.cm-2 on tissue culture plastic, polished,
SLA and modSLA Ti surfaces. Number of attached cells were determined at 5, 15, 30 and 60
min by discarding non-adherent cells and measuring fluorescence intensity as described in
section 2.5.2. The number of cells attached to polished Ti was significantly higher than all
other samples. There were no major differences between tissue culture plastic and the rough
surfaces in this time interval. * = p < 0.05, TCP vs. Ti. ## = p < 0.01, polished vs.
SLA/modSLA.
3.3.1.3 Image analysis of early cellular attachment
The Ti discs with adherent cells from 3.3.1.2 were examined with back scattered SEM. An objective
software based analysis of the images could not be conducted due to the inability of the software to
distinguish between the weak signals generated from certain samples, in which cells that had
undergone a high degree of spreading. A set of images derived from this analysis for one donor are
presented in figure 3-3. These are x100 magnification views of uncoated discs at 5, 15 and 30 min.
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A subjective assessment of these images, using a manual count of dark objects, corroborated the
findings presented in 3.3.1.2, which is of a higher number of cells attach to the polished surface
compared to the rough at any time during the initial 30 min post seeding. This is indicated in the
images in figure 3-3 as a higher number of dark objects on the P surface compared to the rough
surfaces. The panel of images of adherent cells at 60 min could not be provided due to cellular
spreading causing faintness in signal intensity in samples of the polished surfaces.
Morphological differences were assessed by sputter coating samples and imaging under high
resolution. The images obtained are presented in figures 3-4, 3-5 and 3-6 for polished, hydrophobic
SLA and hydrophilic modSLA. These indicate the human MSCs attach and spread comparatively
faster and in symmetric fashion to the polished Ti substrate (figure 3-4). Cells initially have a
spherical appearance at 5 min with the cytosol forming an even base under a large nucleus. These
cells proceed to evenly spread their membranes and cytoplasm, and eventually acquire a flattened
form, characteristic of an hMSCs in tissue culture plastic. On the rough surfaces, cells seem to
initially take a rather constricted morphology, being mostly round with very few extensions trying to
‘peg’ the cell into the rough topography. These cells do not appear to alter much in form over the
course of 60 min. At 3 h, the cells appear as stretched with extensions emanating from all sides to
farther spots in the near vicinity, presumably to secure cellular attachment. The cells at 3 h have a
smoothened upper or dorsal side. Though an analysis to view the under or ventral side could not be
ascertained, it can be imagined that it would be highly asymmetric, un-even, with a lot of tension
being exerted towards the cytoskeletal and nuclear apparatus. These cells appear stretched, as if
they were tents held up by cytoplasmic extension ‘pegs’.
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Figure 3-4 Morphology of cells on polished Ti surface
Figure is a panel of scanning electron micrographs of human MSCs that have attached
polished Ti discs. The experimental details are provided in section 3.2.1.3.
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Figure 3-5 Morphology of cells on rough
Figure is a panel of scanning electron micrographs of human MSCs that have attached to
SLA Ti discs. Experimental details are provided in section 3.2.1.3. (A) At 5 min after contact,
cells are still rounded with processes being extended towards the rough topogrphy (x1500
magnification). (B) Cells at 30 min are somewhat rounded and seem to be in the process of
attachment (x500 mag.). (C) Cellular spreading does not seem to significantly increase by 60
min (x1000 mag.). (D) At 3 hours, cells have adapted to the rough topography
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Figure 3-6 Morphology of cells on rough
Figure is a panel of scanning electron micrographs of human MSCs that ha
modSLA Ti discs. Experimental details are provided in section 3.2.1.3. (A) The hMSCs are
round at 5 min of attachment (x1500 magnification). (B) They appear to have attached with
an asymmetric morphology at 30 min, but are still somewhat rou
seem to have adapted to the rough topography by extending over the rough substrate by 60
min (x2000 mag.). (D) The cells adapt a stretched asymmetric form on the rough surfaces.
Image shows two cells in the left half, which are
heading further out onto the substrate. The round objects in the right half of the image are
likely dust particles (x1500 mag.). These micrographs indicate that hMSCs adapt to modSLA
in a way similar to the SLA surface
extensions essentially hooking cells into place synonymous to the fastening of an outdoor
tent. Cells seem comfortable by 3 hours and like the SLA, bear a smoothened dorsum but a
surely very asymmetric/rough
titanium
-hydrophilic modSLA Ti surface
nd (x500 mag.). (C) Cells do
stretched into place with extensions
. Cells adhere but in an asymmetric manner, with
ventral face in direct contact with the rough topography.
3.3 Results
88
ve attached to
3 Phenotypic responses of hMSCs to modified titanium 3.3 Results
89
3.3.2 Cellular viability
3.3.2.1 Cellular proliferation
The proliferation of 2000 cells per disc was serially examined till confluence with AlamarBlue. This
analysis was conducted in GM and OM due to the differential effects of these media on cellular
growth. The results of this analysis are presented in figure 3-7. The graphs indicate a similar
number of cells on all surfaces at 1 d post seeding. In the later days, an increase in cell numbers
takes place that is magnitudinally higher in GM than OM.
In GM (figure 3-7 A),a gradual increase in cell numbers was observed on all surfaces till 5 d. The
cells cultured on TCP and P had significantly increased in numbers by several folds at 7 d in
culture; and progressed at this higher rate of replication through 10 d, leading to a confluent
monolayer by 14 d post seeding. The hMSCs cultured on the rough surfaces displayed a relative
lag in cellular proliferation till 7 d of culture. The number of cells on the rough surfaces increased by
10 d, and cultures attained near confluent numbers by 18 d post seeding. The smooth surfaces had
yielded significantly higher number of cells at all time points compared to the rough. A phenomenon
of monolayer delamination was observed to occur very frequently on the TCP than Ti; particularly
after the 14 d time point. This event is characterised by the detachment of the monolayer from one
end and its sequestering into a stretched sheet or a compact aggregate at the opposite end.
In OM (figure 3-7 B), cellular proliferation occurred at a very slow rate on all surfaces from 1 to 7 d
post seeding. Cells cultured on TCP plateaued at attaining 80 % confluence by 14 d. Cells cultured
on all Ti surfaces ceased to increase in cell numbers from 7 d and displayed a similar number of
cells through the remainder of culture.
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a. Effects of substrates on hMSC proliferation in growth medium
1 3 5 7 10 14 18
0
5.010 4
1.010 5
1.510 5
2.010 5
TCP GM
SMO GM
SLA GM
modSLA GM
Time in culture (days)
N
um
be
r
of
ce
lls
b. Effects of substrates on hMSC proliferation in osteogenic medium
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Figure 3-7 Serial analysis of cellular proliferation of hMSCs cultured on Ti surfaces
Figure shows mean + 1SD (N = 3, n = 3) number of cells plotted against time in culture. A
total of 2000 cells were seeded per disc and numbers determined till confluence. (a) In
growth medium, cells proliferated at a significantly higher rate on TCP and polsihed Ti, and
attained confluence by 10 days post seeding. Cells initially proliferated at similar rates on
both rough surfaces but were relatively restricted on the modSLA than SLA at 10 and 14
days, attaining confluence by 18 days post seeding. (b) Osteogenic medium caused a
decline in the rate of cell proliferation and changes in cell number. TCP permitted the
highest cell proliferation compare to Ti from 7 to 18 days. P was similar to TCP at 5 and 7
days but plateaued with the rough Ti surfaces from 7 to 18 days. These indicate cells
proliferate at higher rate on smooth surfaces and are affected by osteogenic medium
supplements, which restrict proliferation at later times.
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3.3.2.2 Gene expression analysis of viability related markers
The expression of viability related genes caspase 3 (pro-apoptotic), BCL-XL (anti-apoptotic) and Ki-
67 antigen (proliferation association antigen) were assessed with RT-PCT through the course of the
initial 10 d culture in GM and OM. The results of these analyses are presented in figures 3-8, 3-9
and 3-10, respectively. The values presented are folds relative to reference, which were cells in
suspension at time zero of the experiment (reference fold value = 1).
a. Effect of substrates on transcription of caspase 3 in growth medium
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b. Effect of substrates on transcription of caspase 3 in osteogenic medium
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Figure 3-8 RT-PCR analysis of caspase 3 expression
Figure shows mean + 1SD (N=3, n=3) fold expression values plotted against time in culture,
evaluated in (a) growth and (b) osteogenic media. The pro-apoptotic gene was transcribed at
a higher fold value by rough surfaces than smooth in the early stages of culture at 3 d in GM
however, 1 d in OM. It was transcribed at a basal level in all samples through the remainder
of experiment. * = p < 0.05, TCP vs. Ti. # = p < 0.05, P vs. rough.
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Caspase 3 was expressed at low levels through the experiment in both media conditions (figure 3-
8). In GM, caspase 3 was up-regulated by the rough substrates (p < 0.05, modSLA vs. TCP /
polished) at 3 d post seeding. A similar significant relative up-regulation of the gene was observed
in OM at 1 d post seeding on both rough surfaces. The cells displayed a similar upregulation on all
surfaces at 7 d in OM. The TCP seeded cells maintained the increased expression at 10 d; while
having been the Ti relatively decreased by the Ti.
a. Effect of substrates on transcription of BCL-XL in growth medium
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b. Effect of substrates on transcription of BCL-XL in osteogenic medium
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Figure 3-9 RTPCR analysis of BCL-XL expression
Figure shows mean + 1SD (N=3, n=3) fold expression values plotted against time in culture,
evaluated in (a) growth and (b) osteogenic media. The anti-apoptotic gene was transcribed in
all sample at a higher fold value following early contact. Its expression in hMSCs seemed
higher on the rough surfaces than smooth. It was transcribed at a basal level in all samples
through the remainder of experiment, which was higher in osteogenic than growth medium.
The anti-apoptotic BCL-XL was expressed at varying levels in all samples thought the course of
culture (figure 3-9). In GM, the gene was up-regulated several folds by cells on all surfaces at 1 d
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post seeding, which were reduced to lower fold values from 3 to 10 d post seeding. In osteogenic
medium, the gene was upregulated by all surfaces at 1 d post seeding. Its expression relatively
increased on the Ti than TCP by 3 d; but was down-regulated to a similar level by 5 d. BCL-XL
expression relatively increased on all surfaces to a similar level similar at 7 to 10 d post seeding in
OM
a. Effect of substrates on transcription of Ki-67 in growth medium
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b. Effect of substrates on transcription of Ki-67 in osteogenic medium
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Figure 3-10 RTPCR analysis of Ki-67 expression
Figure shows mean + 1SD (N=3, n=3) fold expression values plotted against time in culture,
evaluated in (a) growth and (b) osteogenic media. (a) Ki-67 was expressed on all substrates
at 1 and 3 d, but later decreased to basal levels. (b) The gene was initially transcribed higher
on smooth surfaces compared to both rough surfaces. Its expression significantly increased
many fold than TCP at 3 d. The expression of the gene was relatively higher in OM cultured
cells than GM. * = p < 0.05, TCP vs. Ti surfaces.
The proliferation specific Ki-67 antigen was detected in all samples analysed (figure 3-10). In GM, it
was up-regulated by cells on all surfaces at 1 d post seeding. The mean level of expression was
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higher on TCP than Ti surfaces; but this difference was insignificant. The gene was expressed at
relatively low levels on all surfaces through the remainder of culture. In OM, Ki-67 was upregulated
by TCP compared to the Ti surfaces at 1 d post seeding. The levels of expression of the gene
significantly increased on the Ti surfaces compared to TCP at 3 d; but had reduced to a relatively
low level on all surfaces by 5 d. A similar upregulation was detected from 7 to 10 d.
3.4 Discussion
3.4.1 Cellular attachment
In the experimental results presented here, the hMSCs were observed to have attached at near
maximal numbers by 1 h post seeding on the respective surfaces. These experiments were
conducted in conditions that minimized protein interference in attachment, as is normally the case in
a two dimensional in vitro cell culture model. In both analyses conducted, the cells displayed a
higher affinity of attachment to the smooth than rough Ti surfaces by 1 h. This affinity was
differentially higher for P than TCP at earlier time points. The higher affinity of the hMSC to Ti was
decreased by topographical modifications of the SLA and modSLA surfaces. This differential
behavior of cells to the modified Ti surfaces had extended to cellular spreading, and was most
evident in the delayed spreading on SLA and modSLA compared to polished at 60 min post
seeding. The micrographs of cells attached at 5, 30, 60 and 180 min exhibit this difference quite
starkly.
3.4.2 Cellular viability
Similar to attachment and morphology, the viability of hMSCs was differentially affected by the
various surfaces used in this study. In conditions that favored cellular proliferation (GM), the hMSCs
increased to similar numbers at a higher rate on TCP and P; but displayed an extended lag on the
rough Ti surfaces at all corresponding time points. However, in conditions that promoted cellular
differentiation to an osteoblastic phenotype (OM), cellular proliferation took place on all surfaces;
but was comparatively higher on TCP while having plateaued to a similar level on all Ti surfaces
from 7 to 18 d of culture.
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The early upregulation of caspase 3 in cells cultured on rough surfaces, in both media conditions,
suggests a degree of apoptosis to have been faced by these cells. This upregulation of Caspase 3
is seemingly paralleled by downstream induction of anti-apoptotic BCL-XL and Ki-67; suggesting
that if the caspase 3 event was an external pressure of ‘death’ exerted by the rough topographies
on the cells, then it was countered by an intrinsic pressure to survive and proliferate by the cells. A
complication derived from these results is the late upregulation of caspase 3 parallel with BCL-XL
and Ki-67 at 7 to 10 d post seeding in OM; discussed below.
3.4.3 Significance of findings
The analyses conducted in this section show differences in the phenotypic responses of hMSCs,
considered a highly adherent and proliferative cell type, to four different substrates. The parameters
of attachment, morphology and viability are inter-related; the way cells attach affects their spreading
and hence, the dynamics of their replication. Interestingly, morphological change in the form of
increased stretch has been implied to instigate phenotypic differentiation in uncommitted cells
(section 1.3.6). Though this last point has not been specifically evaluated here by correlating shape
with gene expression, the findings clearly indicate phenotypic differences in the form of differential
attachment and morphological spreading, to bear an impact on downstream phenotypic function,
which in this case is cellular proliferation.
This restriction in proliferation by the rough surfaces has been suggested to be due to a degree of
apoptosis that may occur very early in cell – rough surface contact, and is highest on the modSLA
and then SLA compared to smooth (Wall et al., 2009). An analysis of apoptosis with a specified
method, such as terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), may have
discreetly elaborated the occurrence of apoptosis, and determined any specificity with the rough-
hydrophilic modSLA surface. However, the gene expression analyses showed an early upregulation
of caspase 3 followed by an upregulation of anti-apoptotic genes BCL-XL and Ki-67; which together
support the notion that cells are challenged by a degree of death from the rough surfaces.
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Parallel to the increased apoptosis, (Wall et al. 2009) also reported an increase in Stro-1 positive
cells in samples cultured on the modSLA surface. This marker is associated with stem cell identity
within the current confines of our understanding of adult stem cells, and based on which the authors
implied the observed cell death to be specific to Stro-1 negative non-adult stem cells present in the
heterogeneous hMSC specimen. Hence, the heterogeneity of the hMSC specimen is a further
factor that complicates the observed phenotypic response of altered viability on the different
surfaces.
The results suggest a synchrony between pro and anti-apoptotic activity of cells at early and late
periods of culture, which may negate the exclusive association of apoptosis, or caspase 3, with
non-adult stem cells of the specimen. Interestingly, caspase 3 has been assigned a function in
mediating osteogenesis; indicated in the observed lack of runx2/cbfa expression in caspase 3 (-/-) (-
/+) mice (Miura et al., 2004) as well as other cellular phenotypes (Lamkanfi et al., 2007). This
compares the likelihood of the association of caspase 3 with apoptosis against its possible role in
the enhancement of osteogenic differentiation in the hMSCs on the rough surfaces, as has been
previously reported for these surfaces by several authors (see section 1.3.6), and that can be
anticipated from osteogenic medium. Additionally, considering the strong possibility that an
apoptotic cell may relinquish its adherent phenotype and be ‘released’ into suspension due to loss
of structural integrity of the cytoskeletal apparatus, further complicates the argument of apoptosis by
rough substrates and instead leans towards the idea of temporal osteogenic priming by the
modified topographies.
The likely association of caspase 3 with hMSC differentiation on the rough is to a degree supported
by (Wall et al. 2009)’s apoptosis analysis, in which the authors used an anti-Annexin V antibody in
flow cytometric analysis of hMSCs in early contact with the different surfaces. Importantly, Annexin
V occurs richly in matrix vesicles as part of their outer membranes (Arispe et al., 1996). As the anti
Annexin V antibody of the kit could detect apoptotic bodies and matrix vesicles alike, it could be
suggested, theoretically, that the entity detected in those experiments had likely not as much to do
with apoptosis as it might have had with matrix vesicle secretion. This, in turn, could explain the
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relative upregulation of caspase 3 at the later times in osteogenic medium, as the cells would have
been induced and cultured for a sufficient period to express an osteogenic phenotype.
However, it is the pattern of BCL-XL and Ki-67 expression downstream to caspase 3 in both media
conditions and times that underscores its likelihood with apoptotic stimuli; at least within the initial
frame of contact. Accordingly, it seems the rough surfaces influence an extrinsic signal of death on
hMSC cell populations, which is overcome by the downstream upregulation of anti-apoptotic and
proliferative genes.
The results indicate that hMSCs are sensitive to substrate material, capable of differentially
identifying Ti surfaces to TCP and rough from smooth topography. An interesting effect of the
surfaces was unmasked in OM, which caused cells on all Ti surfaces to replicate uniformly; and in
stark contrast to the TCP. This suggests the presence of sensory mechanisms capable of
distinguishing and responding between substrate materials and topography.
3.5 Summary
The phenotypic characteristics of hMSCs are affected by substrate material, topography and
chemistry.
 The hMSCs attach at higher numbers to polished than rough surfaces at earlier times, but
are near similar at 3 h; indicating differences in their initial potentials to attach to the
different substrates.
 The hMSCs seem to spread at a faster rate on the smooth surfaces during the initial 1 h
following contact, with the rough surface seeded cells exhibiting a relatively stretched
morphology. This is indicative of differences in the influence of substrate topography on cell
shape (a scenario for tensegrity, influence of tension on integrity).
 Cellular proliferation at low density is comparatively restricted on the rough Ti surfaces
compared to the smooth. In the presence of osteogenic inducers, Ti seeded cells proliferate
similarly without surface dependent effects compared to plastic.
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 Apoptosis seems to be faced by hMSCs on the rough surfaces at some time points that is
responded to by the downstream upregulation of survival and proliferative factors.
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4 Osteogenic responses of hMSCs to modified Ti surfaces
4.1 Introduction
Modified Ti implant surfaces promote implant integration by increasing, amongst several factors, the
extent of bone-implant contact and denser bone accrual in the peri-implant zone (Wennerberg and
Albrektsson, 2009). Attempts at understanding the biological basis of these observations have led
investigators to examine osteoblastic cell responses to various Ti surfaces in vitro (Mendonca G et
al., 2008). The present evidence indicates that rough and additionally rough-hydrophilic Ti surfaces
induce distinct temporal differences in the transcriptional regulation of genes key to bone-
physiology, which correlate with higher matrix mineralisation and increased synthesis of osteoblast-
specific factors (section 1.3.5)(Brett PM et al., 2004; Rausch-Fan et al., 2007). The biological
mechanisms underlying these observations remain largely unexplained. Recent findings indicating
the selective engagement of cell surface integrin molecules (ITGA2 and ITGB1) in synchrony with
increased downstream osteoclastogenic regulator synthesis (Schwartz et al., 2009b). These lines of
preliminary evidence are strongly suggestive that cells are capable of differentially sensing Ti
substrates and topography, and may undergo a temporal and magnitudinal enhancement in
osteoblastic function compared to control polished surfaces.
Although the osteoblast is functionally important in generating bone in implant integration, its
existence at the bone implant interface is a derivative of migrating adult stem cells (Davies, 2003).
These precursors are important reparative cells of mesenchymal tissues that are recruited very
early to the site of implant placement for bone regeneration (Caplan, 2008). The importance of their
early interaction with the implant surface in determining the efficacy of downstream events renders
them an important position in the conundrum of osseointegration. The studies of the osteogenic
responses of these cells to modified Ti surfaces have been relatively few and inconclusive. These
have shown the hMSCs are affected in a way similar to osteoblastic cells by exhibiting enhanced
osteogenic phenotypic expression on the modified Ti surfaces compared to plastic or polished Ti
(Wall et al., 2009; Olivares-Navarrete et al., 2010a; Olivares-Navarrete et al., 2011).
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This early intermediate section of the study hypothesised that rough and rough Ti implant surfaces
induce an enhancement in hMSC osteogenic responses. It aimed to examine the affects of modified
Ti implant surfaces on the osteogenic phenotypic differentiation of hMSCs, with the belief that a
mechanism underlying the superior clinical performance and in vitro effects of modified Ti implant
surfaces is a preferential pressure exerted on adult stem cells to acceleratedly differentiate and
function as osteoblasts. The specific objectives were to comparatively (i) examine transcriptional
changes in key osteogenic genes, (ii) evaluate osteogenic ECM mineralisation related parameters
and (iii) assess the synthesis of osteoblastic phenotypic markers in hMSCs cultured on TCP, P,
SLA and modSLA over the course of 21 d.
The genes analysed included markers representing different facets of osteogenic differentiation.
These were
 the master osteogenic runt-related transcription factor (Runx2) responsible for commitment
and initiation of differentiation;
 extracellular matrix vesicle associated calcium nucleating proteins osteopontin (OP / SSP1 /
BSP1) and integrin dependent bone sialoprotein (IBSP / BSP2);
 osteo-specific extracellular matrix collagen (COL1A1);
 inorganic phosphate donor alkaline phosphatase (ALP);
 osteoblast specific negative regulators of osteoclastogenesis, osteoprotegrin (OPG) and
growth differentiation factor type 15 (GDF-15);
 transforming growth factor beta 1 (TGF-b1) with
 the upstream integrin subunits alpha 2 (ITGA2) and beta 1 (ITGB1) implicated to be
differentially modulated by Ti and furthermore, Ti surface modifications;
 bone matrix associated soluble osteocalcin or gamma-carboxyglutamic acid-containing
protein osteocalcin (OC / BGLAP);
 non-canonical Wnt5a due to its implicated role in the early events of osteogenic
differentiation and mechanotransduction.
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In addition, the gene encoding peroxisome proliferator-activated receptor (PPARγ), a marker of 
adipogenic differentiation (David, 2007), was used to further compare the dynamics of phenotypic
change in hMSCs on the different surfaces. The osteogenic ECM mineralisation of samples was
assessed by quantifying calcium deposited in ECM monolayers cultured on the different substrates
at 7, 14 and 21 d. This was paralleled by quantifications of total ECM collagen formation and
relative estimation of ECM alkaline phosphatase levels. The soluble osteoblastic protein markers
comparatively assessed were the osteoclastogenic inhibitors OPG and GDF-15; their implicated
upstream instigator TGFb1, as well as the bone formation associated matrix molecule osteocalcin
(OC / BGLAP). These parameters were analysed over the course of 21 d that is a duration
considered paralleling that of an osteogenic cell in its native context.
4.2 Experimental protocols
In these experiments, the Ti discs were prepared as described in section 2.1.2. The cellular
specimens were cultured according to the methods described in 2.2.3.
4.2.1 Gene expression analysis of osteogenic genes
Transcriptional changes were analysed in a set of genes associated with different parameters of
osteogenic differentiation using Real time PCR. The set of genes and their importance in
differentiation are tabulated in table 4-1. For this experiment, hMSCs were seeded at a density of
~2.5 x 104 cells.ml-1 in OM on TCP, P, SLA and modSLA. Analyses were conducted at 1, 7, 14 and
21 d post seeding by lysing monolayers, extracting total RNA and converting it to cDNA, followed by
PCR with Taqman probes. The methods used in this experiment are detailed in section 2.6. Details
of the Taqman® probes used are in table 9-10 (appendix IV).
4.2.2 Assessment of osteogenic mineralisation
The osteogenic mineralisation of hMSCs was examined in samples formed by seeding cells on
TCP. P, SLA and modSLA at an initial density of ~1.25x 104 cells.cm-2 in OM. Cultures were
maintained with bi-weekly medium changes. The specific parameters evaluated in these samples
are described below:
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4.2.2.1 Semi-quantitative assessment of mineralisation with Alizarin red S Stain
The semi-quantitative Alizarin Red S dye method was used to initially assess cellular mineralisation
at 7 d post seeding. The method for this stain is detailed in 2.7.1.
4.2.2.2 Quantitative assessment of total ECM calcium deposition
A quantitative estimate of ECM deposited calcium was conducted at 7, 14 and 21 days post
seeding with the QuantiChrom Calcium assay, according to the method described in 2.7.2. Cell
numbers were estimated with the AlamarBlue assay described in 2.5.3.
4.2.2.3 Quantification of total ECM collagen
The total ECM collagen formed by cells was measured at 7, 14 and 21 days post seeding according
to the Sircol method described in 2.8. Total collagen was not measurable within a single well due to
small quantities formed by the small number of cells. Hence, collagen isolates from three replicates
of a sample were pooled, concentrated with kit reagents and then stained, to obtain a reading. This
was normalized to total cell numbers that were estimated with the AlamarBlue assay as in 2.5.3.
4.2.2.4 Comparison of alkaline phosphatase synthesis
The relative quantity of ECM ALP formed on individual surfaces was evaluated at 7, 14 and 21 days
post seeding; by assaying ALP Specific activity per cell according to the method described in 2.9.
Cell numbers of samples were estimated with the AlamarBlue assay as in 2.5.3.
4.2.3 Assessment of osteoblastic protein secretion
Secreted proteins associated with the osteoblastic phenotype were examined at 7, 14 and 21 days
post seeding with specific ELISA kits; described in 2.10. The soluble proteins quantified were
osteocalcin (OC), osteoprotegrin (OPG), growth differentiation factor 15 (GDF15) and transforming
growth factor beta type 1 (TGF-b1). These molecules were quantified in culture supernatants of
hMSCs, plated on different surfaces at an initial density of 1.25 x 104 cells / cm-2, collected and
replaced daily for 21 days. Samples were diluted x10 prior to assay in di-cation-free PBS. Cell
numbers were estimated with the AlamarBlue assay as in 2.5.3.
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4.3 Results
4.3.1 Gene expression analysis of osteogenic genes
The real time PCR method was used to examine temporal changes in the expression of osteogenic
genes (Appendix IV, table 9-10). The results of this analysis are presented in the paragraphs below.
The Runx2 gene, shown in figure 4-1, was significantly more upregulated by rough surfaces than 1
day post seeding compared to both smooth surfaces. The gene was expressed at low level by cells
on all surfaces through the remainder of culture period.
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Figure 4-1 RT-PCT analysis of Runx2 expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. Runx2 was significantly upregulated at 1 d by the rough surfaces
compared to tissue culture plastic and polished Ti. It was expressed at a baseline through
the remaining times. N=3, n=3; * = p < 0.05, TCP vs. any Ti. # = p < 0.05, P vs. Rough
surfaces.
The bone sialoprotein type 2 (BSP2) gene was upregulated by the Ti surfaces at 1 d post seeding
compared to TCP, as shown in figure 4-2. The gene was expressed at low levels on all surfaces at
7 and 14 d. It was significantly upregulated several fold on the smooth surfaces compared to rough
at 21 d post seeding.
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Figure 4-2 RT-PCT analysis of BSP2 expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. BSP2 was upregulated at 1 d by the Ti surfaces compared to tissue
culture plastic. The surfaces did not modulate the extracellular matrix protein until 21 d while
the smooth surfaces exhibited highly significant upregulation compared to the rough
surfaces. N=3, n=3; *** = p < 0.001, TCP vs. any Ti. # = p < 0.05, polished vs. rough Ti
surfaces.
The osteopontin (OP) gene (figure 4-3) was significantly upregulated on the rough surfaces
compared to TCP and polished at 1 day post seeding. The gene was expressed at low levels on all
surfaces at 7 and 14 d. It was upregulated to a significantly higher fold value by cells on TCP and
polished at 21 d post seeding compared to rough.
4 Osteogenic responses of hMSCs to modified Ti surfaces 4.3 Results
105
Osteopontin (OP)
1 7 14 21
0
50
100
150
200
***
###
*
***
*
###
TCP
P
SLA
modSLA
Time in culture (days)
Re
la
tiv
e
fo
ld
ex
pr
es
si
on
Figure 4-3 RT-PCT analysis of osteopontin expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. OP was highly significantly upregulated at 1 day by the Ti surfaces. The
cells did not modulate the extracellular matrix protein in the intermediate period of culture.
At 21 days, the smooth surfaces seemingly induced a highly significant upregulation of OP
compared to the rough. N=3, n=3; *** = p < 0.001, TCP vs. Ti surface. ### = p < 0.001, P vs.
Rough surfaces. + = p < 0.05, SLA vs. modSLA.
The extracellular matrix collagen type 1 alpha chain (Col1a1) gene was upregulated several fold on
the TCP compared to all Ti surfaces through the course of the experiment (shown in figure 4-4).
The polished Ti seeded cells seemed to display a relative increase in Col1a1 expression till 14 d of
culture. The rough surfaces displayed no change in the gene’s transcription between the first and
last time points.
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Figure 4-4 RT-PCT analysis of collagen 1 alpha 1 expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. The Col1a1 gene was expressed significantly higher on TCP than Ti at all
time points. N=3, n=3; *, **, *** = p < 0.05, 0.01, 0.001, respectively for TCP vs. Ti.
The ALP gene shown in figure 4-5 was expressed at similar levels on all surfaces at 1 and 14 d. It
had been significantly upregulated at 7 d by TCP compared to the rest, and later at 21 d by
modSLA compared to all samples.
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Figure 4-5 RT-PCT analysis of alkaline phosphatase expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
ALP was expressed at similar levels at 1 d by all samples. Its expression had increased
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significantly higher on TCP than Ti surfaces at 7 d. It was expressed at baseline levels
through the remainder of culture, but was significantly upregelated more on the modSLA
rough0hydrophilic Ti surfaces at 21 d. N=3, n=3; * = p < 0.05, TCP vs. Ti surface. # = p < 0.05,
polished vs. rough Ti surfaces. + = p < 0.05, SLA vs. modSLA.
The result for OPG is shown in figure 4-6. It shows the gene was significantly upregulated by TCP
and P at 3 d compared to rough surfaces. The expression of the gene increased significantly on the
rough whilst decreasing on the smooth by 21 d.
Osteoprotegrin (OPG)
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Figure 4-6 RT-PCT analysis of osteoprotegrin expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. OPG was initially transcribed at significantly higher levels by cells on
smooth than rough Ti. This trend was inversed at 21 d with stark expression of the gene in
the rough surfaces than smooth. N=3, n=3; * = p < 0.05, TCP vs. Ti surface. # = p < 0.05,
polished vs. rough Ti surfaces. + = p < 0.05, SLA vs. modSLA.
GDF-15 was, as shown in figure 4-7, was expressed at a significantly higher level on the rough
surfaces at 1 d post seeding. The expression of the gene had increased on the smooth surfaces at
7 and 14 d; but had equilibrated by 21 d.
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Growth differentiation factor 15 (GDF15)
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Figure 4-7 RT-PCT analysis of GDF-15 expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. Growth differentiation factor 15 (GDF-15) was initially transcribed at
significantly higher levels by cells on rough Ti than tissue culture plastic and polished Ti.
The gene was seemingly transcribed at higher levels at 14 d. N=3, n=3; * = p < 0.05, TCP vs.
Ti surface.
The results for TGF-β1 are shown in figure 4-8. The gene did not display any early differences in 
expression between the surfaces. It was significantly downregulated by the rough surfaces at 14 d
compared to smooth, which later fell to near equal levels on all surfaces by 21 d.
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Transforming Growth Factor 1 (TGF1)
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Figure 4-8 RT-PCT analysis of TGFβ1 expression in hMSCs 
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcripts investigated at 1, 7, 14
and 21 days in OM. TGFβ1 was initially transcribed at similar levels by cells at 1 and 7 d. Its 
expression significantly increased on the smooth by 14 d while decreasing on the rough.
Levels of the gene had equilibrated by 21 d. N=3, n=3; * = p < 0.05, TCP vs. Ti surface.
The integrin molecules ITGα2 and ITGβ1, shown in figure 4-9, displayed a significantly higher fold 
expression on TCP compared to the Ti surfaces. This difference occurred late for ITGα2 but was 
observable very early for ITGβ1.  These molecules are cell surface adhesion receptors, which have 
been previously suggested to be highly specific to Ti. The experiment here reveals these
molecules, at the genetic level, are induced to be expressed at significantly higher fold values by
the TCP than Ti,
4 Osteogenic responses of hMSCs to modified Ti surfaces 4.3 Results
110
a. Integrin alpha 2 (ITG2)
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b. Integrin beta 1 (ITG1)
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Figure 4-9 RT-PCT analysis of integrin molecules ITG α2 and β1 expression in hMSCs 
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcription examined at 1, 7, 14
and 21 days in OM. (a) A semi-log graph with relative fold expression presented as log10 due
to the small relative values achieved for sample at 1 d. ITGα2 was seemingly upregulated by 
cells on the rough Ti than smooth surfaces by a very small fold value at 1 d. This
upregulation was highly significant at 14 and 21 d between TCP and any Ti surface. (b) ITGβ1 
was initially expressed at a slightly higher fold value in cells on TCP than Ti surfaces. Its
levels of expression had equilibrated at similar levels on all surfaces by 21 days in culture.
The gene was seemingly transcribed at higher levels at 14 d. N=3, n=3; *** = p < 0.001, TCP
vs. Ti surface.
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The Wnt5a pro-osteogenic molecule (figure 4-10) was comparatively upregulated by the rough
surfaces at 1 d. It had decreased on the rough by 7 d. Its expression increased to similar levels on
all surfaces by 21 d.
Wnt5a
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Figure 4-10 RT-PCT analysis of Wnt5a expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcription examined at 1, 7, 14
and 21 days in OM. The Wnt5a molecule was upregulated to a relatively higher fold value by
cells on modSLA than other surfaces at 1 d post seeding. The expression of the gene
decreased by 7 d but was significantly upregulated by TCP compared to other surfaces by
14 d. The gene seemed to be expressed at similar levels by all samples at 21 d. N=3, n=3; * =
p < 0.05, TCP vs. Ti surface.
The osteocalcin molecule (OC / BGLAP), as shown in figure 4-11, exhibited a relative heightened
expression on the rough surfaces than smooth at 7 d, which was significantly higher at 21 d. The
smooth surfaces seemingly had upregulated the gene highly significantly at 14 d, which had
decreased compared to the rough surfaces by 21 d.
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Figure 4-11 RT-PCT analysis of osteocalcin expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcription examined at 1, 7, 14
and 21 days in OM. The molecule was initially upregulated to a relatively higher fold value by
modSLA at 1 d post seeding. The expression of the gene relatively increased on the rough Ti
than smooth surfaces by 7 d. A significant downregulation was observed on the rough than
smooth by 14 d, which was reversed by the final time point to be significantly higher on the
rough than smooth surfaces. N=3, n=3; *** = p < 0.001, TCP vs. Ti surface. ## = p < 0.01, P
vs. Rough Ti surfaces.
The peroxisome proliferator-activated receptor (PPARγ) is a nuclear receptor that is a potent 
instigator of adipogenic differentiation. The gene seemed initially expressed higher on Ti than TCP.
Its expression, shown in figure 4-12, was markedly upregulated on TCP and P compared to the
rough at 3 d post seeding. Expression of the gene persisted through the culture period; and was
seemingly higher on the Ti than TCP at 21 d.
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peroxisome proliferator-activated receptor gamma (PPAR )
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Figure 4-12 RT-PCT analysis of osteocalcin expression in hMSCs
A bar chart with mean+1SD fold values of relative expression plotted against time in culture.
Cells were seeded at 25,000 cell/disc and relative levels of transcription examined at 1, 7, 14
and 21 days in OM. The molecule was detected in all samples at 1 d post seeding. Its
expression had increased by 3 d, and was higher on the smooth surfaces than rough. The
modSLA hydrophilic surface had relatively decreased expression than SLA at 3 d mark. The
gene displayed expression through the later phases of culture. N=3, n=3.
4.3.2 Assessment of osteogenic mineralisation
4.3.2.1 Semi-quantitative assessment of mineralisation with Alizarin Red S Stain
This experiment was an initial assessment of the relative levels of calcium deposition on different
surfaces at 7 d post seeding in OM. The results of this experiment at presented in figure 4-13. The
results show the modSLA surface to have significantly (p < 0.001) induced the highest level of
Alizarin red s stain compared to all surfaces. It was magnitudinally followed by SLA and then P, with
the least stain present on TCP. The difference between TCP and P was much smaller than of P
with SLA or modSLA; indicating a significantly higher level of calcium deposition on the rough.
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Figure 4-13 Semi-quantitative assessment of mineralisation with Alizarin Red S Stain
Box and whisker plot with minimum to maximum readings (T-bars), median (horizontal line),
centre quartiles (coloured boxes above and below median) and mean depicted by centre
cross (+) near median line. A total of 25,000 cells were seeded per disc. Samples were fixed
and stained after 7 d culture in osteogenic medium. The rough surfaces had induced
significantly higher levels of calcium deposition by this time. There were no significant
differences between tissue culture plastic and polished Ti. The hydrophilic modSLA surface
had caused significantly higher levels of calcium deposition than hydrophobic SLA. N = 1; n
= 3. *** = p < 0.001, TCP vs. any Ti. ### = p < 0.001, P vs. rough. +++ = p < 0.001, SLA vs.
modSLA.
4.3.2.2 Quantitative assessment of total extracellular matrix calcium deposition
The quantity of calcium deposited per cell number was evaluated at 7, 14 and 21 d post seeding.
The results of this analysis are illustrated in figure 4-14. The result shows the rough surface seeded
cells had deposited significantly higher levels of calcium at 7, 14 and 21 d post seeding compared
to TCP and P. The P surface had induced a significantly higher level of calcium deposition at 14
and 21 d post seeding compared to TCP. The modSLA surface had significantly induced higher
calcium mineralisation compared to SLA at 14 and 21 d.
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Quantitative estimation of calcium deposition
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Figure 4-14 Quantitative assessment of total extracellular matrix calcium deposition
Bar chart indicating mean + 1SD of calcium deposited per cell number per surface type.
Approximately 25,000 cells were seeded per disc in OM. Quantities of deposited calcium and
cell numbers were estimated at 7, 14 and 21 d post seeding in OM. The chart indicates
calcium deposition was higher on rough surfaces than smooth at all time points. TCP was
observably weaker in inducing calcium mineralisation compared to the Ti surfaces. N = 3, n
= 3. **** = p < 0.001, TCP vs. any Ti. ### = p < 0.05, P vs. rough. ++, +++ = p < 0.01, 0.001
respectively, SLA vs. modSLA.
4.3.2.3 Quantification of total extracellular matrix collagen formation
The total amount of collagen formed in triplicates was normalized to total cell numbers across three
wells to evaluate differences in the synthesis of the ECM molecule. The results obtained are
illustrated in figure 4-15. The analysis indicates that cells on all surfaces initially formed similar
levels of collagen by 7 d. This progressively increased significantly more on the TCP compared to Ti
through the remainder of the experiment. The rough surfaces had induced a significantly higher
level of collagen synthesis compared to polished surface at 14 and 21 d.
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Figure 4-15 Quantification of total extracellular matrix collagen formation
Bar chart indicating mean + 1SD of collagen formed per cell number per surface type.
Approximately 25,000 cells were seeded per disc in OM. Quantities of collagen formed per
cell numbers were estimated at 7, 14 and 21 d post seeding in OM. The chart indicates
collagen formation was higher TCP than Ti surface. The rough surfaces had deposited
significantly higher levels of collagen compared to polished Ti. N =3, n = 3. * = p < 0.05, TCP
vs. any Ti. # = p < 0.05, P vs. rough.
A ratio of total calcium per collagen was calculated from data collected in 4.3.2.2 and 4.3.2.3. This
was performed to assess differences in the extent of calcification of the extracellular matrix of the
hMSC monolayers cultured in OM on the different surfaces. This was initiated by calculating the
total amount of calcium present in three wells by summing values of the three replicates in μg. This 
sum was divided by the total quantity of collagen (μg) assayed in a replica pool of triplicates. This 
ratio was separately calculated for each of the three donors and the mean of the resulting three
donors specific values calculated and plotted in a bar chart presented in figure 4-16. It shows the Ti
surfaces, particularly modSLA, to have induced a significantly higher amount of calcification per
collagen compared to TCP at all time points examined. This is attributed to a higher rate of collagen
synthesis with a lower rate of calcium deposition on the TCP surface, and vice versa on the rough.
The ratio of calcium per collagen did not increase significantly on the rough surfaces from 14 to 21
d; but had progressively increased on the P surface, exceeding in value to the rough surfaces by 21
d. This was partly due to a relative increase in collagen levels on the rough surfaces at that time; as
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well as a concomitant increase in calcium deposition on the P. Importantly, however, the pattern of
increase in mineral density over the course of time implies the cells to have reached an in vitro limit
of ECM calcification; deduced from the plateau formed on the rough surfaces between 14 and 21 d,
which might represent a limitation of this model. The results indicate that cellular mineralisation
characteristics are highly altered by material type and furthermore, substrate topography.
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Figure 4-16 Ratio of extracellular matrix calcium per collagen
Bar chart indicating mean + 1SD of μg calcium deposited per μg collagen in monolayers 
formed by hMSCs on different discs. The graph shows the Ti surfaces to have formed highly
calcified extracellular matrices compared to tissue culture plastic. This calcification was
significantly higher for the rough Ti surfaces compared to smooth. The hydrophilic modSLA
had induced significantly higher matrix calcification than SLA at 14 d. *, **, *** = p < 0.05,
0.01, 0.001 respectively TCP vs. any Ti. #, ##, ### = p < 0.05, 0.01, 0.001 P vs. Rough
surfaces. +++ = p < 0.001, SLA vs. modSLA.
4.3.2.4 Comparison of alkaline phosphatase activity
The specific activity of ALP per cell was examined in hMSCs cultured on the various surfaces for 7,
14 and 21 d to evaluate differences in enzyme synthesis. The results of this analysis are illustrated
in figure 4-17. The enzyme was observed at a significantly higher level on the rough by 7 and 14 d
in culture compared to TCP and P. Its levels decreased on all Ti surfaces at 21 d compared to TCP,
which displayed a progressive increase in the enzyme’s levels by this time.
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Figure 4-17 Estimation of alkaline phosphatase activity
Bar chart representing the mean + 1SD of the estimated activity of alkaline phosphatase per
cell number per surface type. 25,000 hMSCs cultured on the different discs in OM were
analysed at 7, 14 and 21 d post seeding. The graph indicates the rough surfaces had induced
more alkaline phosphatase expression and activity than TCP and P at 7 and 14 d. The Ti
surfaces seeded cells displayed a decline in enzyme activity per cell number at 21 d
compared to TCP, which progressively increased by this point. N = 1, n = 3. * = p < 0.05, TCP
vs. any Ti. # = p < 0.05, P vs. rough. + = p < 0.05, SLA vs. modSLA.
4.3.3 Assessment of osteoblastic protein secretion
The temporal synthesis of osteoblastic protein markers osteocalin, osteoprotegrin, growth
differentiation factor 15 (GDF-15) and transforming growth factor beta 1 (TGF-β1) was compared in 
culture supernatants, collected every 24 h over the course of 21 d. Samples at 1, 7, 14 and 21 d
were examined for analysis with ELISA. Total quantities were calculated and normalized to cell
numbers. The results of this experiment are presented in figure 4-18 to 4-21. The analysis indicated
the following:
The osteocalin (OC) molecule, shown in figure 4-18, was detected at significantly higher levels on
rough surfaces than TCP and polished through the course of culture. TCP and polished had
induced low levels of the protein through 7 d, which gradually increased by 21 d but were much less
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than on the rough. The peak expression on rough occurred at 7 d. The modSLA had relatively
higher OC levels than SLA at 21 d.
Osteocalcin (OC / BGLAP) protein quantification
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Figure 4-18 Assessment of osteocalcin secretion in hMSCs
Bar chart with mean+1SD secreted protein normalised to total cell number plotted against
time in culture. Secreted protein was quantified in total culture medium collected daily for 21
d. Significantly high levels of osteocalcin were induced by cells on the rough surfaces
compared to the smooth at all time points. The TCP surface, though producing detectable
quantities of the molecule, displayed a small increase over the course of culture. The P
surface seemed a stronger inducer than TCP by 7 d but did not display any significant
differences by the 14 and 21 d time points. N=3, n=3; *, **, *** = p < 0.05, 0.01, 0.001
respectively TCP vs. any Ti. #, ##, ### = p < 0.05, 0.01, 0.001 respectively P vs. Rough
surfaces.
The osteoprotegrin (OPG), shown in figure 4-19, molecule was initially expressed at similar levels
on all surfaces at 1 d. Expression of the protein increased on all samples by 7 d and was seemingly
higher on the rough than smooth. Levels further increased by 14 d but were highly significant on the
rough vs. smooth (p < 0.001). The levels of OPG remained increased on the rough surfaces
(modSLA > SLA) at 21 d while having been decreased substantially on the TCP and P.
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Figure 4-19 Assessment of osteoprotegrin secretion in hMSCs
Bar chart with mean+1SD secreted protein normalised to total cell number plotted against
time in culture. Secreted protein was quantified in total culture medium collected daily for 21
d. Significantly high levels of osteoprotegrin were induced by cells on the rough surfaces
compared to the smooth surfaces at 14 and 21 d. The TCP surface, though producing
detectable quantities of the molecule, displayed a small increase over the course of culture.
The P surface seemed similar in its capacity to induce OPG secretion to TCP. The
hydrophilic modSLA was observed to have induced significantly higher levels of OPG than
its hydrophobic counterpart. N=3, n=3; *, **, *** = p < 0.05, 0.01, 0.001 respectively, TCP vs.
any Ti. #, ##, ### = p < 0.05, 0.01, 0.001 respectively, P vs. Rough surfaces. + = p < 0.05, SLA
vs. modSLA.
Growth differentiation factor-15 (GDF-15), shown in figure 4-20, was initially expressed at a higher
level by cells on the smooth surfaces (P and TCP at 7 and 14 d respectively). The rough surfaces
had induced a significant increase in cytokine synthesis at 21 d compared to TCP and P. The
modSLA surface induced significantly higher GDF-15 levels than SLA.
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Figure 4-20 Assessment of growth differentiation factor 15 secretion in hMSCs
Bar chart with mean+1SD secreted protein normalised to total cell number plotted against
time in culture. Secreted protein was quantified in total culture medium collected daily for 21
d. GDF-15 was detected at 7 d at significantly higher levels on P Ti than all others. TCP
induced an increase in levels of protein by 14 d that were significantly higher than the Ti
surfaces. This trend was reversed by 21 d with a higher level of protein detected on the
rough surfaces. The modSLA induced significantly higher GDF-15 protein in culture
supernatant than all other surfaces at 21 d. N=3, n=3; * = p < 0.05, TCP vs. any Ti. # = p <
0.05, P vs. Rough surfaces. + = p < 0.05, SLA vs. modSLA.
The TGFβ1 molecule, shown in figure 4-21, was detected to be expressed by cells cultured on the 
various surfaces at 1 d. Levels of the molecule had increased significantly on the rough compared
to TCP and P by 7 d. These levels equilibrated by 14 and 21 d on all surfaces.
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Transforming Growth Factor 1 protein quantification
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Figure 4-21 Assessment of transforming growth factor beta 1 secretion in hMSCs
Bar chart with mean+1SD secreted protein normalised to total cell number plotted against
time in culture. Secreted protein was quantified in total culture medium collected daily for 21
d. TGFβ1 was detected in samples at all time points. It was significantly higher in 
supernatants of cells cultured on both rough Ti surfaces compared to TCP and P Ti.
Quantities of the protein decreased to a baseline at 14 and 21 d marks. N=3, n=3; * = p <
0.05, TCP vs. any Ti. # = p < 0.05, P vs. Rough surfaces.
4 Osteogenic responses of hMSCs to modified Ti surfaces 4.4 Discussion
123
4.4 Discussion
4.4.1 Gene expression analysis of osteogenic genes
The panel of genes evaluated in 4.2.1 represents markers important to the osteogenic
differentiation of hMSCs. Runx2 is a master transcription factor that up regulates genes important
for progressing into the pre-osteoblastic phase of differentiation. OP and BSP 2 are important
calcium nucleating proteins, secreted in matrix vesicles that induce heterogeneous calcification of
the ECM (Sikavitsas et al., 2001). ALP is the enzyme that supplies inorganic phosphate to the
developing calcium phosphate crystal within a matrix vesicle to when the crystal matures beyond
the vesicle membranes as well as reduce local pyrophosphate levels, which are a potent inhibitor of
osteogenesis. OPG and GDF-15 are osteoblast secreted negative regulators of osteoclastogenesis.
TGFb1 is a multirole protein, examined here for its significance with OPG synthesis. ITGA2 and
ITGB1 have been implicated in the differential response of cells to Ti, shown to be further
modulated by rough topographies in human mesenchymal stromal cell (Olivares-Navarrete et al.,
2010a). The Wnt5a gene was studied due to its significance with osteogenic commitment and
mechanotransduction based differentiation (Santos et al., 2010).
The genes displayed differences in expression between the surfaces and time points. Most of the
differences occurred either early or during the late half of culture. The differences induced by the
rough surfaces indicate cells were primed to transcribe certain genes at a higher level; suggestive
of a temporal enhancement in differentiation. This idea is mainly deduced from the initial significant
increase in Runx2 expression by the rough surfaces. The ECM components analysed due to their
association with osteogenesis displayed varied patterns of expression. BSP2 was not observed to
be transcribed at high levels initially; but was upregulated at the end of the culture period by the
smooth surfaces. The OP / SPP1 gene was upregulated starkly by the rough surfaces initially; but it
displayed a trend similar to BSP2, by being significantly upregulated on the smooth by the end of
culture period. The COL1A1 gene was highly transcribed by TCP but not Ti; in which the modified
surfaces further reduced its transcription. This was also the case for ALP albeit its expression
increased significantly on the rough modSLA by 21 d. These indicate that the hMSCs were
4 Osteogenic responses of hMSCs to modified Ti surfaces 4.4 Discussion
124
modifying their ECM microenvironments differently on the different surfaces; a loose inference
would be that events occurring earlier on the rough were taking place at a later time on the smooth.
The osteoclastic modulator OPG displayed heightened expression during the early phase of culture
on the smooth surfaces compared to rough. This difference was inversed by 21 d with a higher
expression of the gene on the rough surfaces compared to smooth. GDF-15 synthesis displayed a
variable pattern of but was comparable to the trend of OPG by being initially relatively higher on the
smooth that later inversed to be relatively higher on the rough. Within the context of the biological
functions of these proteins, the results suggest that the cells on the smooth surfaces were being
primed to inhibit osteoclastic differentiation in the initial phase of culture; which was instigated on
the rough at a much higher magnitude towards the end of the three week culture period. This notion
is supported by the expression pattern of TGFb1 paralleling that of OPG and GDF-15. This
molecule is assigned a role in the upstream regulation of OPG synthesis (Schwartz et al., 2009b)
and its expression here is indicative of the suggested pattern of osteoclast regulator synthesis by
cells on the different surfaces.
An expression analysis of the integrin subunits ITGA2 and ITGB1 showed these genes to be
strongly expressed by cells on TCP and P compared to the rough surfaces. This is interesting as
published literature has indicated these to be functionally Ti specific and to be highly affected by
modified Ti surfaces. These molecules are receptors for molecules found in bone (laminin, collagen,
fibronectin, etc.) and are expected to be co-altered with any change of the process of osteogenic
differentiation of cells expressing them. However, the lack of protein evidence, may prevent the
discrediting of the association of these molecules with modified Ti surfaces.
Of further interest, however, is the WNT5A gene due to the known role in mediating rock Rho
mediated osteogenic differentiation (Santos et al., 2010). Its differential upregulation on the rough
surfaces very early is a strong indicator of its potential association with transducing mechanical
stimuli to affect osteogenic differentiation; considering the cell morphological differences reported in
the previous chapter. The proposed initial enhancement in osteogenic differentiation on the rough
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and the role of cellular morphology within it is supported by the parallel downregulation of the
adipogenic PPAR-γ compared to the smooth surfaces.   
However, it is important to state that genes and their transcriptional findings are highly dynamic,
which allow an inference to be drawn but not a conclusion. This hindrance in due to a gene’s
possible multifunctional role complicated further by the synthetic in vitro environmental situation that
the cell encounters and adapts to. The implications of these findings rely on the phenotypic
analyses of cells on different surfaces; discussed below.
4.4.2 Assessment of osteogenic mineralisation
The effect of modified Ti implant surfaces on the osteogenic mineralisation of hMSCs in vitro was
assessed by analysing osteogenic calcium deposition, collagen content of the ECM, and ALP
levels. The results of this analysis indicate that the process of osteogenic mineralisation in hMSCs
is dynamic, and can manifest differently depending on micro-environmental stimuli. Further, the
results show that Ti metal increases osteogenic mineralisation compared to TCP; and that this
effect is further enhanced by modified topographies.
The differential enhancement of osteogenic mineralisation by Ti compared to TCP is evident in the
latter half of the culture period. This is characterised by significantly higher calcium and calcium /
collagen values formed on Ti than plastic, suggestive of an earlier initiation of osteogenic matrix
formation on the former. This relative enhancement in mineralisation of Ti is further significantly
enhanced by the high surface roughness and energy of the SLA and modSLA surfaces in the form
of a magnitudinal increase in calcium deposition, calcium/collagen and ALP expression.
The process of in vitro mineralisation of a cellular monolayer has limitations. One of these
presented in figure 4-6, is the saturation of the ECM by calcium as seen in the form of a stagnant
calcium/collagen ratio from 14 to 21 d on the rough substrates. The parallel pattern of ALP
synthesis on the rough, progressing till 14 d and then decreasing by 21 d, supports this idea. It
indicates cells on the rough surfaces temporally deposit higher levels of calcium than on the
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smooth; and are, likely through some kind of feedback loop, informed to cease mineralisation. This
inference further supports the hypothesised enhancement of differentiation and phenotypic function
by the rough Ti surfaces.
4.4.3 Assessment of osteoblastic protein secretion
The secretion of osteoblastic soluble proteins OC, OPG, GDF-15 and TGF-b1 per cell number was
examined in hMSCs cultured on the different surfaces in OM for 21 days. This was conducted by
collecting conditioned medium daily and estimating quantities in 1, 7, 14 and 21 d samples with
sandwich ELISA kits. OC is an apatite binding protein generally associated with bone formation.
OPG and GDF-15 are inhibitors of osteoclastogenesis. TGF-b1 is multifunctional molecule that has
been shown to be an upstream instigator of OPG secretion in cell to surface responses in addition
to its wider role in osteogenic differentiation processes. The analysis indicated the differential
metabolic state of cells on the different substrates in the form of variable cytokine secretion.
The OC molecule was markedly increased by the rough very early. Levels of OPG and GDF-15
were similar in all samples by 7 d; but had increased several folds on the rough in the latter half of
culture. TGFb1 was increased many fold on the rough by 7 d; which did not tally with the results of
OPG and GDF-15 as the latter’s association with TGFb1 was considered in 4.4.1. The findings
indicate that the rough substrates increase the secretion of bone formation related cytokines and
also modulate the temporal synthesis of negative regulators of osteoclastogenesis.
4.4.4 Significance of findings
The results of the three sets of analyses conducted here corroborate each other in suggesting that
the effect of modified Ti surfaces on hMSC differentiation is of a temporal and magnitudinal
enhancement. They indicate a strong influence of modified surfaces on the differentiation of
hMSCs. This influence causes cell to commit and transform relatively quicker, and deposit calcified
matrix earlier on the rough than P and TCP.
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In the previous chapter, differential cellular attachment and morphology were inferred to underpin
the altered hMSC phenotypic responses of restricted proliferation. Three viability related markers
were studied for their importance in cellular apoptosis. It was observed that caspase 3 was
comparatively upregulated on the rough surfaces at early and late times of a 10 d culture period in
OM. The importance of this molecule in osteogenic differentiation has been highlighted in the
absence of runx2 / cbfa activity in caspase 3 null mice (Miura. et al. 2004), and based on which, it
was suggested that the Caspase 3 upregulation in hMSCs in OM may have been due to an
osteogenic event in cells resulting from altered attachment and morphology on the rough surfaces.
The genetic and phenotypic findings in this section indirectly support this notion of Caspase 3’s
association with osteogenesis; as well strongly indicating the influence of modified Ti surfaces on
hMSC fate determination towards an osteogenic lineage.
The results parallel the differences observed between the performance different implant surfaces in
vivo (section 1.3.4). These further indicate that the multipotent hMSCs are highly sensitive to
substrate material, topography and chemistry; as well as that Ti metal is a highly ‘osteo-compatible’
material that promotes osteoblastic phenotypic differentiation in comparison with the in vitro
standard substrate, TCP.
4.5 Summary
Ti surfaces of modified topography influence a temporal and magnitudinal enhancement in the
osteogenic responses of hMSCs compared to polished and plastic. The main points are.
 Genetic expression of key bone physiology related genes is differentially modulated by
surface topography. Cells on the rough surfaces promote the expression of pro-osteogenic
genes earlier than smooth. Osteoblastic phenotypic markers are upregulated many fold on
the rough at the end of a 21 d culture period. Certain cell surface receptors implicated in the
differential response to Ti were found to be upregulated on TCP and not Ti; raising a
possible conflict of opinion with the investigators. The basis of possibility is due to the fluid
nature of gene expression analysis; that differs starkly from the activity of its protein entity.
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 Phenotypic function of the osteogenic differentiation of cells on the surfaces is highly
enhanced by modified topography. This extends to calcium mineralisation and phenotypic
marker secretion.
.
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5 Surface induced differential modulation of Axl/Gas6 molecules
5.1 Introduction
The hMSC is an uncommitted cell that can be induced to undergo osteogenic like differentiation in
vitro that leads to the attainment of a phenotype, molecularly and functionally similar, but not
identical, to a true osteoblast. The process of osteogenic differentiation can be affected by the
material and topographical features of a substrate. The modified Ti surfaces used in this study are
shown to increase various osteogenic parameters compared to control polished Ti in hMSCs,
examined in chapters 4, which are suggestive of a relative temporal and magnitudinal enhancement
in cellular differentiation and function by the rough Ti substrates. This differential response of cells is
hypothesised to be due to the engagement of additional molecular systems by surface topography,
which alter the course of cell fate, leading to comparatively earlier commitment and increased
phenotypic expression.
Axl is a gene implicated to be differentially modulated by rough Ti surfaces. It has been
demonstrated with global gene expression arrays to be selectively upregulated by committed
human alveolar bone cells in contact with rough Ti (Brett et al. 2004). The association of the
signaling pathway with various cellular functions, notably the process of cellular calcification in
different biological scenarios, renders it an important and informative marker in elucidating
variances in the up and downstream molecular processes of cells in contact with different
substrates.
This late intermediate section of the study hypothesised that the receptor Axl and its ligand Gas6
are differentially modulated in the osteogenic responses of hMSCs (a cell type of limited phenotypic
capacity) to rough Ti surfaces. It aimed to compare the modulation of the Axl and Gas6 in hMSCs
cultured on the modified Ti surfaces; and then examine the effects of receptor deregulation on cell-
substrate responses. The analyses were conducted in a 7 d time frame. This was due the high
probability of the requirement of the receptors functioning in the initial stages of mineralisation, as
inferred from previous observations (Collet et al. 2003; Collet et al. 2008).
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The first aim was undertaken with genetic and protein expression analyses of Axl and Gas6 in cells
cultured on the different surfaces. The genetic expression of an associated downstream effector
called Twist 1 was included; due to its specified role in inhibiting osteogenic commitment (Lee et al.,
1999). The second aim was to deregulate the signaling pathway with receptor agonist or
antagonists, and compare differences in phenotypic parameters to the controls. The specific
phenotypic parameters evaluated were cellular proliferation, osteogenic calcium deposition,
collagen formation, and osteoblastic protein marker expression.
A dose curve of the effects of receptor agonist and antagonist on calcium mineralisation was
performed to delineate the concentrations of reagents to be used in experiments (sub-section
2.11.2). This dose-curve analysis evaluated the effects of deregulating Axl signaling on osteogenic
calcium deposition only.
5.2 Experimental protocols
5.2.1 Differential modulation of Axl/Gas6
5.2.1.1 Gene expression analysis
The genetic expression of Axl and Gas6 were investigated in hMSCs cultured on TCP, P, SLA and
modSLA at 1, 3 and 7 d post seeding. This analysis was conducted in GM and OM, due to the
different effects of these media on cellular function. The hMSCs (N=3, n=3) were seeded at a
density of ~2.5 x 104 cell.disc-1 in 24 well plates. Samples were processed for RTPCR as described
in section 2.8. In addition, a downstream effector of the Axl/Gas6 signaling pathway called Twist1
was studied due to its reported role as an inhibitor of osteogenic differentiation and hence,
likelihood to modulate the pathways suggested osteo-inhibitory effects.
5.2.1.2 Protein expression analysis
The Axl and Gas6 proteins were quantified in hMSCs cultured on TCP, P, SLA and modSLA for 1, 3
and 7 d. This analysis was conducted in OM by seeding cells at a density of ~2.5 x 104 cell.disc-1 in
24 well plates. Due to minute levels of these proteins, the analyses were setup with six replicates
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per sample that were pooled for measurement. For Gas6, culture supernatants were collected daily;
these were pooled (Vf = 6 ml), frozen at -80oC, lyophilised and finally, reconstituted with 0.5 ml of 1
% BSA in divalent cation-free PBS, to concentrate samples x12 for ELISA. The cell surface Axl was
sampled by homogenising monolayers with 100 ul lysis buffer for 20 min at 4oC and then pooling six
replicates for storage at -80oC till assay. The ELISAs were conducted to quantify total Axl protein,
relative estimate of Axl tyrosine phosphorylation and supernatant Gas6. The methods used are
detailed in section 2.10. Cell numbers were determined with AlamarBlue as described in section
2.5.3.
5.2.2 Effects of Axl/Gas6 recombinant proteins on cellular proliferation
The assessment of the effects of Axl signaling was conducted by incubating cells in culture medium
supplemented with an agonist or antagonist of the pathway. The receptor agonist used in these
experiments was recombinant human Gas6 (rhGas6), used at a concentration of 1 µg.ml-1 (detailed
in section 2.11.2). The receptor antagonist (MAb) was a mixture of recombinant proteins: these
were Axl-extra cellular domain and anti-Axl/anti-Gas6 monoclonal antibodies (MAb; Cf = 4 ug.ml-1 of
Axl-extra cellular domain; with anti-Axl blockade monoclonal antibodies, Cf = 2.5 μg.ml
-1; and anti-
Gas6 monoclonal antibodies, Cf = 10 μg.ml
-1).
The possible influence of Axl/Gas6 signaling on cellular proliferation was assessed with the
AlamarBlue method. The method is detailed in section 2.5.3. This analysis was conducted by
seeding cells in GM supplemented with receptor agonist or antagonist at a density of 1 x 104
cells.disc-1 in 24 well plates. Cell numbers were estimated at 1, 3 and 7 d post seeding.
5.2.3 Effects of Axl/Gas6 recombinant proteins on cellular osteogenic responses
5.2.3.1 Osteogenic mineralisation
The effects of Axl/Gas6 signaling on cellular osteogenic mineralisation were assayed by quantifying
ECM calcium deposition and collagen formation. These parameters were quantified in cultures of
hMSCs incubated in OM, with agonist (Gas6) or antagonist (MAb) for 10 d on TCP, P, SLA and
modSLA. Calcium deposition was examined in two instances. In the first instance, 6 x 105 cells
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were plated in a 9.6 cm2 6-well plate in the following five condition; GM, OM, OM with agonist
(rhGas6), OM with antagonist (MAb), and a 1:1 (v / v) mixture of the two recombinant protein
supplemented media (rhGas6 + MAb); and relative calcification estimated with the Alizarin Red S
stain according to the method described in section 2.7.1. In the second instance, hMSCs were
cultured on TCP, P, SLA and modSLA at a density of 2.5 x 104 cells.disc-1 OM, OM with agonist or
OM with antagonist for 7 d. Total calcium deposited per monolayer were quantified with the
QuantiChrom calcium assay, as described in section 2.7.2. Calcium quantities were normalized to
total cell numbers that were estimated with the AlamarBlue assay as described in 2.5.3. The
receptor agonist used in these experiments was recombinant human Gas6 (rhGas6), used at a
concentration of 1 µg.ml-1 (detailed in section 2.11.2). The receptor antagonist (MAb) was a mixture
of recombinant proteins: these were Axl-extra cellular domain and anti-Axl/anti-Gas6 monoclonal
antibodies (MAb; Cf = 4 ug.ml-1 of Axl-extra cellular domain; with anti-Axl blockade monoclonal
antibodies, Cf = 2.5 μg.ml
-1
; and anti-Gas6 monoclonal antibodies, Cf = 10 μg.ml
-1).
5.2.3.2 Osteogenic ECM collagen formation
Total matrix collagen was estimated at 7 d on TCP, P, SLA and modSLA with the Sircol Collagen
assay kit, according to the method described in 2.8. Cells were seeded at a density of ~2.5 x 104
cells.disc-1 in 24-well plates in OM alone, and OM with agonist or antagonist. Due to the minute
quantities of collagen formed in individual wells of a 24 well plate, three replicates of a sample were
pooled, concentrated overnight with kit reagents and then assayed total quantities.
5.2.3.3 Osteoblastic cytokine synthesis
The effect of Axl/Gas6 signaling on osteoclastic inhibitors OPG and GDF-15 synthesis was
examined by quantifying cytokines in culture supernatants of hMSCs cultured for 7 d on different
surfaces. The experiment comprised seeding 2.5 x 104 cells.disc-1 on TCP, P, SLA and modSLA in
OM, OM with agonist and OM with antagonist. Culture supernatant was collected everyday for 7 d
and assayed with ELISA according to the methods described in 2.10. Cell numbers were estimated
with the AlamarBlue assay as described in 2.5.3
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5.3 Results
5.3.1 Differential modulation of Axl/Gas6 in hMSCs
5.3.1.1 Gene expression analysis
The transcriptional modulation of receptor tyrosine kinase Axl, Gas6 and a likely downstream
effecter called Twist1 were examined with real time PCR. The analysis was conducted at 1, 3 and 7
d post contact with the different substrates, and in GM and OM due to the differential effects of
these media on cellular function. The results of this analysis are presented in figure 5-1, 5-2 and 5-
3.
Analyses of the Axl gene (figure 5-1) indicate it to be expressed at similarly low levels by cells in all
conditions at 1 d post seeding. The Ti surfaces significantly increased Axl transcription at 3 d
compared to the TCP surface albeit in OM only and a very small relative difference. The GM did not
seem to modulate the transcription of Axl, which decreased to initial levels in all samples by 7 d.
The Gas6 gene (figure 5-2) seemed transcribed at a basal level in GM through the course of the
experiment. In OM, the gene was significantly upregulated by the Ti surfaces at 3 d when compared
to plastic surface. The expression of Gas6 increased on all surfaces by 7 d, with the expression
seemingly higher on the TCP than Ti.
Twist1 displayed varied results. Its expression was relatively higher in GM than OM. In the former, it
was initially expressed at a similar level on all surfaces by 1 d. Transcription had increased several
fold on the rough compared to P > TCP at 3 d but decreased by 7 d. In OM, Twist1 was initially
expressed higher on the TCP compared to Ti surfaces. It gradually decreased on all surfaces by 7
d, with expression in the order of TCP > P > SLA > modSLA.
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Figure 5-1 Assessing the effects of substrates on the transcription of Axl
Bar chart with mean + SEM of the relative fold expression of Axl plotted against time in
culture. A total of 25,000 cells were plated on each substrate and fold differences determined
with the ΔΔCt method. (a) Growth medium did not cause a significant change in Axl 
expression. (b) Axl was significantly upregulated compared to the Ti surfaces at 3 d in OM.
The level of transcription of the gene decreased at 7 d on all surfaces. N=3, n=1; * = p < 0.05,
TCP vs. Ti surfaces.
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a. Transcription analysis of Gas6 in growth medium
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b. Transcription analysis of Gas6 in osteogenic medium
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Figure 5-2 Assessing the effects of substrates on the transcription of Gas6
Bar chart with mean + SEM of the relative fold expression of Gas6 plotted against time in
culture. A total of 25,000 cells were plated on each substrate and fold differences determined
with the ΔΔCt method. (a) In growth medium, Gas6 did not display any change in expression 
on any surface. (b) In osteogenic medium, its transcription progressively increased on all
surfaces. The differences between the samples were found to be insignificant.
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a. Transcription analysis of Twist1 in growth medium
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b. Transcription analysis of Twist1 in osteogenic medium
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Figure 5-3 Assessing the effects of substrates on the transcription of Twist1
Bar chart with mean + SEM of the relative fold expression of Twist1 plotted against time in
culture. A total of 25,000 cells were plated on each substrate and fold differences determined
with the ΔΔCt method. (a) In GM, Twist1 was found detected in all samples. Its transcription 
seemed higher on the rough surfaces at 1d and was significantly higher than TCP surface at
3d. Levels lowered in all samples by 7d. (b) Twist1 was detected in samples at 1 d albeit at
lower levels than in GM. Its expression gradually decreased with the progression of time in
osteogenic medium. Its mean value was relatively lower on the rough Ti surfaces than TCP
and polished at 7 d. N=3, n=3. * = p < 0.05, TCP vs. Ti.
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5.3.1.2 Protein expression analysis
The receptor tyrosine kinase Axl and its ligand Gas6 were quantified in pools of six replicates of
hMSC specimens, cultured on TCP, P, SLA and modSLA in OM. In addition, the post translation
modification of tyrosine phosphorylation was evaluated in Axl isolates. The results of this
experiment are presented in figure 5-4, 5-5 and 5-6 for total Axl, phospho Axl and Gas6,
respectively, protein quantities normalised to total cell numbers, In summary, the results show that
the hMSCs temporally down-regulate Axl receptor quantities and phosphorylation on the rough Ti
surfaces compared to TCP and polished Ti surfaces. The TCP incurs a highly significant (p < 0.001)
progressive increase in Axl protein quantity and phosphorylation compared to Ti, comparisons
between which indicate the rough surfaces to cause a significant early down regulation of the
receptor compared to the polished surface by 3 and 7 d.
Protein analysis of total Axl changes in cells
1 3 7
0
1
2
3
Time in culture (days)
To
ta
lA
xl
p
e
r
ce
ll
(p
g
/c
e
ll.
10
3 ) TCP
P
SLA
modSLA
*
*** ***
*** *** ***
#
Figure 5-4 Protein expression analysis of total Axl
Bar chart of mean + SEM of quantities of Axl protein per cell calculated for each sample
plotted against time in culture. A total of 25,000 hMSCs were cultured on the different
surfaces and cell surface protein quantified in a pool of six replicates with ELISA. It indicates
hMSCs expressed Axl protein at initial contact with substrates. The quantities of this protein
per cell increased on TCP and slightly on polished Ti by 3 d, while in comparison
significantly decreasing on the rough substrates. The TCP surface supported expression of
Axl protein at 7 d while it had been downregulated highly significantly by the Ti surfaces. N =
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3, n = 1; *, **, *** = p < 0.05, 0.01, 0.001, respectively TCP vs. Ti surfaces. # = p < 0.05, P vs.
rough surfaces.
The findings for total Axl were corroborated by relatively lower receptor phosphotyrosine estimates
at 1 and 7 d on the rough vs. smooth (p < 0.05) (figure 5-5).
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Figure 5-5 Protein expression analysis of Phospho Axl in hMSCs
Bar chart of mean + SEM of Axl protein phosphorylation plotted against time in culture. A
total of 25,000 hMSCs were cultured on the different surfaces and cell surface protein
assessed for its relative degree of phosphorylation in a pool of six replicates with ELISA.
Phosphorylated Axl was detected in all samples at 1 d post seeding. The relative extent of
phosphorylated protein increased on the TCP while it remained at a baseline level on all Ti
surfaces. The difference between TCP and the Ti surfaces was highly significant at 7 d. N=1,
n=3; *** = p < 0.001, TCP vs. Ti surfaces.
The secreted cytokine Gas6 was present at similar levels on all surfaces at 1 d. Its levels increased
on TCP, P and SLA surfaces at 3 d, while decreasing on the modSLA. Quantities of the cytokine
decreased on all surfaces by 7 d, but were observably lower on the modSLA compared to all other
surfaces.
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Protein expression analysis of Gas6
1 3 7
0
20
40
60
80
100
Time in culture (days)
G
as
6
p
er
ce
ll
(p
g
/c
el
l.1
03
) TCP
P
SLA
modSLA
*
#
+
Figure 5-6 Protein expression analysis of Gas6 in hMSCs
Bar chart of mean + SEM of Gas6 protein normalised to total cell numbers per surface
plotted against time in culture. A total of 25,000 hMSCs were cultured on the different
surfaces and soluble Gas6 quantified in culture supernatants by pooling medium from six
replicates, conditioned with surface attached cells for 24 h. The protein was detected in all
samples at 1 d. Its levels increased on all surfaces but had significantly decreased on the
modSLA by 3 d. Levels of the protein decreased in all samples by 7 d in culture. N=1, n=3; *
= p < 0.05, TCP vs. Ti surfaces; # = p < 0.05, P vs. rough Ti surfaces; + = p < 0.05, SLA vs.
modSLA.
5.3.2 Effects of Axl/Gas6 recombinant proteins on cellular proliferation
The effect of Axl/Gas6 pathway deregulation on hMSC proliferation was assessed with AlamarBlue.
This analysis was conducted at 1, 3 and 7 d post seeding in growth medium alone, and GM
supplemented with receptor agonist or antagonist. The results of this analysis are shown in figure 5-
7. It shows that the pathway does not interfere in the proliferation of cells from their normal pattern
as desmonstrated in comparison with control growth medium condition. Hence, Axl receptor
deregulation does not bear any obvious affect on hMSC proliferation, and is likely not involved in
the differential proliferative behavior of cells on the modified Ti substrates.
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Figure 5-7 Lack of effect of Axl/Gas6 pathway deregulation on hMSC proliferation
Bar shows mean + 1SD (N=3, n=3) of fluorescence emission values recorded for each
samples plotted against time in culture. A total 10,000 cells were plated per surface in GM,
GM with rhGas6 (agonist) and GM with MAb (antagonist). Cellular proliferastion was
assessed with AlamarBlue fluorescence at 1, 3 and 7 d post seeding. The graphs shows that
cells proliferated highly on smooth surfaces than the rough as has been previously shown in
section 3. Receptor deregulation did not present any observable changes in cell numbers
within any surface type relative to GM only controls.
5.3.3 Effects of Axl/Gas6 recombinant proteins on cellular osteogenic responses
5.3.3.1 ECM matrix calcification
The affects of Axl receptor deregulation on hMSC osteogenic mineralisation was assessed by an
initial qualitative assessment with Alizarin Red S stain; followed by a quantitative analysis with a
calcium quantification assay. In the first analysis, hMSCs were cultured in 6 well plates in the
following conditions: GM, OM, OM with antagonist, OM with agonist, and a combination of both
agonist and antagonist. The results of this experiment are presented in figure 5-8. The GM and OM
cultured control samples displayed negative and positive stained monolayers, respectively. The OM
with antagonist did display mineral, but was visibly lower than the control OM. The OM with
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antagonist culture displayed a stark decline in stain compared to control and OM with antagonist.
The combination of agonist and antagonist supplemented media yielded a stain intermediate in
extent to both states of receptor deregulation.
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In the second analysis, the amount of calcium per cell of monolayer was determined with
colorimetric assays. The result of this experiment is shown in figure 5-9. It indicates the hMSCs to
mineralise along a trend expected for the control condition, OM only. The addition of receptor
agonist decreased the quantity of calcium per sample relative to controls; the trend of higher
mineralisation on modSLA > SLA > P > TCP was still preserved, albeit the magnitude was
significantly smaller.
The receptor antagonist did not affect mineralisation compared to control OM on all surfaces. The
TCP and SLA cultured cells did not display any difference compared to their controls; however, P
and modSLA did cause a noticeable decrease in mineralisation.
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Figure 5-9 Inhibitory effects of Axl receptor deregulation on calcium mineralisation
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Bars show mean + 1SD of calcium per cell plotted against surface type. For this analysis,
25,000 cells were cultured on all surfaces in OM, OM + agonist or OM + antagonist for 7 d.
Calcium quantities were determined and normalised to total cell numbers. Graph shows
control OM induced mineralisation in the order of modSLA (hydrophilic-rough) > SLA
(hydrophobic-rough) > P (polished Ti) > TCP (tissue culture plastic), as had been previously
noted in section 4. The addition of agonist rhGas6 significantly decreased calcium
mineralisation on each surface respective to controls; but did not inhibit the process. This
effect was most prominent on the TCP and modSLA surfaces. The addition of antagonist did
not increase mineralisation relative to controls on any surface. It did, however, decrease
calcium mineralisation on P and modSLA cultured cells relative to their respective controls.
N=3, n=3. # = p < 0.05, control vs. condition of any one surface type; *, **, *** = p < 0.05, 0.01,
0.001, respectively; ns represents non-significant. α represents a grouped comparison 
between the TCP and the Ti surfaces for each condition; ‘β’ between P vs. rough Ti surfaces; 
γ represents SLA vs. modSLA comparisons. Full lines represent control surface vs. surface 
comparisons; dashed lines (---) between agonist surface vs. surface; and dotted line
antagonist surface vs. surface.
5.3.3.2 ECM collagen formation
The ECM collagen formed by samples was estimated at 7 d. The results of this analysis are
illustrated in figure 5-10. It indicates collagen synthesis was not affected by receptor deregulation.
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Figure 5-10 Lack of effect of Axl deregulation on cellular collagen synthesis
Bar chart with mean + 1SD (N=3, n=1) collagen per cell number plotted against surface type.
For this analysis, 25,000 cells were cultured on all surfaces in OM, OM + agonist or OM +
antagonist for 7 d. Total collagen and cell numbers were estimated. The formation of
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collagen was similar between the surfaces. The receptor deregulation did not affect collagen
synthesis.
The ratio of extracellular matrix calcium to collagen was assessed similar to section 4.3.2.3. The
results of this analysis are shown in figure 5-11. It indicates the trend observed previously for
calcium per collagen ratios of samples in control conditions; modSLA > SLA > P > TCP. The
receptor agonist was observed to have significantly decreased calcium to collagen ratio on TCP. A
relative decrease in this ratio occurs on the rough surfaces but not on P.
The receptor antagonist increased the calcium/collagen ratio only on the modSLA; the remaining
surfaces did not exhibit any significant difference.
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Figure 5-11 Effect of Axl deregulation on extracellular matrix Ca to collagen ratio
Bars show mean + 1SD extracellular matrix calcium to collagen ratio values. The surfaces
repeated the pattern of calcification previously observed in section 4. Receptor agonist
caused a significant decrease in calcium per collagen only on TCP (tissue culture plastic).
The modSLA seeded cells deposited a significantly higher calcified ECM with receptor
antagonist. N=3, n=3. # = p < 0.05, control vs. condition of any one surface type; *, **, *** = p
< 0.05, 0.01, 0.001, respectively; ns represents non-significant. α represents a grouped 
comparison between the TCP and the Ti surfaces for each condition; ‘β’ between P vs. rough 
Ti surfaces; γ represents SLA vs. modSLA comparisons. Full lines represent control surface 
vs. surface comparisons; dashed lines (---) between agonist surface vs. surface; and dotted
line antagonist surface vs. surface.
5.3.3.3 Osteoblastic cytokine quantification
The osteoblast associated cytokines OPG and GDF-15 were quantified in culture supernatants of
hMSCs on the different surfaces in control, agonist or antagonist media conditions. The results of
this experiment are shown in figures 6-11 and 6-12. The OPG was expressed at a baseline by cells
at this time in control medium. Both media conditions inducing receptor deregulation had modulated
an increase in OPG synthesis. This increase was statistically significant for MAb compared to
control, as opposed to the relatively small increase with agonist rhGas6. Additionally, the MAb
cultured rough surface seeded cells secreted OPG significantly higher than TCP and P.
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Effects of Axl deregulation on OPG synthesis
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Figure 5-12 Effect of Axl receptor-deregulation on OPG synthesis
Bars show mean + SEM; N=3, n=3. The hMSCs were cultured for 7 d on TCP, P, SLA and
modSLA. Quantities of secreted OPG and cell numbers were evaluated. Results indicate
receptor antagonist MAb to increase OPG levels by 7 d compared to control. #, ##, ### = p <
0.05, 0.01, 0.001, respectively, control vs. Condition. *, **, *** = p < 0.05, 0.01, 0.001,
respectively, samples vs. samples connected by lines. Black lines are control vs. any
sample, green lines are agonist vs. any sample, and red lines are antagonist vs. any sample.
A similar effect was obvious for GDF-15. Its secretion was relatively higher on the rough compared
to smooth at 7 d in control medium. Receptor agonist did not cause any significant change
compared to controls. However, the antagonist did significantly increase GDF-15 synthesis
compared to control medium. Like OPG, this affect was more pronounced in cells on the rough
surfaces compared to smooth.
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Effects of Axl on GDF-15 synthesis
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Figure 5-13 Effects of Axl receptor deregulation on GDF-15 synthesis
Bars show mean + SEM; N=3, n=3. The hMSCs were cultured for 7 d on TCP, P, SLA and
modSLA. Quantities of secreted GDF-15 and cell numbers were evaluated. Results indicate
receptor antagonist MAb to increase GDF-15 levels by 7 d compared to respective control,
OM only. *, **, *** = p < 0.05, 0.01, 0.001, respectively, samples vs. modSLA connected by
black lines.
5.4 Discussion
5.4.1 Differential modulation of Axl and Gas6 in hMSCs
The expression of Axl and Gas6 was found to be influenced by surface modifications. The Axl gene
was transcribed at a basal level by cells at the start of culture. Its modulation was different across
the surfaces, but a general pattern comprised increasing from 1 to 3 d and then decreasing by 7d.
Comparisons of Axl gene expression between the different surfaces indicate it to be temporally
upregulated earlier on the rough compared to smooth; and undergoing downregulation at a similar
rate in the later phase of culture.
This trend in expression of the Axl gene was also evident at the protein level. The Axl protein was
detected at a lower level on the rough surfaces than smooth at 1 d, which while continually
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increasing on the TCP and P, progressively decreased on the rough surfaces by 3 and 7 days.
Furthermore, the state of Axl phosphorylation greatly decreased on the Ti surfaces compared to
TCP through the course of culture. This state of post translational modification was relatively higher
on the P than rough at 1 d but decreased to similar levels at 3 and 7 d. These indicate that cells on
the rough surfaces, while probably requiring Axl receptor in the initial stage of culture, were inclined
to down-regulate its activity at a comparably faster rate than on the smooth.
A similar pattern of expression was exhibited by Gas6. The molecule was nominally transcribed in
GM but was markedly upregulated in OM. Its expression was similar between the surfaces at 1 d. At
3 d, it was expressed comparatively higher on the Ti than TCP. But this trend was reversed by 7 d
with a higher expression of the gene on TCP than Ti. There were no significant differences between
the Ti surfaces in affecting Gas6 secretion. The Gas6 protein, like the Axl molecule, was initially
detected at a similar level between the samples at 1 d. Its levels increased to at 3 d on all surfaces,
except for modSLA, which seemed to have had significantly decreased Gas6 synthesis at this time.
The detectable levels of Gas6 decreased on all surfaces to lower level by 7 d.
The expression patterns observed for Axl and Gas6 in hMSCs on the different surfaces correspond
to the trends in mineralisation recorded here, as well as in section 4. These findings suggest that
the implied osteo-inhibitory function of Axl/Gas6 pathway is downregulated by the modified Ti
surfaces temporally earlier than TCP or P; most likely resulting an accelerated form of phenotypic
differentiation.
This notion is supported by the differential decrease in Twist1 transcription in OM over the course of
culture. Its transcription follows a trend consisting of TCP > P > SLA > modSLA; inversely
proportional to the extent of mineralisation achieved on these surfaces.
5.4.2 Effects of receptor deregulation on hMSC responses
The affects of deregulating the Axl/Gas6 pathway were examined on hMSC responses to the
modified Ti surfaces. The responses evaluated were proliferation, osteogenic mineralisation and
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cytokine secretion. The proliferation analysis indicated that receptor signaling was not important for
cellular viability.
The effects of Axl deregulation were, however, starkly obvious in the experiments querying
osteogenic mineralisation and osteoblastic cytokine synthesis. Osteogenic mineralisation, in terms
of calcium deposited per cell, followed the similar trend observed in section 4, consisting of a higher
mineral content on modSLA > SLA > P > TCP. The presence of Gas6 decreased mineralisation but
did not inhibit it. This is considered largely to be due to the inefficiency of the applied method in
completely blocking the paracrine release of Gas6. The agonist induced decrease in calcium
mineralisation was markedly higher on TCP than the Ti. A proportionally expected increase in
calcium mineralisation compared to control condition occurred only for modSLA with receptor
antagonist. It also increased OPG and GF-15 synthesis in cells on the rough.
5.4.3 Significance of findings
The Axl receptor is assigned a role in cellular osteogenic differentiation. It is suggested to be
important in the initial phases of osteogenic differentiation following induction but is required to be
downregulated for calcium mineralisation to occur. The findings show that Axl and Gas6 are
downregulated by cells during a 7 d culture period; the end time point corresponding with detectable
calcium mineralisation. This downregulation is seemingly initiated earlier on the rough surfaces than
smooth.
Deregulating receptor signaling can generate a contrast in cellular responses compared to control.
The findings show that (i) increasing receptor signaling can impede calcium mineralisation but
decreasing it does not enhance the process; (ii) decreasing receptor signaling can augment
osteoclastic regulators OPG and GDF-15 secretion; and (iii) the impediment of mineralisation is
higher on TCP, while augmentation of OPG and GDF-15 is higher on rough, when measured at a 7
d time point. These strongly suggest that the Axl/Gas6 pathway plays a part in the initial phases of
osteogenic differentiation; in which it is steadily downregulated as the cell progresses from the state
of an uncommitted state to a maturing naïve-osteoblastic phenotype.
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This idea is inferred from the comparative outlook of cellular responses to the different surfaces,
which reveal cells to seemingly differentiate and mineralize in a temporally enhanced manner in
response to the rough surfaces compared to TCP and P. Accordingly, at the 7 d time point, whilst
the cells on the rough surfaces have undergone a relatively farther level of osteogenic
differentiation, those on the TCP are still in a upstream phase of differentiation; resulting in relatively
higher mineral content on the rough compared to smooth at this time.
Being in a relatively precursory state than an osteoblastic phenotype, the hMSCs on the TCP seem
relatively more prone to the osteo-inhibitory effects of Axl agonist on mineralisation. While this may
also have been the case for the rough surfaces, the detection of this event by 7 d would not have
been permissive due to the stimulus to heighten mineralisation incurred by cells on the rough.
However, these do represent a state of phenotype much differentiated and mature than the TCP
and P at 7 d. In these cells, mineralisation due to the relatively mature state of cells may not be
affected by receptor deregulation; however, their process to synthesise and secrete osteoclastic
modulators is enhanced several fold by blocking receptor signaling. This may be perceived as the
effect of receptor deregulation on cells, at a farther state of osteoblastic differentiation, on the
rough.
The Axl / Gas6 pathway’s (i) importance in early cell-substrate events; (ii) downregulation prior to
calcium mineralisation; (iii) upregulation decreasing mineral content; and (iv) enhancement of
phenotypic marker synthesis in the relatively more differentiated rough surface seeded cells imply
an association of the pathway with hMSC stemness, and its association with the enhanced
transformation to a committed phenotype on the rough surfaces.
5.5 Summary
The Axl / Gas6 pathway is differentially modulated by hMSCs on the different surfaces. The main
points are.
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 The Axl receptor and its cognate ligand Gas6 are downregulated at the genetic and protein
levels on the rough Ti surfaces earlier than polished and even more on plastic; suggesting
that a reduction in signaling might underlie the enhancement in osteogenic parameters by
modified substrates.
 The pathway affects calcium deposition but not ECM formation. The Axl agonist
significantly decreases ECM calcification. This decrease is relative to the surface type.
 The pathway affects osteoblastic marker secretion. The Axl antagonist increases levels of
OPG and GDF-15, which are promoted by the rough Ti surfaces.
 The collection of results suggests that hMSCs require Axl pathway initially following
substrate contact; but that as the point of initiation of mineralisation approaches, it is
downregulated. This downregulation is temporally enhanced on the rough surfaces.
 This implies that the pathway may be important to the pre-osteoblastic phase of a
differentiating hMSC, whose function might likely be associated with stemness.
6 Differential regulation of hMSC pluripotency gene expression 6.1 Introduction
152
6 Differential regulation of hMSC pluripotency gene expression
6.1 Introduction
Modified Ti surfaces exert an observable enhancement on hMSC differentiation and function. This
differential effect is believed to be modulated by transcriptional changes in various genetic clusters
that govern specific aspects of cellular function. An aspect of interest is the cellular specimens’
plasticity to functionally differentiate to an osteoblastic phenotype. Experimental evidence derived
from embryonic stem cell research strongly indicates that the cohort expression of a particular set of
genes imparts cellular plasticity by engaging relevant cell regulatory processes, which prevent
lineage commitment and phenotypic differentiation. This is reinforced by the observation of the
presence of transcripts of various lineage specifying transcription factors in un-induced or
undifferentiated adult stem cells.
It is implied that if not all, then a subset of the implicated stemness genes will have to be expressed
in uncommitted hMSCs to maintain their undifferentiated state. These genes will incur
transcriptional change once the hMSC receives an over-writing pleiotropic stimulus from its direct
microenvironment. In the context of the present study, the microenvironment constitutes medium
and substrate, which due to the multiple subtypes of both variable, would variably affect the
comparative loss of expression of stemness related genes.
The hypothesis of this section of the study stated that different Ti substrates would differentially
down regulate stemness gene expression in hMSCs. Furthermore, it considers this differential
regulation of gene expression to be modulated, in part, by the Axl/Gas6 signaling pathway;
according to which, it extends to state that the differential regulation and activity of the Axl receptor
and its ligand Gas6 is linked to any loss of stemness genes on the respective surfaces.
This hypothesis was evaluated by comparing the expression of a select set of 96 genes in hMSCs
using Taqman microfluidic 384 well card miniarrays. These were procured with the award from the
University of London Central Research Fund. The arrays comprise four sets of genes, categorized
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on their implicated function: controls, maintenance of pluripotency, correlation to stemness, and
differentiation markers. These genes are selected from the findings of the International Stem Cell
Initiative consortium (International Stem Cell Initiative, 2007). They represent a defined set of
validated genetic markers normally associated with human embryonic stem (ES) cell identity. The
details of the four gene sets in the frame of stem cell science are tabulated in tables 9-11, 9-12, 9-
13 and 9-14 (Appendix V), respectively.
This experiment was conducted by seeding hMSCs on the P, SLA and modSLA Ti surfaces.
Analyses were conducted at 1 and 7 days post seeding comparing two different sets of conditions.
Samples cultured in GM and OM only were assayed at 1 d post seeding. While samples cultured in
OM, OM with agonist (rhGas6) or OM with antagonist (MAb) were assayed at 7 d. The former
addressed the immediate changes caused by surface topography, while the latter evaluated Axl’s
possible involvement in modulating the stemness gene expression changes.
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6.2 Experimental protocols
6.2.1 Miniarray RT-PCR analysis
The effects of modified Ti surfaces and of Axl/Gas6 signaling on hMSC stemness gene expression
were evaluated by quantifying fold differences in the expression of cellular stemness related genes.
The analysis was conducted with Taqman Stem Cell Pluripotency Microfluidic Arrays
(AppliedBiosystems; 4385344). These arrays are specialized 384-well plates (8rows, 48 columns)
that contain four assortments of 96 genes distributed across two 48 well rows.
The experiment was conducted by culturing hMSCs from three donors (N=3, n=1) on polished, SLA
and modSLA at a density of 1.25x 104 cells.cm-2 in GM, OM, OM with receptor agonist (OM +
rhGas6) and OM with receptor antagonist (OM + MAb). Samples were assayed for gene expression
at 1 day (GM and OM) and at 7 days (OM, OM+Gas6 and OM+MAb) according to the methods
described in section. The arrays were processed in an AppliedBiosystems 9700 Real Time PCR
thermocycler at the UCL Institute of Child Health (London, UK). The receptor agonist used in these
experiments was recombinant human Gas6 (rhGas6), used at a concentration of 1 µg.ml-1 (detailed
in section 2.11.2). The receptor antagonist (MAb) was a mixture of recombinant proteins: these
were Axl-extra cellular domain and anti-Axl/anti-Gas6 monoclonal antibodies (MAb; Cf = 4 ug.ml-1 of
Axl-extra cellular domain; with anti-Axl blockade monoclonal antibodies, Cf = 2.5 μg.ml
-1; and anti-
Gas6 monoclonal antibodies, Cf = 10 μg.ml
-1).
6.2.2 Miniarray data analysis
Fold values of sampled genes were calculated from the threshold cycle ‘Ct’ values, which were then
computed with the 2-ddCt formula to obtain relative fold differences between the genes. Samples
were calibrated to the reference control, which consisted of cells in suspension prior to seeding.
The gene used here as a calibrator was 18S RNA. Mean values from three donors were plotted in a
heatmap with the R software. This map was composed of an x-axis with samples and y-axis with
genes. The entities represented on these axes were clustered into groups on the basis of similarity.
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This similarity was measured using the Euclidean distance. The default heat map colors are from
red for low values, to orange or yellow or white, for medium and high values, respectively.
6.3 Results
6.3.1 Overview
A total of 43 of the 96 genes analysed were found expressed in hMSCs. These were expressed in
the references sample (t = 0, cells in suspension) as well as target samples. A total of 53 genes
were not detected expressed in the reference and target samples. This was considered to be due to
their putative embryonic stem cell specific nature; and hence, the likelihood of not being transcribed
in the hMSCs used in this study. These were in addition to the non-expression of differentiation
markers incapable of being transcribed in the osteogenic inductive media.
The transcribed genes were 18S ribosomal RNA (endogenous control); ACTB; ACTC; BRIX; CD9;
CGB; COL1A1; COMMD3; CRABP2; CTNNB1; DES; DNMT3B; FGF5; FLT1; FN1; GABRB3;
GAPD; GATA6; GFAP; GRB7; IFITM1; IFITM2; IL6ST; IMP2; KIT; LAMA1; LAMB1; LAMC1; LIFR;
Nanog ; NES; NOG; NR6A1; PECAM1; PODXL; POU5F1; RAF1; REST; RUNX2; SEMA3A;
SERPINA1; SST; and SYP. The details of these genes are provided in tables 10-4, 10-5, 10-6 and
10-7 (Appendix II).
The results of this analysis are presented in two stages. A graphical representation of the collective
data sets is illustrated in a heatmap in figure 7-1. This was generated with the R software courtesy
of Dr Shazia Anjum of the UCL Institute of Child Health (London, UK). It represents mean fold
values derived from three donor analyses (N = 3), assayed in one experimental instance (n = 1). In
the presented figure, detected genes form the vertical axis and samples, arranged in an ascending
order, form the horizontal axis. The genes displaying similar patterns of expression are highlighted
on a dandogram drawn on the left vertical axis of the map; calculated with the Euclidean distance
algorithm.
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This is followed by a description of the individual gene sets (controls; maintenance of stemness;
correlation of stemness; differentiation genes) with horizontal single gene bar charts depicting
individual gene’s expression.
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igure 6-1 Expression values from human pluripotency miniarrays
mage is a heatmap of fold expression values derived with the 2-∆∆Ct method. The hMSCs were cultured on P,
LA and modSLA. Gene expression was analysed at 1 d in growth and osteogenic media only, and later at 7 d
etween OM alone, OM with agonist Gas6 and OM with antagonist MAb. Plots represent mean values of N = 3, n
1. Key provided top left.
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6.3.2 Controls
18S RNA was used as the endogenous reference to calculate relative fold expression levels. It
along with the control genes β-actin, β-catennin, GAPDH (glyceraldehyde dehydrogenase) and 
RAF1 oncogene were expressed in all samples analysed. The EEF1A1 gene was not detected. The
18S RNA was found to be expressed invariably in all samples whilst the remaining did display
surface or condition dependent changes.
ACTB was transcribed lower in GM than OM at 1 d. It was expressed higher on polished than rough
at 1 d in both media conditions. Its expression increased by 7d in OM.It was transcribed at a higher
fold value on polished than rough in OM only. Axl receptor agonist decreased its expression, while
Axl antagonist increased it on all surfaces.
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Figure 6-2 Miniarray analysis of effects of Axl signaling on ACTB gene expression
A vertical bar chart with mean relative fold expression values from three donors plotted
along the x-axis (N=3, n=1) against samples on the y-axis. Gene cards define ACTB (β-actin) 
as a non-muscle cytoskeletal protein likely involved in cellular shape. The gene was
expressed higher on the P than rough at 1 d in both media. Its expression increased on the
rough at 7 vs. 1 d. Axl agonist decreased expression of the gene, particularly on the rough
than P, when compared to OM. Axl antagonist increased expression on the rough relative to
OM and OM with agonist. The gene, being a cytoskeletal component suggests an
association of Axl signalling with modifications of cellular shape.
The expression pattern of Beta-catennin (figure 6-3) seemed condition and surface dependent. It
was upregulated starkly at 1 d in cell cultured in growth medium on the modSLA but not SLA nor
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polished surfaces. While expression decreased by 7 d in osteogenic medium (OM) and OM
supplemented with Axl agonist, the Axl antagonist caused an increase in expression on all surfaces.
.
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Figure 6-3 Miniarray analysis of effects of Axl signaling on CTNNB1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define CTNNB1 (cadherin-associated β-
cantenin) as an adherins junction associated molecule that apart from regulating cellular
adhesion, acts as a downstream effector of ligand induced canonical Wnt pathway. The gene
was upregulated several fold by modSLA at 1 d in GM. Expression was raised several fold by
all samples in OM. Expression had downregulated to similar levels by 7 d in OM. Agonist did
not have a notable effct on P nor SLA; but did incur a small upregulation on modSLA. All
surfaces were upregulated by receptor antagonist.
The GAPD gene, not shown here, had been modulated higher on the rough compared to polished
but differences were absent at 7 d in all conditions. The RAF1 oncogene (figure 6-4) was found
expressed in all samples. Its expression was relatively higher on the modSLA than polished and
SLA at 1 d in both media conditions. Its expression was found higher on polished than both rough
surfaces at 7 d in OM. The Axl agonist seemed to have reduced expression in cells cultured on
polished and SLA at 7 d compared to an increase on the modSLA. The Axl antagonist had slightly
increased transcription of the gene, the levels of which were similar between the surfaces.
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Figure 6-4 Miniarray analysis of effects of Axl signaling on RAF1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define RAF1 (MAP kinase kinase kinase) as a
serine/threonine kinase that is activated by the small GTPase molecule Ras and transduces
a mitogenic signals from cell membrane to the nucleus. This gene was upregulated several
fold by modSLA at 1 d in GM and OM. Expression decreased in all samples by 7 d, but was
relatively higher on the P than rough surfaces. Agonist seemed to decrease expression
while antagonist slightly increased expression of the gene.
6.3.3 Maintenance of pluripotency
Five of the seven genes of this category were detected expressed in all samples. The expressed
genes were DNMT3B, fibrobrlast growth factor 5 (FGF5), GABRB3, Nanog and POU5F1. The
unexpressed genes were SOX2 and GDF3. DNMT3B (figure 6-5), FGF5 (figures 6-6) and GABRB3
(figure 6-7) displayed similar patterns of expression, comprising a relative increase on modSLA in
GM and polished in osteogenic medium at 1 d. This was seemingly followed by a downregulation at
7 d in OM, with the Axl antagonist upregulating expression of genes at this time.
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Figure 6-5 Miniarray analysis of effects of Axl signaling on DNMT3B gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define DNMT3B (DNA (cytosine-5-)-
methyltransferase 3 beta)) as DNA methylating factor that methylates non-methylated CpG
islands. this gene was upregulated several fold by modSLA at 1 d In GM. The OM showed an
inverse trend to that of GM 1d with expression comparatively higher on P and SLA.
Expression decreased in all samples by 7 d, but was relatively higher on the P than rough
surfaces. Agonist seemed to non-affect expression while antagonist markedly increased
expression of the gene in all samples.
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Figure 6-6 Miniarray analysis of effects of Axl signaling on FGF5 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define FGF5 (fibroblast growth factor 5) as an
oncogene that can transform cells upon transfection. This gene was upregulated several
fold by modSLA at 1 d In GM. In OM, samples expressed the gene at near similar levels.
Expression had decreased in all samples by 7 d, but was relatively higher on the polished
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than rough surfaces. Agonist did not seem to affect expression while antagonist markedly
increased expression of the gene in all samples.
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Figure 6-7 Miniarray analysis of effects of Axl signaling on GABRB3 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define GABRB3 (gamma-aminobutyric acid
(GABA) A receptor, beta 3) is the major inhibitory neurotransmitter in the vertebrate brain,
which mediates neuronal inhibition by binding the GABA/benzodiazepine receptor and
opening an integral chloride channel. This gene was upregulated several fold by modSLA at
1 d In GM and OM. The gene was detectable at low levels in all samples by 7 d in OM, with
expression seemingly higher on P than the rough. Agonist did not affect expression while
antagonist markedly increased expression of the gene in all samples.
The PO5F1 gene (figure 6-8) was upregulated slightly by modSLA compared to other surfaces in
growth medium at 1 d. Its expression was highest on SLA, being similar on the others, in
osteogenic medium at this time. Expression was higher on polished than rough at 7 d in OM. The
Axl antagonist had caused an increase in levels of this gene on all surfaces by this time. Nanog,
shown in figure 6-9, displayed a pattern of expression similar to POU5F1.
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Figure 6-8 Miniarray analysis of effects of Axl signaling on POU5F1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define POU5F1 (POU class 5 homeobox 1)
forms a trimeric complex with SOX2 and controls the expression of a number of genes
involved in embryonic development. This gene was expressed at similar levels by cells at 1 d
in GM and OM, apart from an unexpected increase by the SLA. Its expression remained high
on the P by 7 d, while having decreased several fold on the rough. Agonist did not affect
expression apart from an upregulation on modSLA. Antagonist increased experssion of the
gene compared to the 7d control samples.
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Figure 6-9 Miniarray analysis of effects of Axl signaling on NANOG gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define NANOG as a transcription factor that
regulates inner cell mass and embryonic stem cell proliferation and self-renewal. This gene
was expressed higher on the modSLA in GM and SLA in OM at 1 d. Expression seemed to be
retained at a higher level by 7 d on modSLA but had decreased on the P and SLA surfaces.
The agonist and antagonist relatively decreased expression of the gene compared to 7 d
controls.
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6.3.4 Correlation with stemness
A total of fifteen genes were detected expressed in this category. These were BRIX, CD9,
COMMD3, CRABP2, GRB7, IFITM1, IFITM2, IL6ST, IMP2, KIT, LIFR, NOG, NR6A1, PODXL, and
REST.
BRIX was transcribed at 1 d in all samples (figure 6-10). It was not differentially modulated at 1 d in
GM, but was increased several fold on the modSLA in OM. Its expression was detected at 7 d in
OM; higher on polished than SLA than modSLA. This trend in expression was not present in
presence of Axl agonist; expression was downregulated. The Axl antagonist had caused an
observable increase in expression.
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Figure 6-10 Miniarray analysis of effects of Axl signaling on BRIX gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define BRIX as a protein required for the
biogenesis of the 60S ribosomal subunit. This gene was expressed at similarly low levels in
cells cultured on all surfaces. Expression had increased on the P and SLA surfaces
compared to modSLA t 7 d. Agonist reduced expression while antagonist increased it.
CD9 (figure 6-11) and COMMD3 (6-12) displayed similarities in expression patterns, although the
expression of CD9 was magnitudinally several fold higher. These genes were modulated relatively
higher on modSLA than other surfaces at 1 d in GM. OM caused an upregulation in all samples
compared to GM. Expression levels of both genes were detectable at 7 d in OM but at relatively
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lower levels than the initial time point. The addition of Axl agonist caused a decrease in expression
whereas Axl antagonist caused an upregulation, which in the case of CD9 seemed surface
dependent being higher on modSLA than SLA than polished.
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Figure 6-11 Miniarray analysis of effects of Axl signaling on CD9 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define CD9 as a member of the tetraspanins, a
class of cell surface glycoproteins with four transmembrane domains that form multimeric
complexes with other cell surface, and are involved in differentiation, adhesion, and signal
transduction. The gene was markedly upregulated by modSLA than polished and SLA at 1 d
in GM. The OM caused an upregulation in all samples. Expression of the gene had decreased
to lower levels in all samples by 7 d. Agonist generally seemed to have decreased
expression compared to controls; it displayed increased expression on modSLA. Antagonist
increased expression in all surfaces relative to OM only; this increase was higher for
modSLA than the other surfaces.
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Figure 6-12 Miniarray analysis of effects of Axl signaling on COMMD3 gene expression
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A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define COMMD3 (COMM domain containing 3) is
a protein that may negatively regulate the activation of NF-kappa-B by associating with a
homolog, COMMD1. Expression of COMMD3 was present at 1 d in all samples, being
comparatively higher on the modSLA and SLA surfaces in GM and OM, respectively.
Expression was detected at low levels in all samples at 7 d. Agonist seemed to decrease
while antagonist increased expression.
CRABP2 (figure 6-13) and GRB7 (6-14) displayed similarities in expression patterns. These genes
were comparatively expressed higher on modSLA at 1 d post seeding in GM but in a reverse trend
in OM with polished displayed higher fold expression than both rough surfaces. The genes seemed
expressed very similarly at 7 d post seeding. Expression had decreased at this time in osteogenic
medium only. Axl agonist seemed to have had no effect but a slight upregulation was detectable for
CRABP2, while GRB7 seemed selectively downregulated in rough surface seeded cells by the Axl
agonist and antagonist at this time point.
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Figure 6-13 Miniarray analysis of effects of Axl signaling on CRABP2 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define CRABP2 as a cytosol-to-nuclear shuttling
protein that transports retinoic acid to its cognate receptor. The gene was expressed at 1 d
in all samples. At 1 d in GM, it was expressed highest on modSLA while OM caused an
increase in expression in both P and modSLA samples. Expression had decreased starkly
by 7 d with no-transcripts detected for modSLA. Agonist abolished expression of the gene in
P and SLA while increasing it on modSLA, when compared to OM only controls. Antagonist
starkly reduced expression of the gene in all samples.
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Figure 6-14 Miniarray analysis of effects of Axl signaling on GRB7 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define GRB7 (growth factor receptor-bound
protein 7) as an adaptor molecule that interacts with the cytoplasmic domains of tyrosine
kinases, mainly epidermal growth factor receptor and ephrin receptors. GRB7 was detected
at similar levels at 1 d in GM in all samples. Its expression was markedly increased by the P
in OM than both rough surface, which differed with a higher comparative expression on SLA.
Expression of the gene was present at 7 d in OM. Agonsit increased expression on modSLA
but antagonist seemed to abolish expression in P and modSLA while not affecting cell on
SLA.
IFITM1 (figure 6-15) and IFITM2 (figure 6-16) displayed similar expression at 7 d in OM; being
higher on P than the rough. Agonist and antagonist increased expression on rough compared to P.
At 1 d, however, the genes were different. The former was transcribed higher in OM on the rough.
The latter was not initially expressed.
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Figure 6-15 Miniarray analysis of effects of Axl signaling on IFITM1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define IFITM1 (interferon induced
transmembrane protein 1) as an antiviral protein that mediate cellular innate immunity,
multimeric complex involved in the transduction of antiproliferative and homotypic
adhesion. IFITM1 was expressed higher on P and SLA in GM at 1 d. OM had reduced
expression of the gene but not on the SLA surface. Expression at 7 was highest on P > SLA
> modSLA. Agonist and antagonist increased expression on the rough surfaces while
reducing its expression on the P surface.
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Figure 6-16 Miniarray analysis of effects of Axl signaling on IFITM2 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define IFITM2 (interferon induced
transmembrane protein 2) is a protein similar to IFITM1 but also implicated in the Induction
of cell cycle arrest and apoptosis by caspase activation independent of p53. Its expression
was at a similarly low level on all surfaces at 1 d in both media. Its expression had increased
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by 7 d on P than rough, and was higher on SLA than modSLA. Agonist and antagonist
increased expression on the rough surfaces compared to P.
The analysis grouped IL6ST, IMP2, KIT, NOG and NR6A1 genes together. This was due to
similarities in their patterns of expression at certain times and condition. The IL6ST gene, shown in
figure 6-17, seemed modulated higher in osteogenic than growth medium at 1 d. It was expressed
relatively higher on modSLA in GM and P in OM. Its expression had decreased by 7 d in OM on all
surfaces. Addition of Gas6 did not affect gene expression (considering modSLA OM+Gas6 7d as
possibly erroneous). However, receptor antagonist did cause notable increase in expression
relative to OM and OM + Gas6 in all samples.
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Figure 6-17 Miniarray analysis of effects of Axl signaling on IL6ST gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define IL6ST (interleukin 6 signal transducer) as
a signal transduction molecule, associated with the receptors for key immunity related
cytokines. IL6ST was expressed at a higher level by P cultured cells in OM. Its expression
had decreased by 7 d on all surfaces. While agonist seemed to induce a downregulation,
antagonist caused an upregulation of the gene at 7 d.
IMP2 (figure 6-18) was modulated very small fold relative to time zero reference. It was expressed
lower in GM than OM; being higher on modSLA on the former, while bearing an inverse trend in
OM. Peak expression of the gene occurred on P at 7 d in OM only, which was higher than SLA and
then modSLA. Receptor Axl deregulation decreased expression across all samples relative to OM.
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Figure 6-18 Miniarray analysis of effects of Axl signaling on IMP2 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define IMP2 as the enzymatic sub-unit of an
inner mitochondrial protein complex, which cleaves transit peptides and facilitates the
targeting of the molecules to the inner mitochondrial matrix. IMP2 was found expressed
comparatively higher on the modSLA and P in GM and OM, respectively. Expression of the
gene was retained by 7 d with higher fold expression on the P than rough. Agonist and
antagonist decreased expression on P but did not affect the rough surface seeded cells.
KIT (figure 6-19) was similar in their patterns of expression. It was upregulated by P compared to
rough in GM and OM at 1 d. It remained upregulated on P compared to rough at 1 d in OM. Agonist
decreased expression on P but not rough. Axl agonist increased expression in all samples.
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Figure 6-19 Miniarray analysis of effects of Axl signaling on KIT gene expression
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A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define KIT as a tyrosine kinase protein that acts
as a receptor for stem cell factor. Kit was expressed higher on P surface at 1 d in both media
types. Expression was retained at similar levels by 7 d on P but had decresed on the rough
in OM only. Agonist decreased expression on P and SLA but not modSLA. Antagonist
increased expression in all samples.
The NOG (figure 6-20) and NR6A1 (figure 6-21) genes displayed similar expression patterns. Both
genes were upregulated comparatively by modSLA in GM and polished in OM at 1 d. Genes were
expressed at high levels on P at 7 d in OM compared to rough. Axl agonist decreased expression
on polished but not rough. Axl antgonist increased expression in all samples.
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Figure 6-20 Miniarray analysis of effects of Axl signaling on NOG gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define NOG (noggin) as a polypeptide which
negatively regulates transforming growth factor beta family members, such as bone
morphogenic protein type 4, and thus inhibits bone formation. It is considered to be
important for cartilage formation. NOG was expressed high on modSLA than others in GM at
1 d. But its expression was greatly reduced in OM, with a higher fold value on P than both
rough surfaces. The P surface retained expression by 7 d, which had lowered on the rough
surfaces compared to OM 1 d. Agonist seemed to not affect expression but antagonist
starkly upregulated the gene.
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Figure 6-21 Miniarray analysis of effects of Axl signaling on NR6A1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define NR6A1 (nuclear receptor subfamily 6,
group A, member 1) as a nuclear receptor that may be involved in neurogenesis and germ
cell development. Its expression was comparatively higher on modSLA at 1 d in GM, the
pattern of which was reversed with a relatively lower expression of the gene on modSLA in
OM at 1 d. All samples retained expression by 7 d. Agonist did not have a stark affect on the
expression of the gene, apart from an upregulation on modSLA. Antagonist increased
expression relative to OM 7 d controls.
LIFR (figure 6-22) was transcribed higher in OM at 1 and 7 d. It was modulated higher on modSLA
only at 1 d in GM. The Axl antagonist upregulated expression in polished surface cultured cells at 7
d.
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Figure 6-22 Miniarray analysis of effects of Axl signaling on LIFR gene expression
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A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define LIFR (leukemia inhibitory factor receptor
alpha) as subunit of a complex that mediates the action of the leukemia inhibitory factor, a
polyfunctional cytokine that is involved in cellular differentiation, proliferation and survival
in the adult and the embryo. This gene was strongly modulated by OM than GM at 1 d. In GM,
expression was detectable on modSLA but not on the other surfaces. Expression was
similar on all surfaces by 7 d. Agonist seemed to increase expression of the gene but only
on modSLA. Antagonist increased expression of the gene but only on P, when compared to
OM 7 d controls.
PODXL was not modulated in GM (figure 6-23). In osteogenic medium, it was higher on polished
than rough. It was not transcribed at 7 d in osteogenic medium only. Axl antagonist caused a
relative upregulation compared to 7 d control medium.
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Figure 6-23 Miniarray analysis of effects of Axl signaling on PODXL gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define PODXL (podocalyxin-like) as a protein
that regulates cell adhesion and morphology, and affects cancer progression. PODXL was
expressed a similar levels at 1 d in GM. Its expression had increased several fold on
modSLA than others in OM at 1 d. Expression of the gene had decreased on all surfaces by 7
d in OM. Antagonist seemed to affect an increase in the expression of the gene on all
surfaces.
6.3.5 Differentiation
The genes detected in this category were ACTC, CGB, COL1A1, DES, FLT1, FN1, GATA6, GFAP,
LAMA1, LAMB1, LAMC1, NES, PECAM1, RUNX2, SEMA3A, SERPINA1, SST, and SYP. ACTC
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(figure 6-24) and GFAP (figure 6-25), myogenic markers, were unexpressed. CGB, GATA6 and
SST, markers associated with lunch epithelium development (Zhang et al., 2008) and embryonic
hepatic cell migration (Jung et al., 2006) respectively, were initially expressed at 1 d in both media
conditions similarly on all surfaces. Genes were unexpressed at later time point and conditions.
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Figure 6-24 Miniarray analysis of effects of Axl signaling on CG8 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define CG8 (peroxisomal biogenesis factor) as a
molecule required for protein import into peroxisomes. CG8 was expressed higher on the
modSLA than others in GM but was modulated many fold higher in OM, with highest
expression on P than others. Expression had decreased by 7 d in OM. Agonist increased
expression on modSLA only; while antagonist increased expression by a very small fold
value on all surfaces.
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Figure 6-25 Miniarray analysis of effects of Axl signaling on GATA6 gene expression
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A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define GATA6 as a transcription factor that
regulates terminal differentiation in different tissue cells such as cardiac myocytes,
intestinal stroma etc. Its expression was higher on the modSLA than the similarly expressed
levels on P and SLA at 1 d in GM. It was expressed relatively higher on the P and modSLA
surfaces than SLA at 1 d in OM. The P surface retained expression of GATA6 by 7 d, with a
very low expression on the rough surfaces. Agonist did not alter expression apart from on
modSLA but antagonist did increase expression compared to OM only in all samples.
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Figure 6-26 Miniarray analysis of effects of Axl signaling on SST gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define SST (Somatostatin) as a peptide hormone
that inhibits secondary hormones and hence regulated the endocrine system. The SST gene
was detected at 1 d in GM. Its expression was highest on the modSLA than SLA and P, the
latter exhibiting very minute expression fold values. Its expression was detected in the P
cultured cells in OM at 1 d. The gene lacked any expression in the later samples.
COL1A1 (figure 6-27), FN1 (figure 6-28), NES (figure 6-29) and SEMA3A (figure 6-30), markers of
osteogenic, angiogenic (Online Mendelian Inheritance in Man, 2011), neural and neural/lung
(Becker et al., 2011) respectively, were expressed lower in growth than osteogenic medium at 1 d
with higher fold expression on polished than rough surfaces. Expression of these genes had
reduced by 7 d in osteogenic medium on all surfaces. The Axl antagonist increased expression on
polished compared to rough surfaces.
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Figure 6-27 Miniarray analysis of effects of Axl signaling on Col1a1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define Col1a1 (collagen type 1, alpha sub-unit 1)
as an extracellular matrix molecule, which forms the collagenous matrix of bone. Its
expression was detected at similar levels at 1 d in GM, while OM seemed to cause an
upregulation of the gene on P compared to the rough surfaces. The P surface retained
expression by 7 d. Agonist did not affect expression apart from on modSLA. Antagonist
increased expression in all samples.
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Figure 6-28 Miniarray analysis of effects of Axl signaling on FN1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define FN1 (fibronectin 1) as an extracellular
matrix and soluble protein important for cell adhesion and survival. FN1 was detected in alls
samples at 1 d. Its expression had decreased on the rough than P by 7 d in OM only. Agonist
did not seem to affect expression, while antagonist increased expression on P and SLA but
not on modSLA.
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Figure 6-29 Miniarray analysis of effects of Axl signaling on NES gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define NES (nestin) as a filamentous molecule
expressed predominantly in stem cells of the central nervous system in the neural tube that
is downregulated and replaced by neurofilaments upon terminal differentiation. Its
expression was observed higher on modSLA than other surfaces at 1 d in GM. This pattern
was repeated in OM but with lower magnitude. Expression was observed at 7 d OM at very
low levels. Expression increased slightly in presence of antagonist.
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Figure 6-30 Miniarray analysis of effects of Axl signaling on SEMA3A gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define SEMA3A as a soluble growth protein that
can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a
chemoattractive agent, stimulating the growth of apical dendrites. This gene was expressed
at basal levels in all samples.
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DES (figure 6-31), a myogenic marker, was expressed at a detectable level in cells. Expression was
lower in GM than OM. They was expressed higher on P than rough in GM and OM at 1 d.
Expression noticeably decreased on rough by 7 d and was still expressed high on P. Receptor Axl
deregulation increased expression levels across all samples.
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Figure 6-31 Miniarray analysis of effects of Axl signaling on BRIX gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define NANOG as a transcription factor that
regulates inner cell mass and embryonic stem cell proliferation and self-renewal. This gene
was expressed higher on the modSLA in GM and SLA in OM at 1 d. Expression seemed to be
retained at a higher level by 7 d on modSLA but had decreased on the P and SLA surfaces.
The agonist and antagonist relatively decreased expression of the gene compared to 7 d
controls. Bars show mean; N = 3, n = 1.
LAMA1, LAMB1, LAMC1, and SYP, all markers of neuronal development (Online Mendelian
Inheritance in Man, 2011) displayed a similar trend in expression as shown in figures 6-32, 6-33, 6-
34 and 6-35. These genes were modulated higher by SLA in OM at 1 d compared to other surfaces.
In all cases, receptor Axl antagonist increased expression at 7 d.
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Figure 6-32 Miniarray analysis of effects of Axl signaling on LAMA1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define LAMA1 (laminin, alpha 1) is part of an
extracellular matrix molecule that manages the attachment and organization of cells into
tissues. This gene was expressed higher on modSLA than others at 1 d in GM. Expression
was similar in all samples at 1 d OM. At 7 d, expression had increased many times on the P
and SLA but not modSLA. Agonist and antagonist did not seem to affect the expression of
the gene apart from on the P surface.
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Figure 6-33 Miniarray analysis of effects of Axl signaling on LAMB1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define LAMB1 (laminin, beta 1 subunit) is part of
an extracellular matrix molecule that manages the attachment and organization of cells into
tissues. This gene was modulated higher on modSLA and SLA in GM and OM, respectively, 1
d post seeding. Expression of the gene was highest on P and then SLA at 7 d in OM, while
being very low on modSLA. The agonist increased expression of modSLA but reduced it in P
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and SLA samples. Antagonist decreased expression on all surfaces compared to 7 d OM
only controls.
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Figure 6-34 Miniarray analysis of effects of Axl signaling on LAMC1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define LAMC1 (laminin, gamma 1 subunit) is
part of an extracellular matrix molecule that manages the attachment and organization of
cells into tissues. Its expression changes took place in a small window of magnitude, with it
being similar on all surfaces by 1 d but being downregulated by 7 d. Agonist decreased
while antagonist increased expression.
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Figure 6-35 Miniarray analysis of effects of Axl signaling on SYP gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define SYP (synaptophysin) as a molecule that
is part of the membrane of small synaptic vesicles in brain and endocrine cells, and is
believed have a structural function in neural cells. Its expression was similar in all samples.
The antagonist increased expression on the rough surfaces relative to OM only.
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FLT1 (figure 6-36) and SERPINA1 (figure 6-37), markers of angiogenesis and were expressed
higher on P than rough in GM 1d. OM decreased expression but was higher on rough than P.
Genes were downregulated at 7 d in OM on all surfaces. Axl antagonist caused increase in
expression on all surfaces.
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Figure 6-36 Miniarray analysis of effects of Axl signaling on FLT1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define FLT1 (vascular endothelial growth
factor/vascular permeability factor receptor tysoine kinase 1) as a molecule regulating
angiogenesis and now-vasculogenesis. FLT1 was highly expressed by P in GM at 1 d
compared to the rough surfaces. Its expression was low in OM at 1 d, with a higher fold
value for modSLA than SLA than P surfaces. Agonist seemed to decrease expression while
antagonist seemed to increase expression of the gene relative to control OM only.
SERPINA1 (figure 6-37), was expressed at similar levels by cells in GM. Expression was variable in
osteogenic medium; it was detected higher on SLA only than others. Expression had diminished by
7 d in all conditions. PECAM1 (figure 6-38), a hematopoietic marker, was expressed higher on
rough than polished in GM at 1 d. Expression was similarly high on all surfaces in OM at 1 d.
Expression decreased at 7 d on all surfaces. Expression was not observably affected by receptor
Axl deregulation.
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Figure 6-37 Miniarray analysis of effects of Axl signaling on SERPINA1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define SERPINA1 (serine proteinase inhibitor)
as a soluble protease inhibitor for molecules like trypsin, elastin, thombin etc. Its expression
was detected highest at 1 d in GM in all samples. Its expression deceased in all samples by 7
d in OM only. Agonist and antagonist did not seem to affect expression of this gene in
comparison with the controls.
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Figure 6-38 Miniarray analysis of effects of Axl signaling on PECAM1 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define PECAM1 (platelet/endothelial cell
adhesion molecule) as a member of the immunoglobulin superfamily, involved in leukocyte
migration, angiogenesis, and integrin activation. Its expression was detected highest on
modSLA compared to P and SLA at 1 d in GM. Expression was detected in OM without a
clear trend. Expression had reduced by 7 d to near zero levels. Antagonist seemed to cause
a tiny increase in expression fold values.
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RUNX2, the master osteogenic regulator, was not expressed in growth medium at 1 d post seeding.
It was upregulation by modSLA higher than SLA and polished in osteogenic medium at 1 d. Its
expression decreased by 7 d and appeared higher on polished than the rough surfaces. The
antagonist increased expression by a small fold value compared to Axl agonist and control.
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Figure 6-39 Miniarray analysis of effects of Axl signaling on RUNX2 gene expression
A vertical bar chart with mean of the relative fold expression values from three donors
plotted on the x-axis (N=3, n=1). Gene cards define RUNX2 (runt related type 2) as a
transcription factor that positively drives the osteogenic differentiation of stem cells. Its
expression was very low in growth medium. In contrast osteogenic medium had caused a
slight upregulation that seemed higher on the rough than P surfaces. Its expression was
retained at a higher level on the P surface and then rough surfaces at 7 d in OM. Agonist did
not starkly affect expression but antagonist comparatively increased expression of the gene
relative to 7 d controls.
6.3.6 Inter-relation of samples
An analysis was conducted to order samples according similarities calculated by Euclidean distance
algorithm. The results of this analysis are shown in figure 6-40. This figure is extracted from a
heatmap shown in figure 6-1 with the exception that samples are arranged in an order of similarity.
Figure 6-40 indicates the sample ‘P OM 1d’ related to all samples. A limitation of this analysis was
that those specific instances attributing the sample with overlap could not be highlighted.
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The ‘primary’ cluster branching from ‘P OM 1d’ consists of a small and large group. The small group
included ‘modSLA GM 1d’ and ‘modSLA OM 1d’. The larger cluster was secondarily divided to
‘modSLA OM + Gas6 7 d’ against the remaining samples.
This cluster forming the remaining samples was further divided into two groups. The first contained
‘P GM 1d’ and ‘SLA GM 1d’ linked to ‘SLA OM + Gas6 7d’; related to ‘P OM + Gas6 7d’ and
‘modSLA OM 7d’ and ‘SLA OM 7d’.
The second consisted of the pairing of ‘P OM 7d’ and ‘SLA OM + MAb 7d’; in an ascending
hierarchy with ‘modSLA OM + MAb 7d’ and ‘P OM + MAb 7d’ to ‘SLA OM 1d’.
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Figure 6-40 Evaluation of similarities between substrate and conditions
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6.4 Discussion
6.4.1 Unexpressed genes
The unexpressed genes were largely differentiation markers for neuronal, myogenic, endothelial,
and angiogenic differentiation. Their lack of expression in the calibrator reference of time zero
indicates the difference in the gene expression pattern of hMSCs and embryonic stem cell markers.
6.4.2 Controls
The process of real time PCR calculates the fold of difference in expression of a target gene in
relation to an internal control. This control is usually assumed to be a ubiquitous gene, constitutively
expressed at a constant rate in a specimen of cells; and largely unaffected in the proposed
experimental system. The results indicate here that 18S RNA, a main requirement for cellular
systems’ protein synthesis apparatus; and GAPD, a vital metabolic effector, were unaffected by any
variables tested.
However, ACTB, CTNNB1 and RAF1 were modulated differently. These genes were upregulated
more in OM than in GM. Their responses to the surfaces differed; however a common overlap was
their increased expression on the smooth surface relative to the rough; and their comparative
upregulation by cells cultured with receptor antagonist. The functions of these molecules suggest
that cells were either approaching or actively enacting a level of
6.4.3 Maintenance of pluripotency
These gene exhibited expression in the hMSCs, indicative of the specimens’ uncommitted and
undifferentiated nature; although different to a similar state in embryonic stem cells, as seen in
absence of expression of the critical SOX2 gene.
The common trend observed was of increased expression in OM within the initial phase of culture;
with a higher expression on P than the rough surfaces. This relative difference between the surface
types was maintained by 7 d; albeit at a lower magnitude. This decrease was attenuated by
receptor antagonist, which increased gene expression.
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6.4.4 Correlation with stemness
These genes seemed largely modulated in the early phase of culture. In general, their increase was
higher in OM than in GM and on P than rough. Like the previous genes, these were increased in
expression by receptor antagonist.
6.4.5 Differentiation genes
This was the most critical section of the experiment; querying the expression of genes known to
induce or drive phenotypic differentiation to a lineage other than osteoblastic. The majority of
markers seemed expressed early in culture. These markers seemed to be expressed higher on P
than the rough surfaces. The osteogenic marker Runx2 displayed a pattern somewhat interpretable
within the context of the experiment. The lack of expression of the gene at 1 d in GM was as
expected. Its upregulation at 1 d in OM on modSLA > SLA > P had been independently observed
within this study in a previous experiment (section 4). Its relative high level on P compared to rough
at 7 d probably suggests that at this early interval in osteogenic differentiation, the gene was still
being transcribed on P. This is, however, confounded by the observation of increase in expression
by receptor antagonist.
6.4.6 Inter-relation of samples
The similarities drawn between the different samples with the Euclidean algorithm indicated two
solitary and four grouped samples. The first solitary sample was P OM 1d. It was found comparable
to all samples but closely linked to ‘modSLA GM 1 d’ and ‘modSLA OM 1 d’. The modSLA surface
enhances osteogenic responses, and as such is highly osteogenic and low stemness; hence, their
grouping together might be indicative of being primed for (osteogenic) differentiation. This is
indicated in the decreased expression of various correlation and maintenance of stemness genes
on this surface.
The second solitary sample is ‘modSLA OM Gas6 7 d’. It is comparable to the remainder of
samples, organised into three groups. The first groups comprises ‘SLA OM Gas6 7d, ‘SLA GM 1 d’
and ‘P GM 1 d. These are low osteogenic and high stemness; the similarities between which imply
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their relative higher expression of stemness markers. The second group, directly related to the
preceding ‘higher stemness group’, includes ‘SLA OM 7 d’, ‘modSLA OM 7 d’ and ‘P OM Gas6 7d’.
This is an unexpected relation, as the initial two samples of this group are known through previous
experiments as being highly osteogenic and hence, low stemness. However, hypothetically, ‘P OM
Gas6 7d’ is a high stemness representing sample, influenced by the relative lag in osteogenic
differentiation compared to rough seen in previous experiments and the presence of Axl promoting
Gas6, theoretically an inhibitor of mineralisation.
The third is a hierarchical group of five samples. The initial two are ‘P OM 7 d’ and ‘SLA OM MAb 7
d’. This relationship is unexplained as, theoretically, the expression of stemness genes on the latter
would be expected to be lower than on the former. The pair is related to ‘modSLA OM MAb 7d’,
which is then related to ‘P OM MAb 7 d’ and then ‘SLA OM 1 d’. The similarities between these
three imply a similar loss of stemness gene expression.
6.4.7 Significance of findings
The experiment shows a differential pressure on hMSC differentiation on the various surfaces and
conditions. The analyses at 1 d indicate that the hMSCs are in an uncommitted state with a high
level of expression of correlation, maintenance and differentiation genes in cells on all surfaces.
The expression of these genes is relatively downregulated by the rough than polished surface at
this initial time. The expression of most genes expectedly decreases with time in inductive medium.
Interestingly, the addition of receptor agonist and antagonist alter the pattern of gene expression in
many genes. This association of receptor de-regulation with the stem cell transcriptome suggests
that Axl signaling might be important to the state of stemness of hMSCs. In the case of β-catennin 
and Runx2, the effect of a relative small fold upregulation at 7 d by antagonist compared to controls,
is indicative of the effect expected from the attenuation of this pathway; positive signaling inhibits
mineralisation and vice versa. A further indication of these results is of a ‘silencing’ effect that the
agonist seems to be causing in the case of many genes (Matt Dalby, Univ. of Glasgow, personal
communication). This may be the reason causing a down instead of an up regulation of the
stemness genes.
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6.5 Summary
The expressions of a subset of genes implicated in imparting a cell with pluripotency are
differentially regulated by modified Ti surfaces. The polished surface promotes stemness gene
expression relatively more than rough. OM causes a decrease in overall stemness gene expression
over time. The inhibition of Axl signaling, for unknown reasons, promotes the expression of several
of these stemness genes at the 7 d time point.
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7 Discussion
7.1 The hypothesis
The question posed by this thesis queried whether the Axl receptor is differentially modulated in
cellular osteogenic responses to rough Ti implant surfaces compared with a control polished
surface. There were two main sets of observations that led to the posed question.
The first was the differential promotive effects of modified Ti surfaces, used in this study, which in
summary can be suggested to cause an accelerated form of osteogenic differentiation in cells. The
results leading to this notion have been presented in several studies examining cell-substrate
interactions on these very surfaces, i.e. polished, rough-hydrophobic SLA and rough-hydrophilic
modSLA (described in sections 1.3.4 and 1.3.5). These studies have applied a wide range of
analyses at the genetic and molecular levels, as well as cell types, including committed osteoblastic
cells, osteogenic cancer cell lines, immune cells, and various stem cells. The in vitro evidence
indicates differences in the capacity of each surface to alter osteogenic differentiation and function.
These suggest an order based on magnitudinal differences in effects with rough-hydrophilic
modSLA relatively more promotive than rough-hydrophobic SLA, which is than polished, which is in
turn is than tissue culture plastic (TCP) in terms of their ability to support and promote osteogenic
activity (Miron et al., 2010; Wall et al., 2009) Mendonca et al. 2008 (Mendonca G et al., 2008)
(Olivares-Navarrete et al., 2011; Olivares-Navarrete et al., 2010a; Wennerberg and Albrektsson,
2009).
The second was the selective upregulation, detected by global gene expression analyses with
microarrays, of a receptor tyrosine kinase Axl in cells cultured on rough-hydrophobic SLA surface
(Brett et al. 2004). This molecule and its ligand, Gas6, are implicated in the negative regulation of
the differentiation of uncommitted bovine pericytes cultured in osteogenic inductive medium (Collet
et al., 2007; Collet et al., 2003). Specifically, the receptor is thought to be important in the pre-
osteogenic phase of differentiation and is down-regulated prior to calcium deposition by cells (Collet
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et al., 2007) suggesting it a probable role in the differential response of cells to the modified Ti
surfaces.
7.2 Overview of thesis
The study was conducted in two parts. The first part evaluated the phenotypic and osteogenic
response of human mesenchymal stromal cells (hMSCs) to the different substrates. The second
examined the modulation of receptor kinase Axl and ligand Gas6 at the transcript and protein level
in control conditions, and later examined the effects of receptor de-regulation on the previously
assessed cellular phenotypic and osteogenic parameters. Receptor de-regulation was achieved
with recombinant proteins and monoclonal antibodies; upregulation with receptor agonist and down-
regulation with antagonist. This method was used due to its simplicity. It was thought of as an
optimum point of initiating the study of Axl’s potential role in differential cellular responses to
different substrates, particularly with respect to the cellular specimens multipotent nature; the very
factor that renders these the preferred cell type for evaluating the pathway’s importance in substrate
influenced cell developmental processes.
The hMSCs are known to gradually lose their multipotentiality with time in culture, and this can veru
easily be further affected by the variable stresses cellular cultures undergo in vitro (Shanti et al.,
2007; Tuan, 2011). As the applied method did not require the biochemical manipulation of cells, i.e.
transfection with expression vectors etc, or gene knock out procedures, the possibilities of any
alterations in the specimens’ normal behavior were relatively reduced, as were the possibilities of
ambiguity in the findings derived from them. The importance of the specimens’ nature was even
more significant due to the perceived higher dependence of these multipotent cells on the Axl
pathway’s osteo-inhibitory effects.
The experiments were conducted on three topographically and chemically different Ti surfaces with
tissue culture plastic used as a control for material based differences. The Ti surfaces were
manufactured by Straumann AG, a Swiss company that specialises in dental products. They re-
produced the implant topographies on 15 mm discs. These substrates have been previously
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characterised by (Rupp et al., 2006), who demonstrated an average roughness measure (Ra,
arithmetic mean of lowest and highest point in a surface profile) of < 0.5 µm compared to ~ 4.2 µm
for the rough-hydrophobic SLA/hydrophobic modSLA, respectively. (Rupp et al., 2006) also
evaluated advancing contact angle measurements to be 0o for the modSLA compared to 138.3 +
4.2o angles for SLA and 96 o angle for P surface (Buser et al., 2004; Zhao et al., 2007). The rough
surfaces, though different in their potential to adsorb water, had the same topography. An easy way
to describe their roughness is as a surface resorbed by osteoclasts, with large craters formed by the
blasting of alumina particles, which is superimposed by many tiny ‘crypt’ like indentations formed by
acid etching that collectively yield a highly uneven topography (Schwartz et al., 2009a; Ferguson et
al., 2006; Rupp et al., 2006). The comparative findings of this thesis are discussed in the following
sub-sections.
7.2.1 Phenotypic responses to modified Ti surfaces
The phenotype of a mesenchymal stromal cell is that of a strongly adherent and mitotic cell. It is
seemingly under pressure to attach to a substrate in order to divide to form larger progeny numbers
(DiGirolamo et al., 1999). When the attachment of an hMSC is tested on the different substrates
studied in this thesis, they seem to attach preferentially and at a higher affinity to the polished
surface, upon which the hMSC begins to attain stability by spreading over the surface at a faster
rate taking a near uniform spherical morphology with a central nucleus, resembling the appearance
of a fried egg. This was similar to what was reported in (Wall et al. 2009) at 3 h.
This does not happen on the rough, which present a topography that the cells need to adapt to. The
cells attach to the roughened surfaces at a rate relatively lower than on the polished, resulting in a
lower number of cells in the initial instances of contact (5 to 60 min). In addition, the cells adapt an
irregular morphology, seemingly constrained or stretched, with cytoplasmic processes emanating in
various directions. The cells, as shown in figure 3-5 and 3-6, seem to resemble a tent pegged to the
ground on all sides. These figures also show that the final state the cell adapts on the rough
surfaces at 3 h is quite different to their earlt appearance, which is highly spherical with very few
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attachment processes. It may have been highly interesting to have evaluated cytoskeletal changes
in the cells per time, with emphasis paid on the positioning of the nucleus.
The differential events of attachment and spreading are followed by stark differences in cellular
viability and proliferation. While the hMSC on a polished surface would initiate proliferation after
adhering stably, forming a higher number of progeny over the course of culture, the cells on the
roughened surfaces exhibit a lag in replication before cell numbers increase significantly in the
intermediate to end stages of a 21 day culture. This relative replicative lag on the rough compared
to polished or tissue culture plastic is considered to be partly due to the events of apoptosis and
necrosis occurring in the specimen at early cell-rough substrate contact as reported in (Wall et al.
2009); and partly due to substrate induced metabolic changes in cells, believed to manifest in the
form of altered fate determination in these cells. The occurrence of apoptosis is inferred from the
patterns of cellular proliferation observed on the different surfaces combined with that of caspase 3,
BCL-XL and Ki-67 transcriptional upregulation on the rough at very early times in culture. The
metabolic differences induced by the rough surfaces resulting in altered cellular responses,
primarily related to the osteogenic activity of the cells on the rough substrates is also implicated
from the transcriptional upregulation of caspase 3; but through its reported association with
osteogenic differentiation in mice and mice MSCs (Miura et al. 2004). It seems that the cells which
survive this ‘selective’ process, through either apoptosis or metabolic enhancement, ultimately are
capable of exhibiting heightened osteogenic activity. This may translate as an induction by rough
surface on cellular ability of producing better quality bone and might therefore be responsible for the
better in vivo performance of the rougher surfaces.
7.2.2 Osteogenic responses to modified Ti surfaces
The metabolic activity taking place in an hMSC differentiating on the rough surface is suggested to
be different than that cultured on the smooth surfaces. The rough surfaces offer a very different set
of variables for the cell to sense and respond to. The effect of these differences appears to induce
the undifferentiated cells to differentiate earlier, adopting an osteoblastic phenotype that is probably
most suited for the detected microenvironment. The cell, being a constituent of the organism’s
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anatomy, would bear a memory and capability of responding to only what it could face in its cognate
microenvironment within the organism; and certainly not an innate object such as Ti metal.
However, it seems that the cell can distinguish Ti metal from TCP and differentiate more profoundly
on the metal, and even more on the modified Ti surfaces. The events taking place on the rough
surfaces apparently occur later on the polished and are further delayed on the TCP. The outcome
of each of these varied processes is the formation of a calcified ECM, reminiscent of true bone
formation in vivo. The rough Ti surfaces apparently induce an increase in the measured
parameters, which can only suggest an increase in cellular differentiation and hence, bone
formation.
These variations in the cell’s behavior on the different substrates are largely down to a differential
set of stimuli received by the cell over time (Tuan, 2011). These stimuli seem pleiotropic in nature.
They can be immediate and direct in the form of topography, chemistry, medium, physical
properties (temperature, humidity, etc), as biological in the form of cell type, context of experiment
etc., and as late culminations of the effects of the initial set of stimuli. This seems true for the cell
attaching and spreading on the rough surfaces, which might engagement extra cell fate
determination mechanisms; supported from the observed pattern of Wnt5a that is a known effector
of osteogenic differentiation the engagement of cell architectural assemblies associated Rock/Rho
GTPase signaling system in MSC like cells (Santos et al., 2010). Though the exact activity of
mechanotransduction elements was not examined in this study, the results strongly suggest that the
hMSC on the rough surfaces uses its genes and molecular systems very differently to the cells the
polished and tissue culture plastic.
7.2.3 Differential modulation of Axl/Gas6 pathway by modified Ti surfaces
The receptor Axl is expressed by osteogenic cells but has not been widely studied in the context of
osteogenic differentiation. However, its significant effects on this process have been demonstrated
experimentally in the context of vascular ossification, which is deemed to be developmentally
overlapping with skeletal osteogenesis (Johnson et al., 2006). It is known that Axl is needed in the
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pre-osteoblastic phase of an osteogenic cell’s life cycle and is downregulated nearing the initiation
of cellular mineralisation (Collet et al. 2003; 2006).
The findings of this study demonstrate that an hMSC cultured on the rough Ti surfaces induces this
downregulation earlier than on polished and TCP. This hMSC would have engaged several different
mechanisms in response to the early direct and late indirect stimuli that seem to affect the
downregulation of Axl. The contrast generated by deregulating receptor signaling suggests it to be
part of cell physiological events preceding the initiation of mineralisation. Specifically, it seems to be
regulating cellular maturation, inferred from 7th day culture observations of receptor deregulation on
cellular osteogenic responses. The experiment showed the downregulation of mineralisation to be
highest on TCP. Though the Ti surfaces did show a decrease in mineralisation, it was substantially
less compared to control conditions. A factor here is Ti metal, which seemed to have been a
significant contributor to the heightened mineralisation of the cells.
Moreover, while the rough substrates do not respond significantly to the Axl agonist, they exhibit a
higher synthesis of osteoblast secreted soluble regulators of osteoclastogenesis (osteoprotegrin
and growth differentiation factor 15). In simple terms, according to the suggestion of an
enhancement in osteogenic differentiation on the rough surfaces, the finding of an enhancement in
OPG and GDF15 may indicate a possible association of Axl with the promotive effects of the
substrates on cellular differentiation.
The correlation of Axl signaling with the hMSC pluripotency apparatus is also evident in the
differences seen in the expression of stem cellness associated genes in chapter 6. The experiment
revealed cells variably regulate the expression of stemness genes. Most of the genes correlating
with the maintenance of stemness and those indicative of cellular pluripotency displayed a higher
expression on the polished that rough at 1 day post seeding. The effects of media were evident,
and several trends observed in growth medium were reversed in osteogenic inductive medium.
However, crucially, the expression of genes at 7 day in control, agonist and antagonist cultured
cells were different. Most of these genes were downregulated by all surfaces in control osteogenic
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medium. The agonist seemed to have caused a similar effect but mostly keeping the expression of
these genes at a low relative fold value. However, it was the antagonist that seemed to have
positively modulated the expression of several genes. Of particular significance are β-catennin and 
Runx2, both of which have been shown to bear an importance in the process of osteogenesis. The
patterns of these genes, being lowered or raised, in comparison to osteogenic medium only controls
at 7 days, by agonist and antagonist respectively, is an encouraging find that supports the notion of
Axl causing an osteoinhibitory effect: receptor de-regulation by agonist increases Axl signaling and
may underpin the relative lower fold expression of the said genes, while their relative upregulation
by antagonist could be representative of the effect of decreasing the pathway’s signaling. In
correlation with the observed pattern of receptor downregulation on the rough, the arrays, too,
suggest that that it is the temporal downregulation of the receptor that the hMSC pursues in
response to osteogenic medium and that the cell on the rough is under a stronger pressure to
decrease the activity of this pathway in order to differentiate and mineralise comparatively faster
than on polished surfaces.
7.3 Correlations and disagreements with other studies
The findings presented in this thesis agree with many of the previous discoveries in cell-implant
interactions concerning the SLA and modSLA surfaces described in section 1.3.5 and 1.4.6. The
studies cited in these sections had shown the differential regulation of alternate cell regulatory and
fate determination systems that instigate enhanced osteogenic differentiation and function on the
rough surfaces. Their comparative highlights between with this study are listed below.
1. Phenotypic responses
a. As reported in (Miron et al. 2010; Wall et al. 2009), cells of a mesenchymal lineage
spread highly on the P and are stretched on the rough. These studies do not
indicate differences in the potential of cells to adhere to the different surfaces.
Those differences have been shown here to manifest in a higher number of
attached cells on the polished than rough at very early times. In addition, this study
provides evidence that the stretched morphology of cells on the rough is a fate that
7 Discussion 7.5 Significance of findings and Future directions
197
the cell would reach at 3 h post contact. Prior, the hMSCs seem to be in a
restricted, non-spread, and spherical shape with fewer cytoplasmic processes fixing
the cell onto the substrate compared to the later time point.
b. The reduction in cellular viability on SLA and modSLA observed here has been
reported previously in (Olivares-Navarrete et al. 2010; Wall et al. 2009; Rausch-fan
et al. 2007). (Wall et al., 2009) indicated that this loss of viability may be due to
apoptosis and necrosis occurring in cells on the rough surfaces. The occurrence of
apoptosis in the cultures used in this study can be anticipated with the finding of a
transcriptional upregulation of caspase 3 and related factors at early times on the
rough compared to smooth. However, a possibility exists that the authors may have
detected Annexin V of matrix vesicles as opposed to that of apoptotic cells, due to
the kits specificity for this antigen. Indeed, the association of caspase 3 with
osteogenesis, as suggested by the knockout and knockdown experiments of (Miura
et al., 2004), though not sufficiently strong evidence, can also be indicative of a
metabolic change occurring in cells. This, in the context of the present set of results
and the observers’ views, could likely be representative of a heightened osteogenic
differentiation as opposed to cell death suggested by (Wall et al., 2009).
2. Osteogenic responses
a. The study agrees with the observations of (Rausch-fan et al. 2007; Olivares-
Navarrete et al. 2010) of the increased synthesis of alkaline phosphatase,
osteocalcin, and osteoprotegrin molecules on the rough surfaces. However, the
dynamics of their synthesis has been evaluated here in a larger time frame that
provides a wider perspective of this process. The temporal effects of the surfaces
on the expression of these molecules, in particular the downregulation on the Ti
surfaces compared to tissue culture plastic at 21 d of ALP (section 4) that parallel’s
the substrates’ significantly higher mineralisation compared to tissue culture plastic,
are demonstrated with relative higher contrast.
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b. The results here agree with (Miron et al. 2010; Wall et al. 2009) that calcium
deposition is higher on the rough than smooth. The results here, however, provide
a quantitative assessment of ECM mineralisation as opposed to a comparative
view. In addition, those studies did not provide an assessment of the state of
density of calcification in the extracellular matrix. Combining the quantification of
calcium and collagen in the extracellular monolayer, this study managed to provide
an additional aspect of mineralisation in the form of density of calcium per matrix
collagen.
c. The differential involvement of Integrins ITGA2 and ITGB1 with Ti and Ti modified
surfaces in regulating TGF-b1 and OPG (Schwartz et al 2009) could not be
ascertained by the gene expression findings of this study. A comparison at the
protein level may have been more informative of this relationship.
3. Differential Axl modulation
a. The trend of Axl quantity and phosphotyrosination decrease suggested by (Collet et
al. 2003; Collet et al. 2006) in pericytic cells was found true. This study provides a
further view consisting of the effects of this pathway on osteoprotegrin and growth
differentiation factor 15 synthesis in the proposed heightened state of osteogenic
differentiation on the rough substrates.
b. De-regulation of this pathway and its effects on stem cellness gene expression had
not been proposed prior. The results in this thesis may serve as a starting point in
querying the association of Axl with human stem cell transcriptome.
A point of contention in this study has been the occurrence of apoptosis on the rouigh substrates,
which the expression of caspase 3 and related survival genes at early times combined with its
potential role in the program of osteogenic differentiation, demonstrated by decreased bone mineral
density due to decreased runx2 expression in caspase 3 null mice (Miura et al. 2004), have made
difficult to solve. (Wall et al., 2009) proposed the apoptosis to be specific to Stro-1 negative cells,
leading to a comparative increase in the number of Stro-1 positive cells on the rough, which were
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further hypothesised to underpin the enhanced mineralisation on the rough. This study could not
evaluate the relative change in Stro-1 positive cells between the populations. The methods applied
in the thesis could not distinguish between the different sub-sets in an hMSC samples. But it did
observe an up regulation of the caspase 3 gene at times and in conditions that relate more to
differentiation than to apoptosis. This is supported by a retrospective view of the apoptosis related
annexin V flow cytometric kit used by (Wall et al. 2009), which suggests that the entity studied by
the authors may have been matrix vesicles that are also rich in Annexin v (Anderson et al., 2005).
There is a disagreement with methodological shortcomings in other studies (Olivares-Nevarrate et
al. 2010; Schwartz et al. 2009) and related publications, in which experiments have been conducted
by seeding cells on the surfaces in growth medium with TCP as a reference to evaluate cellular
confluence. Medium would be changed from growth to osteogenic when cellular confluence was
found in the TCP samples and parameters such as osteoblastic protein marker expression etc.
would be quantified and compared. Whilst this may test the effects of the rough surfaces on the
immediate activity of cells, it negates consideration of substrate influence immediately initiated at
the point of contact, and followed through over the following days in culture. Accordingly, cells
would have sustained many unknown changes, particularly considering the nature of the cells
examined.
In addition, the authors have stated that the calcium mineralisation assay is not an appropriate
method to assay osteogenic differentiation due to the influence of different medium stimulants
(Olivares-Nararrete et al. 2010). This is strongly disagreed here; the use of the calcium
mineralisation assay applied in this study is supported by the parallel trend observed in
mineralization and osteoclastogenic regulator synthesis in hMSCs cultured on the different
surfaces. These findings provide strong evidence that validates the application of this assay. In
addition, the formulation of OM used here did not lead to the suggested destruction of cell numbers;
instead a steady growth of cells, at low and high initial seeding densities, was observed. The model
is not true osteogenic mineralisation; but it can been deemed ‘authentic in an artificial setting’, with
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finite capacity, as seen in the form of a plateau in the ratios of ECM calcium to collagen at 14 d
compared to 21 d on the rough surfaces.
7.4 Conclusion
In conclusion, the findings here implicate the differential sensing of substrate material and hence,
response to substrate topography by osteogenic cells. This differential behavior of cells is a
reflection of the temporal variation in osteogenic events on the different surfaces. The study
proposes that surface topography of the SLA and modSLA ‘accelerates the osteogenic
differentiation of MSCs through some sort of alternative mechanism of phenotypic induction and
differentiation. This temporal and magnitudinal enhancement by the rough surfaces includes the
variable modulation of Axl tyrosine kinase. The pathway is expressed in uncommitted cells implying
its importance to that cellular state. It is downregulated as the cell progresses through commitment
to the state of mineralisation. The faster the process of differentiation, as exemplified by modSLA,
the faster the downregulation of this receptor system, and vice versa.
7.5 Significance of findings and Future directions
The present study, like any form of research, has several implications depending on the perspective
of the observer. It views the human body as a composite of overlapping systems, with the
‘regenerative system’ being one such system that has not been well characterised yet but will be
highlighted in the near future, considering the present drive for ever new therapeutic developments.
It can be loosely seen to consist of cells of an uncommitted / plastic nature, sequestered in tightly
regulated pockets within various forms of tissue (mostly highlighted in blood, bone, muscle), which
are mobilized by cytokines associated with reparative responses to the site of damage with the
intent of repair. Papers from the late 1880s and the post World War 2 eras, periods that saw major
progress in developmental biology, extensively use the term stem cells. Indeed, in many contexts
the use of this term was correct as the investigators were querying the phylogenetic linkage
between cellular entities of a system, notably the hematopoietic system. However, the same
scrutiny at the single cell level has not been demonstrated with the MSC. This is being said not to
discourage the crucial findings of the past but to encourage a consensus for deciphering their
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biological truth that may prove very fruitful in the present momentum of biotechnological
advancement.
The present theoretical implication of MSCs considers them participants in tissue repair that are
limited in the capacity to regenerate but may be sufficient with human intervention in the form of
biomaterials. Ti has been long known to be a biocompatible biomaterial. The exact biological
mechanism(s) that achieve osseointegration are unknown but not for long. In vitro studies have
demonstrated cell phenotypic responses to modified surfaces and will continue to do so- and will
produce much useful to help dissect the important events in osteogenesis leading to the design of
novel molecular therapies.
The therapeutic implications of Ti in the short term would include (i) its use as an in vitro substrate
for the evaluation of osteogenic events and (ii) biomaterial design for bone related tissue
engineering purposes. The long term implications surround identifying relevant sub-cellular target
pathways, which may be manipulated to gain the desired osteogenic outcome with a high degree of
specificity and efficiency. The Axl system is an example of a putative therapeutic target. This may
not be apparent in the present framework but with Axl as a reference point, elucidation of the
dynamics of osteogenic differentiation would identify targets of therapeutic interest.
7.6 Limitations
The relationship between cellular morphology and phenotypic differentiation is an area of study that
is gaining in significance. It would have been interesting to query the structural differences in cells
while attached to different surfaces, and assess in parallel, the relevant components of the currently
known mechanotransduction apparatus in those samples. This could be conducted by confocal
microscopy techniques and immuno staining of various structural and signaling molecules.
In a similar way, it would be interesting to compare the quantitative and qualitative state of key
osteogenesis associated proteins such as Runx2, bone morphogenic proteins and receptors, bone
sialoprotein subtypes etc. at the protein level with western blots. Gene expression is difficult to
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interpret as it does not provide information at the protein level. Proteins levels in some instances
may present more accurate information of an actual event as increased mRNA levels do not always
lead to an increase in the effector molecules (proteins). The accurate identification of the effector
molecules actually participating in the difference could help identify upstream molecular systems.
Different methods of Axl receptor deregulation could have been used to increase the contrast of
cellular responses. The methods used here were sufficient to disrupt the normal activity, above
(agonist) or below (antagonist) the required threshold. However, the method was not highly efficient
in inhibiting receptor activity through binding endogenous Gas6 resulting in only incomplete
inhibition of signaling, and therefore smaller variations in the measured responses. It would have
been ideal to further assess the present findings using (i) transfection of expression vectors with
receptor kinase variants (wild type vs. deficient); (ii) RNA interference to knock-down Gas6
synthesis; (iii) Axl or Gas6 knock-out mice. The disadvantages of these methods largely pertain to
time constraints but may also manifest in altered cellular behavior due to the specimens sensitive
nature. The Axl signaling initiates at the cell surface and progresses through different sub-cellular
systems before generating its transcriptional effect, leading to phenotypic changes in the cells.
Knowledge of the downstream effectors in this cascade would have made it possible to screen for
changes in the protein levels of these molecules and therefore help to elucidate the end-effector
and its concise biological function.
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9 Appendices
9.1 Appendix I: Stem cell identity markers
The appendix I contains tables for cell surface markers presently considered as either positive,
negative or neutral for flow-cytometry based cell identification procedures. These are tables 9-1, 9-
2, and 9-3, respectively.
Table 9-1 Positive human mesenchymal stromal cell markers
These molecules are strongly associated with the positive identification of mutlipotent
fibroblastic cells isolated from bone marrow. Gene annotations obtained from (Gene Cards,
2011).
Molecular
marker
Description General function Reference
Stro 1 A tryspin resistant
unidentified antigen
unknown (Simmons and Torok-
Storb, 1991)
CD 13 Alanyl (membrane)
Aminopeptidase
Integrin family membrane
receptors
(Honczarenko et al.,
2006)
CD 29 Fibronectin Receptor,
Integrin beta 1
Involved in cell adhesion and
recognition
(De Silva Merielles, 2008)
CD 44 Extracellular matrix
receptor-III, Cell Surface
Glycoprotein
Involved in cell adhesion and
recognition
(Gronthos et al., 2003)
CD 63 Lysosomal Membrane
Glycoprotein; Melanoma
1 Antigen
regulation of cell development,
activation, growth and motility
(Stewart et al., 2003)
CD 73 Purine 5-Prime-
Nucleotidase
Catalyses conversion of purine 5-
prime mononucleotides to
(Barry et al., 2001)
CD 90 Thy-1 membrane
glycoprotein precursor
Cell-Cell Interactions (Honczarenko et al.,
2006)
CD 105 Endoglin Component of the transforming
growth factor beta receptor
complex
(Honczarenko et al.,
2006)
CD 166 Activated Leucocyte Cell
Adhesion Molecule
Implicated in cell to cell adhesion
through homophilic and heterphilic
binding
(Wall et al., 2007)
CD 217 IL17RA A ubiquitous type I membrane
glycoprotein that binds with low
affinity to interleukin 17A
(Jones and McGonagle,
2008)
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Table 9-2 Negative expressed human mesenchymal stromal cell marker
Gene annotations obtained from (Gene Cards, 2011)
Molecular
marker
Description General function Reference
CD11b Integrin Alpha M Cell-Cell Interactions (De Silva
Merielles, 2008)
CD14 Monocyte
Differentiation
Antigen
Lipopolysaccharide and apoptotic cell binding
surface protein, expressed on
monocytes/lymphocyte precursors
(Pittenger et al.,
1999)
CD19 B-lymphocyte
antigen
Cell surface molecule which assembles with the
antigen receptor of B lymphocytes in order to
decrease the threshold for antigen receptor-
dependent stimulation.
CD31 Platelet/Endothelial
Cell Adhesion
Molecule
Cell adhesion molecule expressed on platelets
and at endothelial cell intercellular junctions
(Pittenger et al.,
1999)
CD34 Hematopoietic
Progenitor Cell
Antigen
A monomeric cell surface antigen selectively
expressed on human hematopoietic progenitor
cells
(Online
Mendelian
Inheritance in
Man, 2011)
CD45 Leukocyte-common
antigen
Required for T-cell activation through the antigen
receptor
(Zuk et al.,
2002)
CD59 T cell-activating
protein
Regulates complement-mediated cell lysis and is
involved in lymphocyte signal transduction
(Javazon et al.,
2004)
CD79-
alpha
B-cell antigen
receptor complex-
associated protein
alpha chain
CD79B for initiation of the signal transduction
cascade activated by binding of antigen to the B-
cell antigen receptor complex
(Valeria, 2009)
c-Kit Hematopoietic Stem Cell Growth Factor Receptor (Orlic et al.,
2001)
HLA-DR Major
Histocompatibility
Complex Class 2
Presentation of Antigens to CD8+ T-Cells (De Silva
Merielles, 2008)
9 Appendix Stem cell identity markers Appendix I
216
Table 9-3 Variably expressed cell surface markers on hMSCs
Gene annotations obtained from (Gene Cards, 2011)
Molecular
marker
Description General function Reference
hTert Human Telomerase
Enzyme Reverse
Transcriptase
Enzymatic subunit of telomere
length maintaining protein
present in early aged cells
(Colter et al., 2001)Colter et
al 2001
Flk-1 Vascular Endothelial
Growth Factor.
Expressed on RS cells
but not on mMSCs.
Receptor for VEGF or VEGFC.
Has a tyrosine-protein kinase
activity.
(Colter et al., 2001)
CD106 Vascular cell adhesion
molecule
low expression relative to high
Stro1; a cell surface
sialoglycoprotein expressed by
cytokine-activated endothelium
(Gronthos et al., 2003)
Ki-67 Cell Proliferation
Antigen
Absent in fresh isolates (Orlic et al., 2003)
9 Appendix Appendix II
217
9.2 Appendix II: Types of serum tested for culture optimisation
The table 9-4 shows the type, source and batch number of the six different sera types used for the
experiments conducted in section 2.2.4.
Table 9-4 Types of FBS tested for hMSC culture
Type Serum Source Serum
catalogue/Batch No
A Gibco-A 41F8061K
B Gibco-B 41F3083K
C Lonza-A DE14-801C-B0002
D Lonza-B DE14-870C-B0001
E Biosera 05464 S1810
F PAA (Control) A15-151-1570
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9.3 Appendix III: Tabulation of cell culture materials
The tables 9-5 to 9-9 tabulate details of the various equipment and materials used in this project.
Table 9-5 Cell culture environment
Item
No.
Equipment Manufacturer Application
1 Laminar Flow
Cabinet
NUAIRE Class II with
UV-tube
Confined clean work environment; pre-cleaned with
70% ethanol spray and propanol wipes prior to every
use
2 Incubator Nuaire NU-5500 DH
AutoFlow Co2
Incubator
Set at 5% CO2 and 370C for cell incubation; cleaned
every fortnight with bleaches.
3 Cryogenic
cell storage
Thermo Scientific Liquid nitrogen containing chamber with removable lid
and six vertical racks, each capable of containing 5 x
96 sample cryo-boxes. Re-stocked with liquid nitrogen
every fortnight.
4 Water bath ETI 800 series Weekly cleaned 50 L chamber with adjustable
thermostat, set at 370C
5 Inverted
microscope
Olympus CXK31 Standard device with fixed binocular observation tube
and 4, 10, 40 and 100x magnification objective
lenses.
6 Hemocyto-
meter with
trypan blue
Sigma Standard 9x (1 x1 mm) grid with cover slip.
7 Centrifuge Different Tissue culture purposed large centrifuge.
Microcentrifuge for smaller samples.
8 Pipettes Qiagen Calibrated pipette ‘gun’ and 1000, 200, 20 and 10 uL
micropipettes.
Table 9-6 Cell culture consumables
Item
No.
Equipment Manufacturer Applications
1 Flasks Fluka Enclosed polystyrene flasks with a negatively
charged inner substratum for cell culture. Three
sizes used in this study: 150, 75 and 25 cm2
flasks. Inner space accessed through an air-
permeable screw-able cap.
2 Plates Nunc Treated polystyrene multi-well plates with
removable lid. Three types used depending on
individual well size: 9.6 cm2 6-well; 1.9 cm2 24-
well; and 0.19 cm2 96 well plates.
3 Tubes Nunc Sterile polystyrene tubes for various cell culture
purposes. Sizes used: 50, 15, 2 and 1.5 ml.
4 Microtubes Nunc Sterile plastic tubes of 500 and 100 uL.
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5 Cryopreservation
tubes
Nunc Male-screw sterile plastic vials of 2 ml volume for
cryopreserving cells.
6 Tube Racks Generic Autoclavable plastic racks of various sizes.
Table 9-7 Cell culture reagents
Abbreviations of reagents used in text are provided in the corresponding row under the
applications column.
Item
No.
Reagent Manufacturer Applications
1 Alpha minimal essential
medium
Gibco αMEM; L-Glutamine supplemented
basal medium for hMSC propagation
and growth.
2 Dulbecco’s modified
eagle’s medium
PAA Lab. DMEM; L-Glutamine supplemented low-
glucose (1 g / L) basal medium for
hABC growth. Also used as basal
medium for forming osteogenic
inductive medium.
3 Trypsin/EDTA PAA Lab. A solution of 0.05 % / 0.002 %
Trypsin/EDTA in calcium and
magnesium free phosphate buffered
saline.
4 Ca2+ Mg2+ free Phosphate
Buffered Saline
PAA Lab. Dication-free PBS; an isotonic solution
of NaCl in water used for cell washing,
and dilutions.
5 Fetal Bovine Serum (FBS) Gibco FBS; heat inactivated serum sourced
from South America, supplemented to
basal medium to nourish cells whilst in
culture.
6 Antibiotics PAA Lab. A mixture of Penicillin 10 Units / ml and
Streptomycin 10 mg / ml in dication-free
PBS. This was occasionally
supplemented with the fungicide
Amphotericin B at 0.2 % of culture
medium.
7 DMSO Sigma Dimethyl sulfoxide; used as a
cryoprotectant for cryopreserving cells.
8 Dexamethasone Sigma Water soluble glucocorticoid molecule
complexed with Cyclodextrin in
osteogenic differentiation.
9 β-glycerophosphate Fischer  Water soluble phosphate donor in 
osteogenic differentiation.
10 Asorbate-3-phsphate Fischer Metabolite used for collagen synthesis
in osteogenic differentiation.
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Table 9-8 Sterilisation equipment
Item
No.
Equipment Manufacturer Applications
1 Alcohols Various Industrial methylated spirit at 70 % in water and
used as a sterilizing spray. Propanol wipes
(Azowipes) were used also applied to clean
large surfaces.
2 Autoclave Pressurised steam sterilizer set at 126 o C for 20
min.
3 Ultra violet
radiation
Steristorm UV light cabinet set at 255 nm wavelength of
radiation.
4 Bunsen burner Various Portable flame burner used for heat sterilisation
of mainly metallic instruments, such as forceps,
scalpels.
Table 9-9 Volume of medium used per surface area of culture vessel
Cell culture vessel Surface area
of culture
substrate
(cm2)
Volume of liquid
(ml)
Large culture flask T150 150 25
Medium culture flask T75 75 10
Small culture flask T25 25 5
6-well multiwall treated plate 9.6 3
24-well multiwall treated plate 1.96 1
96-well multiwall treated plate 0.3 0.2
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9.4 Appendix IV: Taqman probes for osteogenic markers
Table 9-10 List of genes examined in hMSC responses to Ti surfaces
Category Genes Information Probe serial number
Transcription
factors
Runx2 Master osteogenic regulator Hs01047975_m1
Extracellular
Matrix
components
OP,
BSP2
Col1a1
ALP
Bone matrix component protein
Bone matrix component protein
Primary organic phase of bone
inorganic phosphate synthesis by
cleavage from pyrophosphate
Hs00959010_m1
Hs00913377_m1
Hs00164004_m1
Hs01029144_m1
Secreted
osteogenic
regulators
Wnt5a
OC/BGLAP
OPG, GDF-15
TGF-b1
Regulation of BMP expression
Calcium binding molecule
Negative regulators of
osteoclastogenesis
Regulator of osteoblastic differentiation
Hs00998537_m1
Hs01587814_g1
Hs00900358_m1;
Hs00171132_m1
Hs00998133_m1
Cell surface
integrins
Adipogenic
marker
ITGα2, ITGβ1 
PPARγ 
Implicated Ti-specific cell surface
regulators of cell function
Nuclear protein, important for
adipogenic differentiation
Hs00158127_m1
Hs00559595_m1
Hs01115513_m
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9.5 Appendix V: Stem cell gene array
Four sets of genes were represented on the AppliedBiosystems Human Pluripotency Microfluidic
miniarrays. The details of the genes and their functions are tabulated in tables 9-11, 9-12, 9-13 and
9-14 for controls, maintenance of stem cellness, pluritpotency and differentiation genes,
respectively.
These tables consist of five columns; entitled gene symbol, description, molecule type, process and
gene function. The first and second columns provide information re: gene identity. The third is the
designate of molecule type, extracted from the PANTHER Classification System (Protein ANalysis
Through Evolutionary Relationships)(PANTHER, 2011). The process column states the biological
processes the gene is suggested to be involved in, and these were derived from the Gene Ontology
project (Gene Ontology Project, 2011; PANTHER, 2011) . The presented processes represent the
significance of gene function in the context of stem cell differentiation. Biological descriptions are
derived from NCBI (Online Mendelian Inheritance in Man, 2011) or Gene Cards v 3 (Gene Cards,
2011). These descriptions do not represent the entire repertoire of possible functions of the genes,
but those that are observably significant to stem cell biology. These reference databases were
accessed April, 2011.
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Table 9-11 Miniarray: control genes
Molecule type obtained from (PANTHER, 2011). Process obtained from (Gene Ontology Project, 2011). Gene function obtained
from NCBI (Online Mendelian Inheritance in Man, 2011).
Gene symbol Description Molecule type Process Gene function
18S Ribosomal RNA ribozyme translation Part of the small ribosomal subunit. Aides in catalyzing amino acid transfer from
tRNAs
ACTB actin, beta cytoskeletal protein cytoskeletal a non-muscle cytoskeletal actin; major constituent of the contractile apparatus
CTNNB1 beta catennin cell adhesion
molecule
cell fate specification Involved in the regulation of cell adhesion and canonical Wnt signalling pathway
EEF1A1 eukaryotic translation
elongation factor 1 alpha 1
translation
elongation factor
activity
protein biosynthesis an isoform of the alpha subunit of the elongation factor-1 complex, which is
responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome
GAPD glyceraldehyde-3-
phosphate dehydrogenase
dehydrogenase carbohydrate
metabolism
catalyzes the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in
the presence of inorganic phosphate and nicotinamide adenine dinucleotide
RAF1 murine leukemia viral
oncogene homolog 1
Non-receptor
serine/threonine
protein kinase
activation of MAPKK
activity ; signal
transduction
transduction of mitogenic signals from the cell membrane to the nucleus
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Table 9-12 Miniarray: maintenance of stem cell genes
Gene
symbol
Description Molecule type Process Gene function
NANOG Homeobox transcription
factor Nanog
Transcription factor Regulation of somatic stem
cell maintenance; embryonic
development
transcription regulator influencing embryonic stem cells proliferation and self-
renewal. Imposes pluripotency on ES cells by preventing differentiation.
Overexpression increases proliferation
POU5F1 POU class 5 homeobox 1 Transcription factor cardiac cell fate
determination; somatic stem
cell maintenance;
morphogenesis
translocation of this gene with the Ewing's sarcoma gene has been linked to tumor
formation
TDGF1 teratocarcinoma-derived
growth factor 1
Growth factor cardiac muscle cell
differentiation
an extracellular, membrane-bound signaling protein that plays an essential role in
embryonic development and tumor growth. Mutations in this gene are associated
with forebrain defects
DNMT3B DNA (cytosine-5-)-
methyltransferase 3, beta
DNA
methyltransferase
positive regulation of neuron
differentiation
essential for the establishment of DNA methylation patterns during development
GABRB3 gamma-aminobutyric acid
(GABA) A receptor, beta 3
ligand-gated ion
channel
signal transduction ; synaptic
transmission
is one of at least 13 distinct subunits of a multisubunit chloride ion channel that
serves as the receptor for gamma-aminobutyric acid, the major inhibitory
transmitter of the nervous system
GDF3 Growth differentiation factor
type 3
cytokine growth regulator of cell growth and differentiation in both embryonic and adult tissues
Sox2 SRY (sex determining
region Y)-box 2
transcription factor negative regulator of
osteoblast differentiation ;
positive regulation of
neuroblast proliferation
is required for stem-cell maintenance in the central nervous system
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Table 9-13 Correlation with stemness genes
Gene
symbol
Description Molecule type Process Gene function
BRIX biogenesis of
ribosomes, homolog
Ribosomal protein ribosome and protein
biogenesis
Required for biogenesis of the 60S ribosomal subunit
CD9 Cell surface
glycoprotein
Signal transduction; stem cell
maintenance
functions in many cellular processes including differentiation, adhesion, and signal
transduction
COMMD3 COMM domain
containing 3
unclear
CRABP2 cellular retinoic acid
binding protein 2
Transfer/carrier
protein
epidermis development ;
embryonic forelimb
morphogenesis
a cytosol-to-nuclear retinoic acid binding shuttling protein, which facilitates RA binding to its
cognate receptor complex
EBAF endometrial bleeding
associated factor
secreted member of the TGF-beta family of proteins; implicated in Left-Right axis formation
FGF4 fibroblast growth factor
4
Signaling molecule chondroblast differentiation suggested a function in bone morphogenesis and limb development through the sonic
hedgehog (SHH) signaling pathway
FGF5 fibroblast growth factor
5
Signaling molecule nervous system development involved in a variety of biological processes, including embryonic development, cell growth,
morphogenesis, tissue repair, tumor growth and invasion.
FOXD3 forkhead box D3 Transcription factor cartilage development ;
melanocyte differentiation ;
Required for maintenance of pluripotent cells in the pre-implantation and peri-implantation
stages of embryogenesis
GAL galanin prepropeptide Peptide hormone response to stress ; nervous
system development ;
modulating diverse physiologic functions; primarily as a neurotransmitter. It causes negative
regulation of lymphocyte proliferation
GBX2 gastrulation brain
homeobox 2
Transcription factor hindbrain development ;
autonomic nervous system
development
transcription factor for cell pluripotency and differentiation in the embryo
GRB7 growth factor receptor-
bound protein 7
Trans-membrane
receptor
signal transduction ;
epidermal growth factor
Interacts with the cytoplasmic domain of the epidermal growth factor receptor which is then
inhibited
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pathway
IFITM1 interferon induced
transmembrane protein
1
receptor signaling
protein activity
negative regulation of cell
proliferation ; response to
biotic stimulus
Implicated in the control of cell growth. Component of a multimeric complex involved in the
transduction of anti-proliferative and homotypic adhesion signals
IFITM2 interferon induced
transmembrane protein
2
Miscellaneous
function
immune response ; response
to biotic stimulus
IFN-induced antiviral protein that mediates cellular innate immunity; Induces cell cycle arrest
and mediates apoptosis by caspase activation and in p53-independent manner
IL6ST interleukin 6 signal
transducer
Cytokine receptor positive regulation of cell
proliferation ; positive
regulation of osteoblast
differentiation
a signal transducer shared by many cytokines; Knockout studies in mice suggest that this
gene plays a critical role in regulating myocyte apoptosis
IMP2 IMP2 inner
mitochondrial
membrane peptidase-
like
catalytic subunits of the IMP complex; complex generates mature, active proteins in the
mitochondrial intermembrane space
KIT v-kit Hardy-Zuckerman
4 feline sarcoma viral
oncogene homolog
Tyrosine protein
kinase receptor
lymphoid progenitor cell
differentiation ; hemopoiesis
; somatic stem cell
maintenance; germ cell
programmed cell death
This gene encodes the human homolog of the proto-oncogene c-kit. Mutations in this gene
are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous
lukemia, and piebaldism.
LEFTB left-right determination
factor 1
Signaling molecule development ; somatic stem
cell division ; positive
regulation of long-term
neuronal synaptic plasticity
This gene encodes a member of the TGF-beta family of proteins. A similar secreted protein
in mouse plays a role in left-right asymmetry determination of organ systems during
development.
LIFR leukemia inhibitory
factor receptor alpha
Cytokine receptor organ regeneration This protein combines with a high-affinity converter subunit, gp130, to form a receptor
complex that mediates the action of the leukemia inhibitory factor, a polyfunctional cytokine
that is involved in cellular differentiation, proliferation and survival in the adult and the
embryo. Mutations in this gene cause Schwartz-Jampel syndrome type 2, a disease
belonging to the group of the bent-bone dysplasias.
LIN28 lin-28 homolog A Nucleic acid
binding
stem cell maintenance ; stem
cell differentiation
Acts as a 'translational enhancer', driving specific mRNAs to polysomes and thus increasing
the efficiency of protein synthesis. Essential for skeletal muscle differentiation program
through the translational up-regulation of IGF2 expression.
9 Appendix Appendix V
227
NODAL nodal homolog Cytokine mesoderm formation ;
nervous system development
; stem cell maintenance ;
embryonic heart tube
development
protein encoded by this gene is a member of the TGF-beta superfamily. Studies of the
mouse counterpart suggested that this gene may be essential for mesoderm formation and
subsequent organization of axial structures in early embryonic development
NOG noggin Extracellular matrix
cytokine
embryonic development The secreted polypeptide binds and inactivates members of the transforming growth factor-
beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4. By
diffusing through extracellular matrices more efficiently than members of the TGF-beta
superfamily, this protein may have a principal role in creating morphogenic gradients.
NR5A2 nuclear receptor
subfamily 5, group A,
member 2
Nuclear hormone
receptor
embryonic development a critical cis-element of gene expression and regulation. May contribute to the regulation of
pancreas-specific genes and play important roles in embryonic development
NR6A1 nuclear receptor
subfamily 6, group A,
member 1
Nuclear hormone
receptor
gametogenesis ;
spermatogenesis
This gene encodes an orphan nuclear receptor which is a member of the nuclear hormone
receptor family. Its expression pattern suggests that it may be involved in neurogenesis and
germ cell development.
PODXL podocalyxin-like Extracellular matrix
glycoprotein
epithelial tube formation ;
negative regulation of cell
adhesion
biological activities include: binding in a membrane protein complex with Na+/H+ exchanger
regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell
differentiation, and being expressed in vascular endothelium cells.
PTEN phosphatase and tensin
homolog
Protein
phosphatase
central nervous system
development ; heart
development
is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain
as well as a catalytic domain similar to that of the dual specificity protein tyrosine
phosphatases. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-
trisphosphate in cells and functions as a tumor suppressor by negatively regulating
AKT/PKB signaling pathway.
REST RE1-silencing
transcription factor
transcriptional
repressor
negative regulation of neuron
differentiation
a transcriptional repressor that represses neuronal genes in non-neuronal tissues. The
protein is also found in undifferentiated neuronal progenitor cells and it is thought that this
repressor may act as a master negative regular of neurogenesis.
SEMA3A sema domain,
immunoglobulin domain
(Ig), (semaphorin) 3A
Membrane-bound
signaling molecule
nervous system development This secreted protein can function as either a chemorepulsive agent, inhibiting axonal
outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both
cases, the protein is vital for normal neuronal pattern development.
SFRP2 secreted frizzled-related
protein 2
Signaling molecule positive regulation of fat cell
differentiation ; cartilage
development ; bone
morphogenesis
homologous to the putative Wnt-binding Frizzled proteins. SFRPs act as soluble modulators
of Wnt signaling.
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TERT telomerase reverse
transcriptase
Reverse
transcriptase
telomere maintenance ;
replicative senescence
Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of
the telomere repeat TTAGGG.
TFCP2L1 transcription factor CP2-
like 1
Transcription factor epithelial cell morphogenesis Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation.
Modulates the placental expression of CYP11A1
UTF1 undifferentiated
embryonic cell
transcription factor 1
Transcription factor male gonad development Acts as a transcriptional coactivator of ATF2. Implicated in embryonic stem cell
maintenance.
Xist X (inactive)-specific
transcript (non-protein
coding)
The XIST gene is expressed exclusively from the XIC of the inactive X chromosome. The
transcript is spliced but apparently does not encode a protein. The transcript remains in the
nucleus where it coats the inactive X chromosome.
ZFP42 zinc finger protein 42
homolog (mouse)
Transcription factor meiosis
male gonad development
Involved in self-renewal property of ES cells
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Table 9-14 Differentiation genes
ACTC actin, alpha, cardiac muscle
1
Cytoskeletal
protein
cardiac myofibril assembly;
cardiac muscle
morphogensis
one of three main groups of actin isoforms, alpha, beta, and gamma. The alpha actins
are found in muscle tissues and are a major constituent of the contractile apparatus.
AFP alpha-fetoprotein metal ion binding sexual reproduction;
pancreas development;
organ regeneration
The protein is thought to be the fetal counterpart of serum albumin, and the alpha-
fetoprotein and albumin genes are present in tandem in the same transcriptional
orientation on chromosome 4.
CD34 CD 34 molecule Cell surface regulation of immune
response; immune cell
migration
CD34 is a monomeric cell surface antigen with a molecular mass of approximately 110
kD that is selectively expressed on human hematopoietic progenitor cells
CDH5 cadherin 5, type 2 (vascular
endothelium)
Cell surface Cell adhesion molecule;
negative regulation of cell
proliferation
encoded protein is a calcium-dependent cell-cell adhesion glycoprotein comprised of
five extracellular cadherin repeats, a transmembrane region and a highly conserved
cytoplasmic tail. Functioning as cadherin by imparting to cells homophilic bindings, may
play an important role in endothelial cell biology through control of the cohesion and
organization of the intercellular junctions.
CDX2 caudal type homeobox 2 transcription factor blood vessel development;
blastocyst development;
trophectodermal cell
differentiation
The proteins LMX1 (MIM 600298) and CDX3 are homeodomain proteins that bind an
A/T-rich sequence in the insulin promoter and stimulate its transcription
CGB chorionic gonadotropin,
beta polypeptide
Peptide hormone female gamete generation CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to
synthesize the steroids that are essential for the maintenance of pregnancy.
COL1A1 collagen, type I, alpha 1 Extracellular matrix
structural protein
skeletal development; blood
vessel development;
osteoblast differentiation
Type I is a fibril-forming collagen found in most connective tissues and is abundant in
bone,
COL2A1 collagen, type II, alpha 1 Extracellular matrix
structural protein
skeletal development ;
cartilage condensation;
tissue homeostasis;
endochondral ossification;
chondrocyte differentiation
This gene encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in
cartilage
DDX4 DEAD (Asp-Glu-Ala-Asp)
box polypeptide 4
RNA helicase development ; sperm motility members of this family are believed to be involved in embryogenesis,
spermatogenesis, and cellular growth and division
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DES desmin Cytoskeletal
protein
muscle contraction;
cytoskeleton organization
and biogenesis
encodes a muscle-specific class III intermediate filament.
EOMES eomesodermin Transcription factor endoderm formation ;
mesoderm formation ; cell
differentiation involved in
embryonic placenta
development
gene disrupted in mice is shown to be essential during trophoblast development and
gastrulation
FLT1 fms-related tyrosine kinase
1
Protein kinase
receptor
sprouting angiogenesis ;
development ; pregnancy ;
cell differentiation
gene encodes a member of the vascular endothelial growth factor receptor (VEGFR)
family. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and
plays an important role in angiogenesis and vasculogenesis. Expression of this
receptor is found in vascular endothelial cells, placental trophoblast cells and
peripheral blood monocytes.
FN1 fibronectin 1 Cell adhesion
molecule
angiogenesis gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma,
and in a dimeric or multimeric form at the cell surface and in extracellular matrix;
involved in cell adhesion and migration processes including embryogenesis, wound
healing, blood coagulation, host defense, and metastasis.
FOXA2 forkhead box A2 Transcription factor embryonic development;;
lung development ; neuron
fate specification
gene encodes a member of the forkhead class of DNA-binding proteins. These
hepatocyte nuclear factors are transcriptional activators for liver-specific genes and
also interact with chromatin.
GATA4 GATA binding protein 4 Transcription factor positive regulation of
cardioblast differentiation
gene encodes a member of the GATA family of zinc-finger transcription factors; protein
is thought to regulate genes involved in embryogenesis and in myocardial
differentiation and function. Mutations in this gene have been associated with cardiac
septal defects
GATA6 GATA binding protein 6 Transcription factor endoderm development;
cardiac muscle cell
differentiation
Thought to be important for regulating terminal differentiation and/or proliferation
GCG glucagon Peptide hormone cell proliferation ; regulation
of insulin secretion
plays a key role in glucose metabolism and homeostasis; stimulates intestinal
growth and up-regulates villus height in the small intestine, concomitant with increased
crypt cell proliferation and decreased enterocyte apoptosis.
GCM1 glial cells missing homolog
1
Transcription factor cell differentiation involved in
embryonic placenta
development
Transcription factor that is necessary for placental development. Binds to the
trophoblast-specific element 2 (TSE2) of the aromatase gene enhancer
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GFAP glial fibrillary acidic protein Cytoskeletal
protein
structural constituent of
cytoskeleton
gene encodes one of the major intermediate filament proteins of mature astrocytes. It
is used as a marker to distinguish astrocytes from other glial cells
HBB hemoglobin, beta Transfer/carrier
protein
positive regulation of cell
death
Involved in oxygen transport from the lung to the various peripheral tissues
HBZ hemoglobin, zeta Transfer/carrier
protein
erythrocyte maturation The zeta chain is an alpha-type chain of mammalian embryonic hemoglobin,
synthesized primarily in the yolk sac
HLXB9 motor neuron and pancreas
homeobox 1
Transcription factor morphogenesis ; post-
embryonic development
Putative transcription factor involved in pancreas development and function
IAPP islet amyloid polypeptide Peptide hormone endocrine pancreas
development ; negative
regulation of bone resorption
can induce apoptotic cell-death in particular cultured cells, an effect that may be
relevant to the development of type II diabetes
INS insulin Peptide hormone carbohydrate metabolism ;
positive regulation of cell
proliferation
Insulin decreases blood glucose concentration.
IPF1 pancreatic and duodenal
homeobox 1
Transcription factor positive regulation of cell
proliferation ; organ
morphogenesis
The encoded nuclear protein is involved in the early development of the pancreas and
plays a major role in glucose-dependent regulation of insulin gene expression
ISL1 ISL LIM homeobox 1 Transcription factor generation of precursor
metabolites and energy
The encoded protein is central to the development of pancreatic cell lineages and may
also be required for motor neuron generation. Mutations in this gene have been
associated with maturity-onset diabetes of the young
KRT1 keratin 1 Structural protein epidermis development ;
regulation of angiogenesis
heterotypic keratin chains coexpressed during differentiation of simple and stratified
epithelial tissues. This type II cytokeratin is specifically expressed in the spinous and
granular layers of the epidermis
LAMA1 laminin, alpha 1 Extracellular matrix
linker protein
cell adhesion ; substrate
adhesion-dependent cell
spreading
laminin is thought to mediate the attachment, migration and organization of cells into
tissues during embryonic development by interacting with other extracellular matrix
components
LAMB1 laminin, beta 1 Extracellular matrix
linker protein
cell adhesion; substrate
adhesion-dependent cell
spreading ; odontogenesis ;
laminin is thought to mediate the attachment, migration and organization of cells into
tissues during embryonic development by interacting with other extracellular matrix
components
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LAMC1 laminin, gamma 1 Extracellular matrix
linker protein
protein complex assembly ;
cell adhesion ; extracellular
matrix disassembly ;
adhesion-dependent cell
spreading
Embryos of transgenic mice in which both alleles of the gamma 1 chain gene were
inactivated by homologous recombination, lacked basement membranes, indicating
that laminin, gamma 1 chain is necessary for laminin heterotrimer assembly.
MYF5 myogenic factor 5 Transcription factor muscle cell differentiation ;
muscle cell fate commitment
Involved in muscle differentiation (myogenic factor). Induces fibroblasts to differentiate
into myoblasts.
MYOD1 myogenic differentiation 1 Transcription factor muscle development ;
myoblast cell fate
determination
gene encodes a nuclear protein that belongs to the basic helix-loop-helix family of
transcription factors and the myogenic factors subfamily. It regulates muscle cell
differentiation by inducing cell cycle arrest, a prerequisite for myogenic initiation.
NES nestin Cytoskeletal
protein
It is expressed predominantly in stem cells of the central nervous system in the neural
tube. Upon terminal neural differentiation, nestin is downregulated and replaced by
neurofilaments
NEUROD1 neurogenic differentiation 1 Transcription factor positive regulation of neuron
differentiation ; neurogenesis
Differentiation factor required for dendrite morphogenesis and maintenance in the
cerebellar cortex.
NPPA natriuretic peptide A Peptide hormone negative regulation of cell
growth
Natriuretic peptides are implicated in the control of extracellular fluid volume and
electrolyte homeostasis. Mutations in this gene have been associated with atrial
fibrillation familial type 6
OLIG2 oligodendrocyte lineage
transcription factor 2
Transcription factor nervous system development The protein is an essential regulator of ventral neuroectodermal progenitor cell fate
PAX4 paired box 4 Transcription factor organ morphogenesis These genes play critical roles during fetal development and cancer growth. The paired
box 4 gene is involved in pancreatic islet development and mouse studies have
demonstrated a role for this gene in differentiation of insulin-producing beta cells
PAX6 paired box 6 Transcription factor central nervous system
development
known to bind DNA, and function as regulators of gene transcription. This gene is
expressed in the developing nervous system, and in developing eyes.
PECAM1 platelet/endothelial cell
adhesion molecule
Cell adhesion
molecule
cell recognition ; cell
adhesion
encoded protein is a member of the immunoglobulin superfamily and is likely involved
in leukocyte migration, angiogenesis, and integrin activation
PTF1A pancreas specific
transcription factor, 1a
Transcription factor embryonic development
tissue development
gene encodes a protein that is a component of the pancreas transcription factor 1
complex; and is known to have a role in mammalian pancreatic development.
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RUNX2 runt-related transcription
factor 2
Transcription factor skeletal development gene is a member of the RUNX family of transcription factors and encodes a nuclear
protein; protein is essential for osteoblastic differentiation
SERPINA1 serpin peptidase inhibitor,
clade A
Serine protease
inhibitor
response to organic cyclic
substance
protein encoded by this gene is secreted and is a serine protease inhibitor whose
targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen
activator.
SOX17 SRY (sex determining
region Y)-box 17
Transcription factor cardiac cell fate
determination
gene encodes a member of the SOX (SRY-related HMG-box) family of transcription
factors involved in the regulation of embryonic development and in the determination of
the cell fate
SST somatostatin Peptide hormone negative regulation of cell
proliferation
induction of apoptosis by
hormones
This hormone is an important regulator of the endocrine system through its interactions
with pituitary growth hormone, thyroid stimulating hormone, and most hormones of the
gastrointestinal tract. Somatostatin also affects rates of neurotransmission in the
central nervous system and proliferation of both normal and tumorigenic cells
SYCP3 synaptonemal complex
protein 3
DNA binding cell division encodes an essential structural component of the synaptonemal complex. This
complex is involved in synapsis, recombination and segregation of meiotic
chromosomes
SYP synaptophysin Membrane traffic
regulatory protein
regulation of long-term
neuronal synaptic plasticity ;
synaptic vesicle maturation
Synaptophysin (p38) is an integral membrane protein of small synaptic vesicles in brain
and endocrine cells
T T, brachyury homolog Transcription factor vasculogenesis
somitogenesis
neural plate morphogenesis
Encodes an embryonic nuclear transcription factor that binds to a specific DNA
element, the palindromic T-site. The protein is localized to notochord-derived cells
TAT tyrosine aminotransferase Synthase biosynthesis ;
response to organic cyclic
substance
encodes a mitochondrial protein tyrosine aminotransferase which is present in the liver
and catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate.
TH tyrosine hydroxylase Oxygenase heart development gene is involved in the conversion of tyrosine to dopamine.
WT1 Wilms tumor 1 Transcription factor heart development ;
vasculogenesis ; ureteric bud
development
Transcription factor that plays an important role in cellular development and cell
survival. Regulates the expression of numerous target genes, including EPO. Plays an
essential role for development of the urogenital system.
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9.6 Appendix VI: Specimen characterisation data sheets
The attached documents are of the pre-liminary characterizations of human mesenchymal stromal
cells, isolated from human bone marrow aspirates at Tulane University, New Orleans, USA. The
data sheets are for donors 7032, 7043 and 7081.
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9.8 Appendix VIII: Academic activities
9.8.1 Papers
The differential modulation of key bone matrix components by modified Ti surfaces. MR Khan, N
Donos, V Salih, PM Brett. Bone 2012; 50 (1): 1-8.
Deregulation of the Axl tyrosine kinase pathway in human mesenchymal stromal cell responses to
rough implant surfaces. MR Khan, N Donos, V Salih, PM Brett (submitted).
Differential attachment and morphology of human mesenchymal stromal cells to modified Titanium
surfaces. MR Khan, N Donos, V Salih, N Mordan, M Parkar, PM Brett (in preparation).
9.8.2 Presentations
Oral. Examining Axl receptor tyrosine kinase in cell osteogenic responses to modified surfaces.
European Calcified Tissue Society, Postgraduate course. Rome, Italy. 1-4 September, 2008.
Oral. Investigating the role of tyrosine kinase Axl in modulating Marrow Stromal Cell responses to
Rough Titanium Implant Surfaces. MPhil to PhD upgrade examination. UCL Eastman Dental
Institute, London, UK. 5 November, 2008.
Oral. Modulation of Tyrosine Kinase AXL in Marrow Stromal Cells by Rough Titanium Implant
Surfaces. Presentation to visiting team from Straumann AG (Switzerland). London, UK.15
December, 2008.
Oral. Accelerated osteogenic responses of human marrow stromal cells to modified Ti surfaces.
Biomaterials and tissue engineering Departmental Seminar. UCL Eastman Dental Institute, London,
UK. 8 July, 2009.
Oral. Tissue engineering and future therapeutics. Guest speaker at the surgeons club. Al Khobar,
Saudi Arabia. 9 September, 2009.
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Oral. Differential responses of cells to Ti implant surfaces. Presentation to visiting team from
Straumann AG (Switzerland). 13 October, 2009.
Poster. Novel assessment of mesenchymal stromal cells to modified implant surfaces. International
Association of Dental Research annual meeting. Barcelona, Spain. Date 14-17 July, 2010.
Candidate for Young Investigator Prize.
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Report for MPhil to PhD upgrade to Prof Mark Lewis and Dr Farlan Veraitch. 5 November, 2008 and
with modification on 5 May, 2009.
Study completion report for International Team for Implantology and Straumann AG.
Extended abstract for IADR 2010 Young Investigator Award.
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